var title_f7_17_7440="Complex pleural effusion";
var content_f7_17_7440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Complex pleural effusion on thoracic ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anterolateral view of a complex septate pleural effusion. This pattern may be found in complicated parapneumonic effusion, empyema or hemothorax. The arrow points to the heart which is seen in a short axis view (ie, cross-sectional or transverse) of the ventricle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7440=[""].join("\n");
var outline_f7_17_7440=null;
var title_f7_17_7441="Decremental response with RNS";
var content_f7_17_7441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F53515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F53515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Repetitive nerve stimulation: Decremental response",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 204px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Repetitive nerve stimulation at 3 Hz in a patient with myasthenia gravis. Stimulating the nerve at the wrist recording at the first dorsal interousseous. Maximal decrement is noted to the right of the trace.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Preston DC, Shapiro BE. Neuromuscular junction disorders. In: Electromyography and neuromuscular disorders: Clinical-electrophysiologic correlations, 2nd edition, Butterworth-Heinemann, 2005. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7441=[""].join("\n");
var outline_f7_17_7441=null;
var title_f7_17_7442="First pass RVG";
var content_f7_17_7442=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60808&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60808&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    First pass radioventriculogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immediately after the injection of the radionuclide, a flow study is obtained during the first transit of the agent through the central circulation, from the right side of the heart (frames 1 to 3), through the pulmonary circulation (frames 3 to 5), into the left side of the heart (frames 5 to 8) and then into the aorta (frame 8). Note the temporal separation of right (frame 3) and left (frame 7) ventricular phases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission by Gerson, MC. Cardiac Nuclear Medicine, 3rd ed, McGraw-Hill, New York 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7442=[""].join("\n");
var outline_f7_17_7442=null;
var title_f7_17_7443="Fibroid embolization 4b";
var content_f7_17_7443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Left uterine angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 492px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left uterine angiogram before uterine fibroid embolization demonstrates dilated branches of the left uterine artery supplying multiple hypervascular uterine fibroids (arrows) on the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7443=[""].join("\n");
var outline_f7_17_7443=null;
var title_f7_17_7444="Potassium phosphate and sodium phosphate: Drug information";
var content_f7_17_7444=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Potassium phosphate and sodium phosphate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?24/24/24964?source=see_link\">",
"    see \"Potassium phosphate and sodium phosphate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/3/37940?source=see_link\">",
"    see \"Potassium phosphate and sodium phosphate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F212118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      K-Phos&reg; MF;",
"     </li>",
"     <li>",
"      K-Phos&reg; Neutral;",
"     </li>",
"     <li>",
"      K-Phos&reg; No. 2;",
"     </li>",
"     <li>",
"      Phos-NaK;",
"     </li>",
"     <li>",
"      Phospha 250&trade; Neutral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F212132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Electrolyte Supplement, Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F212121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Phosphate supplement:",
"     </b>",
"     Oral: Elemental phosphorus 250-500 mg 4 times/day after meals and at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F212129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/3/37940?source=see_link\">",
"      see \"Potassium phosphate and sodium phosphate: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Phosphate supplement:",
"     </b>",
"     Oral: Children &ge;4 years: Elemental phosphorus 250 mg 4 times/day after meals and at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F212122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F212108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phos-NaK: Dibasic potassium phosphate, monobasic potassium phosphate, dibasic sodium phosphate, and monobasic sodium phosphate per packet (100s) [sugar free; equivalent to elemental phosphorus 250 mg (8 mmol), sodium 160 mg (6.9 mEq), and potassium 280 mg (7.1 mEq) per packet; fruit flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     K-Phos&reg; MF: Potassium acid phosphate 155 mg and sodium acid phosphate 350 mg [equivalent to elemental phosphorus 125.6 mg (4 mmol), sodium 67 mg (2.9 mEq), and potassium 44.5 mg (1.1 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     K-Phos&reg; Neutral: Monobasic potassium phosphate 155 mg, dibasic sodium phosphate 852 mg, and monobasic sodium phosphate 130 mg [equivalent to elemental phosphorus 250 mg (8 mmol), sodium 298 mg (13 mEq), and potassium 45 mg (1.1 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     K-Phos&reg; No. 2: Potassium acid phosphate 305 mg and sodium acid phosphate 700 mg [equivalent to elemental phosphorus 250 mg (8 mmol), sodium 134 mg (5.8 mEq), and potassium 88 mg (2.3 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phospha 250&trade; Neutral: Monobasic potassium phosphate 155 mg, dibasic sodium phosphate 852 mg, and monobasic sodium phosphate 130 mg [equivalent to elemental phosphorus 250 mg (8 mmol), sodium 298 mg (13 mEq), and potassium 45 mg (1.1 mEq)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F212095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F212110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with food to reduce risk of diarrhea.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder: Phos-NaK: Following dilution of powder, solution may be chilled to increase palatability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet: Should be taken with a full glass of water.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F212109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of conditions associated with excessive renal phosphate loss or inadequate GI absorption of phosphate; to acidify the urine to lower calcium concentrations; to increase the antibacterial activity of methenamine; reduce odor and rash caused by ammonia in urine",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F212139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       K-Phos&reg; Neutral may be confused with Neutra-Phos-K&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F212130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, arrhythmia, chest pain, edema, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Mental confusion, tetany (with large doses of phosphate), headache, dizziness, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperkalemia, alkalosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, stomach pain, flatulence, vomiting, throat pain, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urine output decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness, arthralgia, bone pain, paralysis, paresthesia, pain/weakness of extremities, muscle cramps",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Acute renal failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Thirst",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F212113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Addison's disease, hyperkalemia, hyperphosphatemia, infected urolithiasis or struvite stone formation, patients with severely impaired renal function",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F212098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac disease: Use with caution in patients with cardiac disease, including hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dehydration: Use with caution in patients with acute dehydration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypernatremia: Use with caution in patients with hypernatremia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Metabolic alkalosis: Use with caution in patients with metabolic alkalosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F212103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Potassium Salts may enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: Potassium Salts may enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: May enhance the hypocalcemic effect of Phosphate Supplements.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: May enhance the hyperkalemic effect of Potassium Salts. Management: This combination is contraindicated in patients receiving eplerenone for treatment of hypertension.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: Potassium Salts may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F212104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14287312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Refer to individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F14287314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14287313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F212115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken after meals. In addition to phosphate, products contain potassium and sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F212114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (Phos-NaK Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     280-160-250 mg (100): $38.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Neutra-Phos Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     278-164-250 mg/75 mL (67.5 g): $16.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (K-Phos No 2 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     305-700 mg (100): $31.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (K-Phos-Neutral Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     155-852-130 mg (100): $30.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Phospha 250 Neutral Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     155-852-130 mg (100): $24.35",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F212106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum potassium, sodium, calcium, phosphorus, and magnesium (to facilitate potassium repletion)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F13203126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Reference ranges may vary depending on the laboratory",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum potassium: 3.5-5.2 mEq/L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum phosphorus: Both low and high ends of the normal range are higher in children than in adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants: 4.5-7.5 mg/dL (1.45-2.42 mmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: ~4.0-6.0 mg/dL (1.29-1.94 mmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 2.5-4.5 mg/dL (0.81-1.45 mmol/L)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F212112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9800 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-AD1D6AEAC5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7444=[""].join("\n");
var outline_f7_17_7444=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212118\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212132\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212121\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212129\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212122\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212108\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212095\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212110\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212109\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212139\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212130\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212113\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212098\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299926\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212103\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212104\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287312\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287314\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287313\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212115\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212114\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212106\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13203126\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F212112\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9800\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9800|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?24/24/24964?source=related_link\">",
"      Potassium phosphate and sodium phosphate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/3/37940?source=related_link\">",
"      Potassium phosphate and sodium phosphate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_17_7445="Butalbital, acetaminophen, and caffeine: Patient drug information";
var content_f7_17_7445=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Butalbital, acetaminophen, and caffeine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/21/38231?source=see_link\">",
"     see \"Butalbital, acetaminophen, and caffeine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alagesic LQ;",
"     </li>",
"     <li>",
"      Anolor 300;",
"     </li>",
"     <li>",
"      Dolgic&reg; Plus;",
"     </li>",
"     <li>",
"      Esgic-Plus&trade;;",
"     </li>",
"     <li>",
"      Esgic&reg;;",
"     </li>",
"     <li>",
"      Fioricet&reg;;",
"     </li>",
"     <li>",
"      Margesic;",
"     </li>",
"     <li>",
"      Orbivan&trade;;",
"     </li>",
"     <li>",
"      Repan&reg;;",
"     </li>",
"     <li>",
"      Zebutal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3491790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Acetaminophen may cause very bad liver problems. Your risk is higher if you take more than 4 grams of acetaminophen a day, drink beer, wine, or mixed drinks, or have liver disease. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026765\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat tension headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to butalbital, acetaminophen, caffeine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Liver disease or porphyria.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are addicted to drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink beer, wine, or mixed drinks or take any drugs that have alcohol.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid other sources of acetaminophen. An overdose may cause problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you use other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more than what your doctor told you to take. Liver problems may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698544",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a diary of your headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11551 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-15E18CE5C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7445=[""].join("\n");
var outline_f7_17_7445=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143648\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026763\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026765\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026764\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026769\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026770\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026772\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026767\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026768\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026773\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026774\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/21/38231?source=related_link\">",
"      Butalbital, acetaminophen, and caffeine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_17_7446="Platelet interactions";
var content_f7_17_7446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    The platelet and its interactions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 542px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic drawing of the platelet (top figure), showing its alpha and dense granules and canalicular system. The bottom figure illustrates the platelet's major functions, including secretion of stored products, as well as its attachment, via specific surface glycoproteins (GP), to denuded epithelium (bottom) and other platelets (left).",
"    <div class=\"footnotes\">",
"     VWF: von Willebrand factor; TSP: thrombospondin; PF4: platelet factor 4; PDGF: platelet derived growth factor; &beta;-TG: beta thromboglobulin; ADP: adenosine diphosphate; ATP: adenosine triphosphate.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Coutre, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7446=[""].join("\n");
var outline_f7_17_7446=null;
var title_f7_17_7447="Congenital melanocytic nevi and speckled lentiginous nevi";
var content_f7_17_7447=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital melanocytic nevi and speckled lentiginous nevi",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Julie V Schaffer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Jean L Bolognia, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Hensin Tsao, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7447/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/17/7447/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanocytic nevi (moles) represent benign proliferations of a type of melanocyte known as a \"nevus cell\". The two major differences between ordinary melanocytes that reside in the basal layer of the epidermis and nevus cells are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nevus cells cluster as nests within the lower epidermis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dermis, whereas epidermal melanocytes are evenly dispersed as single units.",
"     </li>",
"     <li>",
"      Nevus cells do not have dendritic processes (with the exception of those within blue nevi).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both melanocytes and nevus cells are capable of producing the pigment melanin. Melanocytic nevi can be congenital or acquired. Congenital melanocytic nevi (CMN) are classically defined as melanocytic nevi present at birth or within the first few months of life. CMN and speckled lentiginous nevi (a subtype of CMN) will be discussed below. Acquired melanocytic nevi and other benign pigmented skin lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=see_link\">",
"     \"Acquired melanocytic nevi (moles)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/17/43287?source=see_link\">",
"     \"Benign pigmented skin lesions other than melanocytic nevi (moles)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital melanocytic nevi (CMN) are proliferations of benign melanocytes that arise during embryogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Congenital nevi tend to extend deeper into the dermis and subcutaneous tissues than acquired nevi. Melanocytes in congenital nevi more often track along hair follicles and neurovascular structures or locate between collagen bundles in a single-file array [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In prospective studies of neonates, 1 to 3 percent had pigmented lesions that were clinically compatible with a diagnosis of CMN [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/4\">",
"     4",
"    </a>",
"    ]. Large or giant CMN occur in approximately 1 of 20,000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMN are classically defined as melanocytic nevi present at birth or within the first few months of life. Small melanocytic nevi that become apparent during early childhood (especially between three months and two years of age) often have clinical and histologic features identical to those of \"true\" CMN and have been referred to as \"tardive CMN\", \"early-onset nevi\", and \"congenital nevus-like nevi\" [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lesions are categorized on the basis of final size into three major groups [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Small &minus; &lt;1.5 cm (",
"      <a class=\"graphic graphic_picture graphicRef74734 \" href=\"UTD.htm?34/36/35392\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Medium-sized &minus; 1.5 to 20 cm (",
"      <a class=\"graphic graphic_picture graphicRef62970 \" href=\"UTD.htm?18/8/18562\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Large or giant &minus; &gt;20 cm or &gt;40 cm, respectively (",
"      <a class=\"graphic graphic_picture graphicRef50057 \" href=\"UTD.htm?4/37/4693\">",
"       picture 3",
"      </a>",
"      ); in a neonate, large CMN are &gt;9 cm on the head or &gt;6 cm on the body",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CMN are usually small or medium sized and solitary and may occur in any cutaneous location. The color of CMN ranges from tan to black, and the borders are often geographic and irregular. Many, but not all, CMN have an increased density of dark, coarse (terminal) hairs.",
"   </p>",
"   <p>",
"    Because of their distribution, giant CMN are sometimes referred to as \"garment\" or \"bathing trunk\" nevi; in addition, they are frequently accompanied by multiple smaller, widely disseminated \"satellite\" nevi (",
"    <a class=\"graphic graphic_picture graphicRef50057 \" href=\"UTD.htm?4/37/4693\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMN enlarge in proportion to the child's growth, with estimated factors for increase in size from infancy to adulthood as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Head &minus; 1.7-fold",
"     </li>",
"     <li>",
"      Trunk and upper extremities &minus; 2.8-fold",
"     </li>",
"     <li>",
"      Lower extremities &minus; 3.4-fold",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to increasing in size, CMN undergo other age-related changes in appearance. They often begin as flat, evenly pigmented patches that later become elevated with a pebbly (",
"    <a class=\"graphic graphic_picture graphicRef62970 \" href=\"UTD.htm?18/8/18562\">",
"     picture 2",
"    </a>",
"    ), verrucous, or cerebriform surface and darker, lighter, mottled, or speckled pigmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/9\">",
"     9",
"    </a>",
"    ]. CMN located on the scalp may have a particular tendency to gradually lighten and regress over time [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Superimposed papules and nodules can also develop, which, depending upon their clinical characteristics (eg, rapid growth, black or red color, ulceration), may require histologic examination to exclude the development of a cutaneous melanoma. Of note, during the neonatal period, transient erosions or ulcerations may arise secondary to increased skin fragility. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Melanoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk for the development of melanoma within small- and medium-sized CMN is controversial and is thought to be less than 1 percent over a lifetime. Melanomas most often occur after puberty and tend to arise at the dermal-epidermal junction, in contrast to the earlier onset and deeper origin of many melanomas arising within large CMN.",
"   </p>",
"   <p>",
"    For patients with large CMN, the risk of developing melanoma (cutaneous or extracutaneous) is estimated to be approximately 5 percent over a lifetime, with approximately one-half of this risk during the first five years of life (ie, one-half of the melanomas that develop do so by three to five years of age) (",
"    <a class=\"graphic graphic_table graphicRef66620 \" href=\"UTD.htm?19/10/19629\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cutaneous melanomas can arise subepidermally, making early recognition difficult. In some patients, the site of the primary melanoma is the CNS or retroperitoneum, whereas others have no identifiable primary site. Patients with a \"giant\" (&gt;40 cm) CMN in a posterior axial location that is associated with numerous satellite nevi have the greatest risk of developing melanoma. Melanomas less often arise within nevi restricted to the head or an extremity; to date, no well-documented primary cutaneous melanomas have been reported to develop within the satellite nevi themselves. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/53/24410?source=see_link\">",
"     \"Risk factors for the development of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neurocutaneous melanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CMN may develop neurocutaneous melanosis (or melanocytosis, NCM), a proliferation of melanocytes in the central nervous system (CNS), as well as the skin. NCM encompasses both leptomeningeal melanosis and CNS melanosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for NCM include [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A large CMN, especially if &gt;40 cm final size and in a posterior axial location",
"     </li>",
"     <li>",
"      Multiple satellite nevi",
"     </li>",
"     <li>",
"      More than two medium-sized CMN (especially if numerous)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of patients with large CMN, 26 of 379 (7 percent) of whom had been diagnosed with NCM, those with &gt;20 satellites had a fivefold increased risk for NCM compared to those with &le;20 satellites [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/16\">",
"     16",
"    </a>",
"    ]. NCM can also develop in patients with nevus of Ota. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/17/43287?source=see_link&amp;anchor=H16#H16\">",
"     \"Benign pigmented skin lesions other than melanocytic nevi (moles)\", section on 'Nevus of Ota'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Structural abnormalities of the CNS (eg, Dandy-Walker",
"    <span class=\"nowrap\">",
"     malformation/posterior",
"    </span>",
"    fossa cysts), defects of the vertebrae or skull, and intraspinal lipomas occasionally occur in association with NCM [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=see_link&amp;anchor=H9#H9\">",
"     \"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly\", section on 'Dandy-Walker malformation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NCM is best detected by magnetic resonance imaging (MRI) with gadolinium, and it is divided into symptomatic and asymptomatic forms. Symptomatic NCM develops in approximately 3 to 10 percent of infants and children with high-risk CMN [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/14\">",
"     14",
"    </a>",
"    ]. Neurologic manifestations (eg, hydrocephalus, seizures) may result from intracranial hemorrhage, impaired cerebrospinal fluid circulation, spinal cord compression, or malignant transformation of the melanocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/1,18\">",
"     1,18",
"    </a>",
"    ]. Clinical presentation occurs at a median age of two years and prognosis is classically poor even in the absence of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/19\">",
"     19",
"    </a>",
"    ]. Developmental delay",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    seizures have been reported in up to 15 to 25 percent of children with large or multiple CMN (some of whom did not have MRI evidence of NCM), with more favorable overall outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/14,17,20\">",
"     14,17,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Asymptomatic NCM, diagnosed on the basis of MRI evidence of CNS melanosis, is found in five to 25 percent of infants and children with high-risk CMN [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/2,21\">",
"     2,21",
"    </a>",
"    ]. In one five-year follow-up study, only 1 of 10 patients with MRI findings suggestive of CNS melanosis went on to develop neurologic symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other malignancies such as rhabdomyosarcoma, liposarcoma, and malignant peripheral nerve sheath tumors have been reported in the setting of large CMN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with large or giant CMN should be referred to a dermatologist. A dermatologist also should be consulted for those with small- or medium-sized CMN when concerning changes arise or surgical excision is considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Small/medium CMN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small- and medium-sized CMN are managed on an individual basis depending on factors that affect ease of monitoring (eg, color,",
"    <span class=\"nowrap\">",
"     thickness/topography,",
"    </span>",
"    and location), clinical history, parents' anxiety, and cosmetic concerns [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, a multinodular black CMN on the scalp that is partially obscured by dense hair growth would be difficult to follow clinically, whereas a thin light brown lesion on the face would be relatively simple to observe. However, the last might be removed for cosmetic reasons, and the former may spontaneously lighten during childhood.",
"   </p>",
"   <p>",
"    Periodic evaluation of small- and medium-sized CMN is most important after puberty, since the risk of melanoma arising within these lesions during childhood is extremely low. Patients and parents should be instructed to perform self-skin examinations and to bring focal",
"    <em>",
"    </em>",
"    changes in color, border, or topography (eg, a red or black papule) to the clinician&rsquo;s attention. Baseline photographs can be helpful, and dermatoscopy represents a useful tool for assessing changes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link&amp;anchor=H1155400#H1155400\">",
"     \"Screening and early detection of melanoma\", section on 'Self-examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/57/38807?source=see_link\">",
"     \"Overview of dermoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/11/13497?source=see_link\">",
"     \"Dermoscopic evaluation of skin lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Large CMN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early surgical removal is often desired for large CMN because of their cosmetic and psychosocial sequelae as well as the potential for malignant transformation. However, complete excision is difficult to achieve, and resection of bulky and cumbersome portions of large CMN can also be beneficial.",
"   </p>",
"   <p>",
"    Factors that affect the decision to perform and timing of surgery include the size and location of the CMN, the technical difficulty of the procedure(s) required, and anesthesia options.",
"   </p>",
"   <p>",
"    Complete removal of large CMN usually necessitates staged excision with the use of tissue expanders and, occasionally, skin grafting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/22\">",
"     22",
"    </a>",
"    ]. Elimination of every nevus cell may be impossible because of the large area of skin affected, the anatomic site (eg, distal extremity, periocular area, genitalia), and involvement of deeper structures (eg, fat, fascia, muscle).",
"   </p>",
"   <p>",
"    When surgical excision is not feasible, cosmetic benefit may potentially be obtained from procedures such as curettage, dermabrasion, and ablative laser therapy (eg, carbon dioxide or erbium:YAG, sometimes combined with pigment-directed lasers). During the neonatal period, there is a lower risk of excessive scarring following such interventions, and nevus cells are more accessible because they are concentrated in the upper dermis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Curettage can be performed during the first two weeks of life, taking advantage of a cleavage plane between the upper and mid-dermis exclusive to neonatal skin. However, nevus cells remain in the dermis after all of these procedures, as evidenced by frequent repigmentation as well as several reports of the subsequent development of melanoma in treated areas [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. This underscores the need for lifelong clinical observation.",
"   </p>",
"   <p>",
"    Regardless of the treatments employed, patients with large CMN (or scars after their excision) should be followed with periodic skin and general physical examinations. Palpation of the nevus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    scars is essential for detection of focal induration. Histologic evaluation is indicated for firm nodules or areas with other suspicious changes, as described above. Even theoretically complete removal of a large CMN does not eliminate the risk of melanoma, since melanoma of the CNS and other visceral primary sites (eg, the retroperitoneum) may still occur [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Proliferative nodules that develop within large CMN during infancy can have histologic features of melanoma yet behave in a benign manner (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Melanoma'",
"    </a>",
"    above). Techniques such as comparative genomic hybridization can help to distinguish proliferative nodules (usually having no chromosomal aberrations or only numeric changes) from melanoma (typically demonstrating",
"    <span class=\"nowrap\">",
"     gains/losses",
"    </span>",
"    of chromosomal fragments) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Surveillance for neurocutaneous melanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a large CMN plus multiple (especially &gt;20) satellite nevi or with multiple medium-sized CMN, are at risk for NCM and should be followed with serial neurologic examinations and developmental assessments [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. This monitoring includes evaluation for signs and symptoms of increased intracranial pressure, mass lesions, and spinal cord compression [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/1,16\">",
"     1,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest that these high-risk patients also be screened for NCM with gadolinium-enhanced MRI of the brain (and spine if the nevus overlies the posterior axis), ideally during the first six months of life before myelination that may obscure evidence of melanosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/19\">",
"     19",
"    </a>",
"    ]. Although administration of gadolinium-containing MRI contrast agents should be avoided in patients with severely impaired renal function because of the risk of nephrogenic systemic fibrosis, severely impaired renal function is unusual in infants (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    ). That said, urogenital structural abnormalities can occasionally be seen in association with large or giant congenital nevi.",
"   </p>",
"   <p>",
"    Patients with abnormal clinical or MRI findings can be referred to a pediatric neurologist for further monitoring. If NCM is detected, repeat MRIs should be performed, with the frequency guided by the degree of involvement and clinical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aggressive surgical procedures for removal of the CMN should be postponed in patients with symptomatic NCM. NCM in an asymptomatic patient does not necessarily preclude skin surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SPECKLED LENTIGINOUS NEVI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several lines of evidence suggest that speckled lentiginous nevi (SLN, nevus spilus), which have a prevalence of approximately 2 percent, represent a subtype of CMN [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/31\">",
"     31",
"    </a>",
"    ]. Some SLN have patterns of distribution reflecting embryonic development, eg, block-like with a sharp demarcation at the midline or following the lines of Blaschko.",
"   </p>",
"   <p>",
"    The \"background\" tan patch (caf&eacute;-au-lait macule-like) of a SLN is usually noted at birth or soon after, with \"spots\" appearing over time (",
"    <a class=\"graphic graphic_picture graphicRef64780 \" href=\"UTD.htm?35/43/36532\">",
"     picture 4",
"    </a>",
"    ). The superimposed pigmented macules and papules can range from lentigines to junctional, compound, and intradermal nevi to Spitz and blue nevi. There are two distinct subtypes of SLN: those with only macular speckles and those with papular as well as macular speckles [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7447/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of developing melanoma in SLN is thought to be similar to classic CMN of the same size range. SLN should therefore be followed clinically with periodic examinations and biopsy of suspicious areas. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Management'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/53/24410?source=see_link&amp;anchor=H15#H15\">",
"     \"Risk factors for the development of melanoma\", section on 'Congenital nevi'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital melanocytic nevi (CMN) occur in 1 to 3 percent of newborn infants; large or giant CMN occur in approximately 1 of 20,000 births. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The color of CMN ranges from tan to black, and the borders often are geographic and irregular. Many CMN have an increased density of dark, coarse hairs (",
"      <a class=\"graphic graphic_picture graphicRef50057 \" href=\"UTD.htm?4/37/4693\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Giant CMN are sometimes referred to as \"garment\" or \"bathing trunk\" nevi and are frequently accompanied by multiple smaller, widely disseminated \"satellite\" nevi (",
"      <a class=\"graphic graphic_picture graphicRef50057 \" href=\"UTD.htm?4/37/4693\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CMN enlarge in proportion to the child's growth and undergo other age-related changes in pigmentation or surface characteristics. Superimposed papules and nodules can develop, which occasionally require histologic examination to exclude the development of a cutaneous melanoma. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of melanoma developing within a CMN is correlated with the size of the nevus (",
"      <a class=\"graphic graphic_table graphicRef66620 \" href=\"UTD.htm?19/10/19629\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Melanoma'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/53/24410?source=see_link&amp;anchor=H15#H15\">",
"       \"Risk factors for the development of melanoma\", section on 'Congenital nevi'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with CMN may have proliferation of melanocytes in the central nervous system as well as the skin (neurocutaneous melanosis, NCM). Patients with either a large CMN accompanied by satellite nevi or numerous smaller CMN are at risk of NCM. NCM can be asymptomatic or present with neurologic symptoms such as hydrocephalus and seizures. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Neurocutaneous melanosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Small- and medium-sized CMN are managed on an individual basis depending upon ease of monitoring (eg, color and location), clinical history, parents' anxiety, and cosmetic concerns. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Small/medium CMN'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early surgical removal is often recommended for large CMN because of their cosmetic and psychosocial sequelae as well as the potential for malignant transformation. The timing of surgery and the surgical techniques are based upon size, location, and anesthesia options. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Large CMN'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that patients at risk of NCM be screened with gadolinium-enhanced magnetic resonance imaging of the brain and (especially if the nevus overlies the posterior axis) spine during the first six months of life (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Surveillance for neurocutaneous melanosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/1\">",
"      Tannous ZS, Mihm MC Jr, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol 2005; 52:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/2\">",
"      Price HN, Schaffer JV. Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies. Clin Dermatol 2010; 28:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/3\">",
"      Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, Oct. 24-26, 1983. J Am Acad Dermatol 1984; 10:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/4\">",
"      Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 2012; 161:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/5\">",
"      Castilla EE, da Gra&ccedil;a Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 1981; 104:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/6\">",
"      Makkar HS, Frieden IJ. Congenital melanocytic nevi: an update for the pediatrician. Curr Opin Pediatr 2002; 14:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/7\">",
"      Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979; 1:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/8\">",
"      Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 1996; 132:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/9\">",
"      Ruiz-Maldonado R, Tamayo L, Laterza AM, Dur&aacute;n C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr 1992; 120:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/10\">",
"      Strauss RM, Newton Bishop JA. Spontaneous involution of congenital melanocytic nevi of the scalp. J Am Acad Dermatol 2008; 58:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/11\">",
"      Watt AJ, Kotsis SV, Chung KC. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 2004; 113:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/12\">",
"      Foster RD, Williams ML, Barkovich AJ, et al. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 2001; 107:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/13\">",
"      DeDavid M, Orlow SJ, Provost N, et al. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 1996; 35:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/14\">",
"      Kinsler VA, Chong WK, Aylett SE, Atherton DJ. Complications of congenital melanocytic naevi in children: analysis of 16 years' experience and clinical practice. Br J Dermatol 2008; 159:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/15\">",
"      Lovett A, Maari C, Decarie JC, et al. Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center's experience. J Am Acad Dermatol 2009; 61:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/16\">",
"      Marghoob AA, Dusza S, Oliveria S, Halpern AC. Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 2004; 140:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/17\">",
"      Krengel S, Breuninger H, Beckwith M, Etchevers HC. Meeting report from the 2011 International Expert Meeting on Large Congenital Melanocytic Nevi and Neurocutaneous Melanocytosis, T&uuml;bingen. Pigment Cell Melanoma Res 2011; 24:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/18\">",
"      Di Rocco F, Sabatino G, Koutzoglou M, et al. Neurocutaneous melanosis. Childs Nerv Syst 2004; 20:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/19\">",
"      Schaffer JV, McNiff JM, Bolognia JL. Cerebral mass due to neurocutaneous melanosis: eight years later. Pediatr Dermatol 2001; 18:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/20\">",
"      Kinsler VA, Birley J, Atherton DJ. Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes. Br J Dermatol 2009; 160:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/21\">",
"      Agero AL, Benvenuto-Andrade C, Dusza SW, et al. Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of cases from an Internet-based registry. J Am Acad Dermatol 2005; 53:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/22\">",
"      Gosain AK, Santoro TD, Larson DL, Gingrass RP. Giant congenital nevi: a 20-year experience and an algorithm for their management. Plast Reconstr Surg 2001; 108:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/23\">",
"      De Raeve LE, Claes A, Ruiter DJ, et al. Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage. Br J Dermatol 2006; 154:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/24\">",
"      De Raeve LE, Roseeuw DI. Curettage of giant congenital melanocytic nevi in neonates: a decade later. Arch Dermatol 2002; 138:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/25\">",
"      Ostertag JU, Quaedvlieg PJ, Kerckhoffs FE, et al. Congenital naevi treated with erbium:YAG laser (Derma K) resurfacing in neonates: clinical results and review of the literature. Br J Dermatol 2006; 154:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/26\">",
"      Kishi K, Matsuda N, Kubota Y, et al. Rapid, severe repigmentation of congenital melanocytic naevi after curettage and dermabrasion: histological features. Br J Dermatol 2007; 156:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/27\">",
"      Sohn S, Kim S, Kang WH. Recurrent pigmented macules after q-switched alexandrite laser treatment of congenital melanocytic nevus. Dermatol Surg 2004; 30:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/28\">",
"      Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol 2005; 52:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/29\">",
"      Streams BN, Lio PA, Mihm MC, Sober AJ. A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal. J Am Acad Dermatol 2004; 50:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/30\">",
"      Rhodes AR, Wood WC, Sober AJ, Mihm MC Jr. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 1981; 67:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/31\">",
"      Schaffer JV, Orlow SJ, Lazova R, Bolognia JL. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol 2001; 137:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7447/abstract/32\">",
"      Happle R. Speckled lentiginous naevus: which of the two disorders do you mean? Clin Exp Dermatol 2009; 34:133.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4847 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7447=[""].join("\n");
var outline_f7_17_7447=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Melanoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neurocutaneous melanosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Small/medium CMN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Large CMN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Surveillance for neurocutaneous melanosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SPECKLED LENTIGINOUS NEVI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/4847\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4847|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/36/35392\" title=\"picture 1\">",
"      Small CMN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/8/18562\" title=\"picture 2\">",
"      Medium CMN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/37/4693\" title=\"picture 3\">",
"      Large CMN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/43/36532\" title=\"picture 4\">",
"      Speckled lentiginous nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4847|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/10/19629\" title=\"table 1\">",
"      Congen melanocytic nevi FAQ",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=related_link\">",
"      Acquired melanocytic nevi (moles)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/17/43287?source=related_link\">",
"      Benign pigmented skin lesions other than melanocytic nevi (moles)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/11/13497?source=related_link\">",
"      Dermoscopic evaluation of skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/57/38807?source=related_link\">",
"      Overview of dermoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=related_link\">",
"      Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/53/24410?source=related_link\">",
"      Risk factors for the development of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=related_link\">",
"      Screening and early detection of melanoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_17_7448="Pityriasis rosea with herald patch";
var content_f7_17_7448=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87126%7EDERM%2F87124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87126%7EDERM%2F87124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pityriasis rosea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and oval plaques are present on the trunk. A larger herald patch is on the right midback.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pityriasis rosea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oval, erythematous papules and small plaques are present on the abdomen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7448=[""].join("\n");
var outline_f7_17_7448=null;
var title_f7_17_7449="Toxic granulations";
var content_f7_17_7449=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1086px;\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Toxic granulations and D&ouml;hle bodies in infection/inflammation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 360px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFoAfADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6k6elNOGBBAKnsaANu7ljk5we3tQc9689uxoZ17aH70S5Xk8dRWbJvUkqCe3fj8K6Lp0pksCTgCRckd+hrzq2E5m5UnZ9un/AOmniOXSRzALSkrgtnoBzn/P9K2tMsxbrvlYBzzjOKrXd3Bbkx2y4xkFgOTWbJeNk5chfSuNSp4efNVd5LsdbjOtGy0R1Hnwn/lqn509CHAZGDL6g5rjXvZFOfMIB55789P8AP9Kkh1SWNgSMn1Xj2x9atZtTb9+DXpr/AJGbwEraM6XUU3Q7tvI4rJWTYwHXPTPetLT71bqDc3KHg7hjFQXdg4YtH869sdR/jRi4SlbE0PeT7bmdJ8j5JksFyNoyevNLPcDacdKy23xjIPTP+TnvTHZzk5471l9e900VBN3JLibfJgc81saYgW23d2/p7VnafZNP+8lOEzjPqK2lUIqqowoGAK6MDCUpOtLZ7f5mWInFLkQ6q9zeRwEr95/TPT60t5OtvCSzbSQefTHU1yk120p4JKk8Vri8asPaC+J/gTh8O6ur2Na51SQthGPIyFUYyPXNRDUpQfvPg/7f9azFYkdSe/405R2JbHYnqK8x42tJ352d6w8Iq1jobTUg2N+WX6cr+XUU+ewhm/eW7iPdydgBRvwrmw7xtlWIx6HitfSLs7wDwCQGGPvZ7/Wuyji4Ym1DExvfZ/1+aOerQdP36bHHSZc4BiYH6j9Kli0t/wDloyKPbmtNwSNvY9ecd6VtxUhTtbHBxnBrqjgKEXs/vOZ4io1uRwQRwLhByerHkmpGJwcYzR9aajeYuQCBkjBGOQcV2K0VaOxg7vViMxHSoxLg/jg1MRUEiEnr7ioc3EqNmWEYGn1UhbB2nPFWFJLHkYwMDH9fyreMlJXJlGw7vjB+tGMjBP5cUDjtS1SZIBgXKgjcACR6D/INMuxmBh64H15qQdRUV6AbWQMNykYI9R6VvH4WC+JGdnJ9aYFADA5ZWYnDnOPpnt7dBnin55HH5UzuP85rBnUZGo6WHG6IFvYdQfb2rJ8p4mx/tcEHP+e3FdWHAk2Z+bbuA2npnnnp3HHX8KZJFFLgvGr8DHHIHqPTrXJOkm7x0OmFdpWZzgvHjTkH6AdP88ce9Yd/cNKBls+o9812cmnQyMAo2rjnrkdx/XP4YrmtXslQ/KciNijLkcc9/Q8fkQa5K3MonVQqQcjEjQvkhSTn67u4rf0zSmnQ7coOMsBjA74PY4z/AJ5qlYR5lG7hgcnHYZ6V2Fm6LDsTAAwT2PtmsKUE9WXiarWiMjUNOWKM+SoztOA3OT7nr+VZUbCCUE5Y88t0P4ent0/nXWTqHU5A9a5jVV2Odm0Efoc06qt7yM6M+b3WbdqYr+DEgPmKvUHkj69TVF/DcKvObfYDLKZXDc/vCBuY+pbAJ554qHw5KfPjw52nKspGRyBgj0HGSO5Yn0rpixx/EccfjWkVGqryRlNypTtFnPDw5Hn5nVSc4wckn8vSr1vpEEORGSTnOWGWxnp/n9a0gc8DH4dOtNOSEIYgDk47+mT6d+2fp1r2UF0Jdab3ZzOpWyx3HDFsngnHPuavaWFVMRg59Cckc1R1rct0SQDk4Ixxnj9PrVjSJMEAkfnnPY1nFpScUdMrummbvOGAbaDkAgZI9DzwfXB4qRyCpUkjI/z/APqqIH3JIHJxj9KSVysbYK5xgE8genFdVzjsYWpAGfKjAJxxzitnRsiB+pwQCaxLyRWnwoPXpnt/nJresYwbRQ6g9cH0+np9faoj8Tsb1fgSZb7fjgYNHB9P8/8A6qaxIznrjmgtn6+ldCaOUfwPTPX1pAQAOAPQUA56dKr38nk2zuMf/Xp81hpXdjI1vWlgBRD/ALOcdT3/AM//AK65abXJZHyHYbDnAY57g5Hcc9+Oh64NUdcume4cbiQp6k/59azY2K4DDjHGRyO9cMq3tHfoe1Rw0YR2Opi1mQkhyCOT710Wl61vYKHLEn7knfnnB9a4GNvvDBznnJ7irttNtkXaAAemMD8vaiFZ03oxVMPCa2PRdQgjvLdpEJ5GM55B/wAa5xi0eDjtnII/H29/f9RsaBeiSHDMNuAcc8HpVm50WJyxgVVyc4AxnueOnOfz711yh7Re0h1POjP2LcJnSYAC44A6c01mVXVecse3bA6/SnmkOeg4Nbs8lDeCTxz61n63dGC22DGX+9zg49B61pL61zXimTeJITgqCob8exrhx1aVGg5R3dl9/wDwDpwsOeqkzGmuWZxgjk4AJwMf/qpjSrFEZJZAkYXJZjgKOueen9KrE5kCncSSTu7LxU0ZAZSDh85HYj3HoeTXzKke9ypImkbAIIBI65A4P8xVcsfm3DBGcnP+f8mnn2A2npn19f8A69NOSPX8Tms6k2xxViS1uHhnwHI3DkA5H0xXR6TquV8qT7wPRj1/wrlUX5gfbseB+Ppj/CpQXjmnYuFj4wu0gg85PXBHI4x2PXjG+ExdWg3KD7ejMa9CFVWZ3YhtrgeZsUk9fUfWj7Hbhs+UuawtBvmafYTyowQf4hXSdRkd6+hoSoYqHtowV+umz/rVHi1oToy5bhxgDoB2pRSfzpRXUnqc5h+JZTgxAkAIGIzjq2M/pXOxYBx1GOw610viCDe8bc/vF8v23A5H9a5lMq2ORz0Azz/n+VfMY1y+t1E/L7rI9vBW9lZGhAgIHzZAH14/z/nrUjoVzjAJHYUWrDAzyo68f54/OpLhgOuB161py+7zA2+axSkYZ4+UdBn9OatWPzSZXHPGKoSsd/f15+v+Navh5EkmTf1Unbg8N3/SpwydStGC6sqt7tNs6UEkAkYNIqhRxnpjkk0por6l7nhBznilFIOayru9d5HRTiIHA2nlhjqfxz0qKlWFFc0y4U3N2RptNEmQzjI61FJcx/LhxjPzfKTxjt+lZYDMB29vWmGN1bqceua5J46VtIm6oR7mupWVNyMCO49PrT42xxWRbzyQyptAIOdzMcce/wDL2rSR1kjWSP7vv1FdFCvGorx+aIqU3H0LY5qpcXyxuVQBsdTn6/4VX1C98krCm7e33iOcegPpn/61UQrSEYIK4x7jtRiMW4Pkp7jpULrmkXY72SS4iG48sAQOB1rSu/8AUN+H86y7aAidGwchgCcDkev069a1Lvi3fv0/nXVgpTlCTqMityqS5TNfg9frmo89+eBnjnNOA2gKOABtA9hTSRxgZ9h71bZaG89iR/SgckgqR0+bjB68f59qOuRnJHHHag9DnGMdqwkUJ1b9aq6lb/aICQNzKOmOoq0T9c96aDzxwP8APFYyV9Cotp3RxEqPbzdDtJyOn4/yrVsb3YArHgHGPU/5FaGp2CXKF04IGSABzXMzQyxMQBnsMAZP+fyrgadJ+R6EXGstdzelv0AZgBuwQeOSPT35P86wNTuN5bLDjPp+f86hZ5DgfNz2J6c9fX/JplvZy3UsYG4YJBGODu9vwBz6+xNROrzaI1hSjT1Zq+HELXKkjdzkj6ZrqMZYHAYjkZxwf6Vn6Vp4tEzIo8zhgOu3B/n0q/njkV00VyxscVaSnO6Ec/KduMgd+g+tGVwcHgccc0Z6ZBOPamdMH+vStLmdjK1+At86jrk5xnFY9nOYmHB64HpXVyxrMjK4z1xgdD6/r/kVhahpDqWeLJXsVwK56id+aJ10akeXkkWE1NdnGOPXj/P+NQ3N+ZMgAnBHB/z+FZv2O4GQoJHIz6c/5/Kr9jpk0rgyKy8ZO7n9e/6delONSUtLFuFOOtx2nW7z3C5zgde2BmulACYUcAcD2qCCFYY/LQDGO/epSRkHtyfpW8FY5Kk+dg4JAVc9/wDP8qUZOQBjPpR1HPb15pQBk9u/IGK1Mx2cqG5wR1POap64D9jJXs3PvVwAFunPc1HeKJLZlbODRJXVhxdpJnlV9GfOY5IYHjA6H1H86qrHx8vpkYb24xn1/p9a3NXgCXzsM7D83A9sc+np+VZyxHaCcnsK8iMuU+gUrxIY1II47Z+g/wAirUWCOM5zgknH4H3/AM+9KkRI+4RyOMcbv8/0qWKFsggnOMgkjOP6Vs3zEOSRp6TctbP8mTngjPUn/P6V3ml3AmhIyCV6H2rzqNsDjYEA5yO2P06iuz8OM2QDycEZyeRxj9c13YabT5WedjYJx5jraDUce/yk83YXH3ioIB9wO30/U04kV0nh2FXqOtcdrTE3Dv1Dnkfj/wDWrri2D6fhWFr9mfmkX7j9/wC6x/xrys2UnQvHVJ3fp3+X/BO3BSUamvU5gAuMxHPUEd/84pQS2RjvyB6896WeMBiTlJFP4/570habA3qkmBgMRivnFteLPcuKrcA7Qe/BBFL1wT83ofy/+vURZv7gPGTuAzj0/P8ADrUkYaSXaWwCecHHSs+e24MtRRHOTzI3IXJOP8/1qK6BT5c5O7H1/wA/0q3BMqqxVcBRgH/PaqcnztwMHv2rapFU4JLd6syg25aj9HcpexPnHBB/z+Vd4mfLXPoM1zGh6W0km+RSsAxnI+/7D8ua6gn8K9rJoTjRlOS0la3yvr8zy8wqRnNKPQO1KKSivWRwEV9brd2kkLcFh8reh7GuTvIGEjGVdsw+8OgY12WarX9qLqMYCbwf4uh9jXBmGC+sJVIfEvxXY6cNiPZOz2ORiLp0GcemKJ7kRwvJK2yNBvZpOAAOpPoOKxfFXirQPDXiO00bWLtbO8uYTMr7v3aDOAHb+HJBwTxxyfWG20m98VyRz39veW2gBg0FnIhD3hHIeUY4TgYQ4J6t/dry1Qqx/iJpej/Duej7em9U9S1oepf2ys1zDA8dhkfZ7hus47uq44XoAT97r0wT3Oh2ZhTz3wAwwiDsO5J9f8KgstIYEF1EaD8SR9OgrZ2qFVQMADA9q9LA4TkqOtONu1/z/rz2OPE4jmjyRdx9FNHpTu2K9ZHAVdRnMUQVeC/f0H+TWTGgaTt9Pf8AnWnqygwK3904/Os2Bxux1OenY15eLk3X5ZbLY7aC/d3RowQ/LwBn+f8An1p8kIxjHHApbeQBByPrSzyqFPOe1dfJDkuYNy5jPmT5sYGe31/pVzTEPkOScktj8qozOHbHGM8+laengiAk8KTlcjHFYYNJ1nbsa1W1AwdSfdqM3XBbb9AB/jWlp6gjkDI/z+FZusxlbl8dd24DB5BxU+k3ClBkjGPeufCzvWmpd2dE1einE3EQBkyeQeMnvzT7v/j3b8P50RsCBgjFNv3WO1dnOFyAfxIr6Sj8DseZq5Izu/PamHkdeCAM04jnp3AqNiMZAGe/+fSsWzpQwiUTIQ6CFUOUKEszZGCGzgDhwVwSSVORgguBO48EEYwSPX3puQen4Y6UcdulYsoD3/w6UxmUbWYEkHAwMnJ44/X04p31HXmmk4J65HXsetZsaGI0m4b0Ut6KxO09cH16dfw6c0kkEUoy0aN746ml4B9lHvRnj3x61m0WtNiodLtc/cPr1wRU0FvHbhhEm3PU45NPZgoy7BVXn5v8/jWDqGtFMrAQij+I9R7/AJVhLljqaxjOpodBg4JIIGOOuMZ/+vSgHHPPJOcdOa4o6rMjAlpARk5BPr/kVes9edSFkIkHA/edfz/xzUKvFu1y3hppXR0rdcjseOPemYz0xnOe4qO1uUuot8QIKjDKeCp9D/jUvJ5xz9K0vcx20YhBwTyOMAnjn3p4ODnGPSkAAHT+tIeDz+ZPv61QDh7gHHelbpjn6YpoYc/rx0oB4Hpx0qkhCnjknHr7fjShuT0BHP0ph5JOeeoz1/zmoLy5FvHu/iP3QePxqr2GlfRE01xHAoDt8xBwo+9j/DpVJ9XXPyRj65z/AJ/z7VkvK9w53HcOvJ/nUn2Ynhs5PBJPSs3Ud9DdUor4jZh1OKQDeMd8jnH+c1ogCRMZ3K2fxrknjdG3jOc5OB3rc0WYtGUI+X7y+mfb/PrVQqczsyKtJJXic3rdoyTv8pLcggj/AD+GKyRGA7YHPP5cf5/A16HqFkl4mOVcDggfoa5LU9Llj3IBsPUEDOMdCPX/AOvXLWpOL5uh2YfEKS5WUowgHIOBz/n/AD2pJ3UAA4HYj1/xpZLedSf3eDnpj+p7dKRbGZ25Vl56jrWcKi2SNnbdsLYNMyhf1Ocd+v1rudCt/Ii3YAUjAx39TWLouksCGkXA7k4/T/GujubyG0jUEjpwvT6/pXo0IcvvSPPxNXnfJE2s/wAqYe/WnY5pD34roZ5KIVz1PT0zTnRZEMbrujcEMv8An/PNP/nSA4FZW7lX7GFPo0kgWSJRtIB8qTG9P9kkZB/MisWexaN9jho2/utkZHtjr9a7cYAGOw/KjOeuCR7V5FfKKMtaL5fxX3dPlodlPGzhvqcdDos8iBiHQseGKZz7+3T+VJNpM0b7WjkRe2ed3/1q7IseRn8aN2OuMVm8mpJe7N3+Vvut+pX9oVL7HHCymxt8twM/LgHmtHTNIdpFMyERZySeuPTFdFu9+aPbjNaUsphGalOTlbp/mRPGzkrJWGw7hEA0ax4yAitkBc8dhzjGR26ZPWn9SetVr29tLCGSW8uIbeNEMjtI4UBR1JJrC1rxPYQRrbnUI7eS5VxFcJhwhAHJ/Poete5ClKo1ZHPClOo/dR031xTS6qcE5yCeBnpXJxXdwkccEl/LdTFCgcxhWd8ZBAHH+Fcxot3e3+qi9B1K8urJGk+xzr5KFnwrIpBwxXHcf/W3hheZNt6L+l/TOiOCbTk3seqq6t91lP41DfXUNhYz3d3IIre3jaWR26KqjJP5CvNPEviHVNQtfIt9MltINpzeCbEkbA/d2+p9TVXwz4m1rS2to7y4F3Yqux2uZP3mSTg5PXH49q3WXzcOa6v2v/X3EfVJtXR5M/w58ZfFbxdf+Ib63Okafdy7o5b0FWWIcIqx9ThQOTgHk5r6g8KaVLoXhzT9Lmvpr97SIRfaJgAzgdMgegwPXjkk81PHqVuyF5JIkXcEHzcknoKuDBGQQVrkqTk9OhzODjuhxoBBpDSfrWNxDqWkB60VSEQ3sTTW7KnLDkc9cVhMhRyGBAJ+ZSSD09j9P1rpRVW7sluGDg7HxjOOD9a4sZhJVX7Wn8Xbv/wTehW5NHsZsc5A5ODSSz7lx9M565qQ6bPnA8okfWpINMkz++YKg7Lz/wDqFcajiJ+4ov5nQ501rcisbc3LsJFwgPOGzuGOPoTzx+vNbQAAAAwB0A7VHBEkCbE6dyepqSvWw1JUYJdepx1anO/Io6nZm4QtGMyjAwTww9K5i2mEbiSJ1kgbOChyMjqM/UEceldrVK806C4LO5ZCR8xU4B+tcOLwU3U9vQ36rv8A8E6MPiVBck9irYXgaSNd2SzL/Op/FDFdDuCuMkoMnoMuoJ/Dr+FZNpAyajEY1YR+aMAHjGetafi5C/h67UEgnYMgZx845weDXfgasqlCbkrf8MFWEVWhbq1+ZQ0+4eezQyBifulsr0H970PTp6j3xOScMOep4z/nHaq+jxPHp6eYpBJ3c8cHpVXVL/yMw2/MnQsP4een19//ANdW5aaj5eaVol1nVMF3VR1yT6fWhZozt2yxc4/jHSuTLyyvzlsn3PJP+NAWZO7+vI6+/wClc0qyR0ew8zrQcqCOQQDnGRj60je3GOn9cVz9jqckTbGO5DwVZjj8PStuKZJ4lljPy+hHI9jQpqRnKm4PUUnkZB9P8+lIGOMZ5HXj3/zzSkYz0GMfhUZB3EDOeuCOn1pNiRna9ceVCIVOA4Oe3H+c1hwQyTuMluTkgd+a0fECnzR12lRgHvyag0eXZMuM8kcAYNcc1zSszup+7TuiOfSZBCW2tjBPP+ev1rDuY2hc5yrEkFjxzn27nmvQJSBEQeCB34ritbkVpso3Bzjrg89B6VlUpq10a4erKTsy1oF+Y50ySQcKw9VJ4+nWuxIBPGMdM/4157pIJuMYB3YFegkHA5Jbp6ZNa4Ztx1MMXFKegc84OP8ACjBIxg4I9OMUcEnHbPbGD/n/ADxTc8enfnjH+f610nIKOSMZ55H0/wA/0pcZ6Z/D601/unuev6/pR1wexOMY6f5xVIY/J/iJB9K5/UpGluWGe+MEVu7gq57YzXMTSbrhiQcHg8VM2b0FqzQsoQRuG4gj1z+FaixAL0A/H/PeqdmwwAQevpyKvbgBzjPPQ0JKxM22ynexgDJAyOhI/D8+aTRp4lmyWULzzn175qlrF2OVUgLgk89axRcSZIJOTknIPr+tZSqKM0jeFJzhqeheYgyA6dcfe6USokq7ZAre5rhFvjnIbntxmtHTtYMRADhVPPJ+XHX8K2jWT30MZYWS1R05tLcjHlrg+opVtoY+UiUHPpmm2dyl0m5CA/Qr6fjU5A64PA/StrJbHM21ozM1HUY7RSqkFx6np6Vzs1/JeSH5iQTkZ447f5/lRrQLXZXJJ9v6f5/pSaZagyJkAlc7flzjp0P5Vg6jm+U7oU4wjzdT0rv29sUg7jIJ9uOO1BJz14prFh0XPP0xzXYeKOP600kcZPfHX9KUnHH48Go28uNkO0BmbaCqZ5P0HH1NZyY0h57ev5UnXvmgDoMClHT/ADxWYDZAxUbGC/MCSRnjPI/H17UuO3NA4HOSRxk96MfQ5pMY5eeD0ptxKIYWfjd0AJxk0o/OuI+KWtf2P4auNYtL0LNp5OLdQG852+RFIz2YhvoK6MNSdacYLd6F0qftJqPcwPiR428N6DbXcGsXDalfOcjS0X7rADKu2PlU989ulcOPiKlhY6Td6h4NMGoZ3RymT78BPzAD1I4BNea2ers13Lea1DbXt9qTKZ7i6+dlffkkDooxgdO3FZLxX+teIrmZbo3KmYGR3lCblzjjPT+lfeYfKKNKChNX7u77W0Stp66v8vpIYSNOKUru/T5f1+tz3MfEyyudW07ULnQNWtp/n8h0AAOcAopPBHq2B9BWlF8YfD1s13FqkGtadJFMURvs6kxgnJBIJ/yeK8vYaRrmlNZ2QuNO/s1C080zl43ycD6c49K5SLX9Utj9kAguIUjaIloFlDJ35Iz070llWHq6OLTWm+2t/NfLzLnhKUo27adz6rvbXS9dmCC4kM9xAs/7g5RoTkqwPT345+vFZdhoFnHLb6ourNrGnRxSb54WTYjK2egzn0PXGM1yHgPxlb6feeFtFT7NJoepReTGVl3SWs+SMHPIUnHynpnivUra3h09NQsdMtI7W3JLjCqII+m7AHqcnp/9bwMRGphHyX0e2212n5p+X56HmVKbpS5H/wAD+v61M3U4dN1yC1lnuI4pUJvVa1lwxVevP5An8K0dD8TQvb2U7SsbC9nZY5rpwhBI+VVHfOP1qIXUNpLKL+CJbSCJIFuDCAJQ3VQP6U0WSX727PYWoe3mWWBblPkCKD9wDhWGevWuSXLy2lt0/r7vQiSjKPLJaHbnp0zSYrn/AAjfPeQSyBrmW1kO+F58cDOCoPUgEcE9sV0PeuGpDklY8upB05OLAdar3d5HaAB/mcjIUHt6n0pNRuRaWpbPzsdq/X1/CuWkndmY5LEtzlutcGLxqw9oQV5G2Hw/tfeexrvrjh8eXGBnpznrjrSHXx5m1Exxwz8g/lWC53Nk5G4Y3Z/zmo8Hcc7eo7dvWvHlmmJ6T/Bf5HorB0ux00OudFliXPbZnBrStLuO5B2MN393/PWuJX5l2k/RgO9WLW5lhnHJDjBBU8MP8a6KGb1U71dV16Nea/y/Iyq4GDXu6M7UH1oqnpt6LuPDH96Bk+hHrVyvdjJTipwd0zypRcHZijrVHWJNkCJ2duR6gDP+FXqxNdcm5VRkBU4x6k//AFq58fV9lh5Pq9PvNMPHmqIisATdRnGAHWtjWYBcadJETgMVyfYMCay7AgTxgggKyqPrmtq+/wCPV/w/nV5XG1Caf9aGmIf7yLOenS2sVeVI41mO4rx8wyFD7c9AdqEgcZxn1rnlHnyfNgkn9a2df2+TE55K5Uc9jjP16Cs3T8Fsfxe/PPrn6UVOx00tI8xdt7NFCkgFiB25xUktpGVyqj6+tWQQMKOOM/596GP+0SO2ahR0I5nc5jUIPLbIHQjHerHh+5InEZyC42kE9x0/z+faptWQFOR25z9R2rJ09yt7CwzkMMNnHf8AUf5+nO/dlodi9+m7nWHA7AL24/rSMduMrgZAAwepPfH+f50p+8xBPXnvTe/HBPoa0vc5LFbU7YXNsNgG9Puj1HcCuVYvauRjAHUEdOeh/OuzDYUYyR06/wCelVryxt7rLMNr/wB4c557isalPm2OilV5NJbHJXOpSMu0mTkcKzdf/r1lsZJXZsZJOT3zzz9T1/ziuvk8OqWOLgBT32c9Rn8+lWLfRLaA7nYydDj7v+eaxdOct2dKxFOC90zPDWnMHEzrhFORwfnPtXTZ3Z757mmFQECqFVQMAA8CjJySD7+nFdVOHKrHHUm6kuZjy2c9CPrSNkDvz2/+t/npQef8+9JkEHAGB3z2q7XMxR8w9seuaTgN2+b/ADxS9CST74NDjKYwfWqSAah3POGAKh9oA5wNq5/Umud1KEwXTbeATkEHORx+f/1q6KLnzTgYMrHPtwP6Ci4gjuIisg59fSiULo1p1ORnP2t0EOMhR09OKuNe/JgggH5foaSTSJASVZSOuf8A6x/H86t2+lqgBmb6qM8855rJJ7GspQ3MG+3MjyMNwPb0rDaVUdiwXJJ+XPfH9QDXc6vDGlm0apxyScdwK86d98pwcgZxg8cYrkrrldl1OzCtTjcvxz+gyR3JyRwP85/SnNMMjIC8ZHt7/mKhhIKtnryKZdNlSEyfTn/PPSoSaV7m1k3Y39G1VopQrNyPuMf5H29q7mGQTwCRB1H3T29vrXkdvKQSVfp0OMfif5fSvQvDF2ZkZGbqCceh/wDr9a78PU5lynn4yio++jK1Lm6O5Tk4yCfbv/n86s6e6rtyBn7xx0H+P+fWrXiC0beZE+6Twe30H+f8KxI53U8bvXnt0/z+FZt+znqEf3kFY9NOaTjcOm4dPakYhWAOcsccc9v/AK1Ka72zxBOcjjjrR1OfwoPTuKO/b2rJsYnA4A4o69P0petJyBzn61DYxaOnv7UlH1/nSuIdkKCx6AE14v8AGTWp4vAk93pcULTR6mgkfG5QBnP64Fes68JW0S+S3uDbTtCypOAD5bEEBsHrg815v4j8N3esfDu5trSe1n1KaNPJlihMaF1xu4PQsAefevVy2VOFWNSeykv6fQ78CoxfPJ9TwmfS3lnbUL/UbCVr2y+2QAY2tJ/EjAfdZefy+tZ3huyhS7fUb+HfDbKssawYkSSRWGA+f4fWpPENi9lINLn1BWSGIEqkedk+PmiyP9rPPSoYoo4NBKWCzLqS7hPE0X7xeefoOn41+gxd4Wvv5dP+GPp5La52Wka1pGrS6le+J9RFtbeY6i0tE2vKSvygAcBeO/JPeszSZ7Kz8H3Vo2v28D3ELTrBHGXZ2Jx5Z4+XjHP1+teo/CHw3plrpUN+H0q7upIs39s6q0sfPGRyQBx25r0yD+zYblvs9rYRTld3y2wRivQH6V4GKzOFGcqcItpNdktPKz+886rjvZzaUXp/XY8D/Z/8ES3+tL4j1aFG0u0DJAsy/wCvmIxkA9QvPPrjHQ175p+lWWnRCOIy+XvYje5bgktg9yoJ4p1pFFBJhMR73LbQPlAx0XsB3pyrd/aLl38uaEZNvEnys4x/E3Tr+lePjcbUxlVzk7Lov6667nnVqrqSbvZGbDZTO2sQiAW++cPC9wCUkYjOV5/Djp0pLW6QTDTxKY7uKLzzNIN0RYfe259O47cVTaRpXvtPuGkmvTIlwJFJIgz12dhtHHHc9+aLjTrMeIbOaXVLxJmgkMVoWGJYv4mkGPfg8dqXItebtpp5b/8ADmvLupP+rFu0vjaalDHHCQi83c0h2r6oFx3NdlaXMd5aw3MBJhlUOpIxxXnUuhF/FFwsdsy6VrFoft++TLSMmNm3uCQT07DPFeg6XE0NmkRbKIAqDuqgYAJ78d658RGFlZ7/ANa+d/wS7nHjYwspLf8Ar9fwM7xBIRcRqp+6hJ/E4rEAO4H/ACPxrW19T9tORkGNSM+xOayV98+h4zXxuLk5Yqpfv+iOrDK1JWIm4OD0znpS4G445PTA55oYfMc/jnof8/5603OeBnpgZ9x61wXOoJGwec4AyQOv/wBf60SttjjdyBggEnjj/wDWe/rTWfjJye9QyvtaNQuHONx6HA7H8f5+9CepSjc6Hw3I327ae6kHOePb9BXSmuT8KhpNRZycbFJwBx6ZzXWV9PlDcsIr93/X33PExytVsArK1iP/AEmGTJwwK/iOR/WtQkDrUV5B9oh2g4cHcp9CK6sZRdehKEd918jnpT5JJsw7BiLiAf8ATQA/XNb9/wD8er5x26/UVgwKVvoxgj96p6dOec1vX5xaSde3T6ipyifPTq+v6G+J+OLOc1dDJYkqBuQh+/8AT61zFvceTKR+ArsCex5XpjPWua1jS2i3TQkGIH3yvPQ+1OtF7o6qEl8LNW2ukdVB6GpGkBXhl/P/AD/n8q48TSROcAgY5PT17/jU5v3KbdxYeue3+FZKorGrwz6F3VLlfug8jn/d71T0WMy36HsGBPPYDv8A59cVTZpJZBhTyRg46n69T/8ArrpNGsja2291xK+DjGNg9Kzb5maTtThbqaOc5yR+ef8A9dHUn0PY8mmEckggHpmnKeMc/wCH1qtjjM7xJqL6NoF9qMUBuJbeIusY7kdvpXmXg34qXep6+LPVhFCkg/dRiMKM+ma9S1q2e80a8t40ZnkiZUUNt5xxz9a+d7DwN4mvvEtr5unTWrxTDfMyFVABHPTn+vpXsZbSw1SlUVayfd+h24aFOdOSnufSUcyyRwuMr5nKjB5IGeew6d/w54plxMIIXkKSMi8kRKWb8B3606NTHDHEW3FVVSw46Y60hJJHzYPY/wCH+f515F1e5xoCwySDx2IGMUFiAPX0Hrn1puSPXI49M0hGScdxgev4/wCe9Uhkqvkggj2wcY/D+n0pV7cfh3FMG4k+vPanjPI5A7juP8/rV6CAngkYNNViBzkZyaefu5JyccGmsuNxx65xQAkXG8ccSMOfT3/D+dSD6j6+tRj5HcEEc5I9+P8AP5U/PI6/QmlzASdM49+tLwTjA/H2pg68dfzNOH146UCM3xEp/s8spxzjpnjB4rzmbcGYnOe/JPP0/n25FeqXcAuYGiPDEcE+tee6pYvBOwwVxxjr+v8Anr2rixS2kejgZpJxZnpMcEY/Drx/hxTJ5s5+YH2PXH+fzqGVW4AA55HHWiOGWQ7QM4OBgVzX0PS5VuTwEsc5GCSFA5/z/wDrrvPBqOERu2Dk/WuY0vSJZ5UXBLZ5654/yeK9D0myFnBjjccnI7e30rswkHfm6HnY6rHl5VuXZYkuImSTBB5z/Wucu9GkV96xk8Z4GT+Pvx/hXTbsKSTgDnmnHumSrEHBxzgDr+Fd1SlGotTyoVZU9ixFCscs0292aYglSx2gAYGB0HHX1/LEpIznpUTMNuY2DAfLgHPIOPzBFJG2cd8cGibSdjms3qTfyqN1J+Yc07qOP170o5+7yahrm2FsHp0/rSc8YwPXv+FV572KGQpyzDqemKQ6hAEz82e4Hb8awdSmm05K68ylTn2LPrRgZzj9Kit7iO4B8vIPXB4zUxH+SKqPvLmjqiWmnZlbU7SC/wBNubW8iE9tKhWSM9GFcbot5Y2ekbLCG8ltrZW3S7S0mN3HA5b6+1d2p7evWuAkX+xdQubJPMsrOIG4FxApYiMtuIGc8k8YGfYV2YeV04Pydv66ndhHzRlB+pxfj74ZW3inUrrVfDuopDf5CzRpgrI3GdwByrDv/KuA1bwnqfhm5afXreSa0cFF1ixZpVjIP/LTHboMHtXtHhTTIf7Svr61tpY7mCWbF1csFGJSHIkXglumc9MiujtLaO1W4jmWeW2uWPmWhjEkaFuoAA+6ff1r3aeaVcM/ZN80Vb1+TXy39H0PRWKnQfIndL7z5zuFt9G16HVraS2eSdwiMjGSBgyYwWUgjPOfQ9quJ488VaLppkXVoGsG/dw/J5k8ZX+DcR0wR17CrvxH0W68Ga0mo+H9O8nSJmdFhlQMgkPABHXBPIz0PFc6666zT6Fe28cTzR+ayQkE72XIBPQZOMgV79L2WIhGpK0lbra9lvprqj0oqFeKbSZ2S+PvENkjzGSy1ywuoh5pgyktsWGNqnOFb2OcmvUfB+v6XdeHNNbSnnFtF/o7rc8yQsvVZD2bPQ18aoJkkMY+0bnbbImCMsK63w14p1jQrqHULOZftc5aKVJuY7hMY+YdCRzz61OMyaFWnano/uT9enzSOSphoV1aKsz6M8YeK5vDpeePTbi8svN/dSBhGplI+Ubv7gOc+5r561TxOmu319q2uahcw37oyAWhJQDoEwTwuOwrqfiRqdvqvh7Qtf06AwWULmKa0knMoMx+9gdsAE579q831PTEkluLm0Utp27Ec7KVVmP8PPU1plWEp0afM1aT0fye3VG1Cj7OF4r3vM7HwR4x1bTNdsLZtdnvbGS0eO2LMSbSQr8oTdxngLjpzX1vpiutjHuJ84orOW5+bAz+tfEHhzRbnU9esNJt/wB9LI6SlosN9nQEFnbtwK+5LSJYoEVGZ1wMM3U8V43EcacJwcbXadzyc2SjaK3/AK0/Ug1G0NxBkY82P5kOO/cfQ1y8i8blHynnGMfhXais+60mKZndGZGY7iOqk/Svg8wwM6rVWiteq7nFhsSqfuz2OYZQ+cdT2xgGomGOcd88j/PvWnLaNG7JLwQerdx65qN4MkhsZPr1rxZUnvazPSjVRmFSTjt6kdf8/lU1vZSXNzsVS7jhQOi+/tW1pmihx5tz5kanO1B8px/Ot22t4bWPy7aJY064UV24XKalZc1X3Y/i/wDIwrY+MPdhqyPTrJLG3EaEM55Z8Y3GrNJS19JThGnFQgrJHkSk5PmluJkElcgnHIpwrn/FHiqw8NNaDUo7rbdSeVG8MJcbvQ46VW0PxPDqfiLVbKG6gmtdPSNJHjjc/vWySu/7pwNvA55rrjQnye1atHe/zt+bNFh6jhzpaHQzWcc08U3KSoQdy9xnofUf5FP1Af6HJ+H8xTVvITIqqWZiQMbTxTtQ/wCPOTHXj+YqKSpcs5U7X62M/e5oqRikZOByT2HNRqxyCv0P+FNnCNAyyBfLK4b0x6/oKwNS1xw7LbjIBwWdBknvXFOokehTpubsjWuNMtpmBZGjOf4TtGfp+NUjoUONxlJUYXhRzXL3Gozsdu84A2gYwAOgA7dsYqODVZ4JgwkdTnnbzz7g+1cjrQvqd0cNVS0Z21tYWtud0cRZv7zc/Sphgng5OeQMc/WqWmahHfQDbtEm0EjsRjqPbtV1twDYIyRwT/8AW/pWl1ujkkpJ2kBH3eMHPfr+H40owMg5OD3pM4OO35YoHXtkHFQ5Ejx+Ix1xWL4n1SfSLUXKRGSCPAcZ5XPAx64/wrYHIz1Hb6/1rO1vSl1QKAPnA4Ibbzn9Qeaui4c659ioWUlzbHNeF/GH9sanLboHlSLG4lQpAJ6j/JFdm4AB7g9Djr9a4PSPBkltrEk1tcNb2LDAUPu/izgegzzx/Wuu1G6NhbqofdMV2pkc/U10Yz2KmnR2Nq0YOdqYmpX8dinz/NJ2X0x61zt1rl5ITs+RR6ADj096id/PmMh+Y7iSeOff61q2FhbzLgNhgOmccf57Vw87eiZtGEKSvJXMpNUvUY7ncYz1b+tbOma6r/LcA4HcDBX/ABpl1pEY4jAHf6duD6+n/wCusi6tXgkGBgDp3PB/+t/kUuecdb3LtTqqyR3KsHUMhVgeQQQc0pAzkkDng+n+eKwfDN2xLQszEM2V5+4fQD07+uSexAHQDqccdvSt4zUlc4akHCXKRYG9eMArjrzx/wDrpx9Dj396V8AbuuDk8duh/nSlQMgH1waepFxNwJ9eakVumTyB1ziolXaRgHHBxwP1qVQcc/5/ChXEx/THH+f84qvfWMV6m2XIbnDelWe/X2//AF0oxn9eKpxUlZiTad0cw/hVcsfMQjuRxnnP581ftNEihTbtVlJPBGSc+/8AhWwPbHfGO/t9Kcep4we/NTGjC+xq8RUas2R21ukC4RAuePl7/jVpSc84x2/XP9P/AK+ajXgcceuKkB7k8V0I527i5DFlwflxnIwD9D3/APrc+79qswLAHBDDPYjuP8etNA7fp/n8akGePTrVIhlp15HJHGOvFMVPTjNS9gCAKQ8YOcVE1cxTBeCBgZNZN9qbfNHDlR03dz71qoSzOpRk2naGOMMMA5GD05xzg8H2Ncq4/eKVPTsa8/H1p0YxUOp04anGbbl0JgrSNnj15HOfXP8An19qlELADHboKdZLz3POQT1xn0Hpx9f539gK574rz4YfnVzedTldjPG6BtyZBBzkcZp8GoSq4y5Pb5uh/CrMseQRt6+g/lWZOMN147d+KmTqUHeErDjy1N0dIjq8YdDhSMis7W9PS9FvKwctBKJAq5+b2I7ipNGm327ITkrzV/8AU17dOpzwVSPX+mcTvSnp0POUgGuSTw6nZ31i8uC7yOGjuAjZVmUdcDHXsPpWxqX9ozbJdPEROGBlklKbskYC46Z9TXQ3+nrdbWWRo2BzlcfMPQ59a5qPQpLSW5ihtttrqE3n3O6QnyWAxuT64HHb+XfHEKTu9LbLdee77dPl2O+NeNTXa3T+vIe+qaXJPHY6nasJDKIovtCearuBnG7245P6159q3w31fT/Fbav4V1SImZ3drS6+7zyybhkYPb8BXfGZoJJPMUs5ARZYuIWB6L/vccmsxteSO3lSe+8gxZF2rQMXtwAcY/vFug6124WvUpN+x6qzT1Tv5f1qb0ueD/d9fmeT61c2+geMLG6lsn0y0jjec2t2oKxSMCCFbGGycfnXCaRrqYvX17T4NQs1mMsShtghdj/CBztOOn9a+l4rjTtUtBBqlhFsnjWR4bvDrg9GKnkHjpWQvhDwppc8v2DR4re6lbcxkTzmiX+8q88ZwMV7VHN6UI8tWD5rJaPs+979fM7li7O0k7nmPhbwFa+I9N8q9uZbO5uUNxbhY3GUY8YzwcZHH61J4n+FN/Z6npenTazCYDG4tAI3ZpXHJBHQH8e1e+WenS6rBbXNzNPFND0KjZyRglR/CCO1XrPwvp8Fz58vm3LqFCCdy4jx3XPQnua45Z7WU+ZPTto9fJtf1qcdTMVGTu/l/wAE5n4YeB7Xwzp2ILaOOS4hUXE8i5nlbqRnsnoor0IDAA9OKX6VBe3ItYN/DO3CL6mvDxGIlVk6tV+rPGq1Z153e7G3t5FZr8/zSH7qDrWcurSyMB8qD0Xn9azZGaeZmJJZj8zev/1quW1oSM4J9q+feOr1qn7nSJ1KhTpx97Vl37ZuGHw3s4zVm2uo2ZE2ou7gFemfSs2W1YDKnB7YFVNzJJncSufvDjb6dPQ1rHHVKUl7RXJ9jCa0OpNRhyZWQxuAFDBzjaSSeBznIxnp3HvhlnP9ogD8Bhww9DUvevZbTV09GcLXK2mLSMSqkgZIGQPWgsFUsxAUDJJ6AVx3xdu76w8C313o7SrqkZQWvlKWYyMwUAAdeGJ/CtKMPaTUb2uXSp+0modzP1X4n+FTo018k7SzWc/ltbvGY5opgDlcPj5sZHHv71b8K+JNP8SaMl/pG5bcsyhCgUA/QV4PfW6+JNA0TTdD0HUj5BkF3PI5JMpYGSRmIALN1yT7DpXufg3RbbSPDlnYWNuYY4wXwSMlj3PvziuLN1S5U4p813ZNp2Xd27n0OIwNLC0Fe/PfvsblrLuvYRuGNy9upzzW7qP/AB5SenH8xWNbwbLmIk4AdcZPvWzqH/HpJ+H8xSypS9hU5v60PDxDTnGxw/iG4kMsVsoUxEFpjnBzj5cDvzgEHoOc5ABzVsXdSxIJ7HoBxjHp/wDrq1rZMWoynPOQdx5P+fy980yK9CwgHge/+fY1jUfQ9KCcYrlMm9tQq/dxjrkdPrWNcx7Dldwwe/Gf14+g/wDrV0F5cqck446E9Ov/ANb+VYd1y5yWI6BSeOf8nrnvXFU0O+i31LHh+6aC8hCN/FwSc57Y59uPoK9AYZB7A+9cDoFoZ7+NcYBbB47dTn1/T+leg7cdBzjHJrWhexx41rn0IwMds47etOCnaAScngnNOCjI4zjgjHNZ+qarBp8ZLfNIQcL0H1P/ANatpaHJFOTsjQXJGeeeTx7804qxB+Vh/n/9VcLdeILqWUhpmQA9EXaB1/E1BLqc8pPmSu2OuWPP9Kx9tFHQsHPqddq+px2yMiMGuCDhf7vua5G+uZJ3Jdy/I7+v9On+cVVa7eRzvbdg9Cc4qZV3oMf7pA9f8/l+FS6l1odVOiqQkSk5YEZ7Ejp9fXtV23nMLA/MAvp1HrUEXUHsBxx19AKlfGAc5HXOB1z/AD5rNe7qi5a6M6q0nF1ATJ98fewODnpVHVoA6nPYZ46iqmiXJimQA8HjB5zk/wCPX8a1dSYJEc4BrpUuZHHyuE7IwdMPlXseMffHA9c9K7E9cA5Ht6Vy+mwNNfJxkA5YjsM/rXUHkk4961oqxOJd5BgHOeRzkY60mDjaTlh1OOvv+X65p2OR0601wTggHIzxnr6itjnHL1Pfn8xT/wAf1/Wozzzk4PenH1HGfTscUCJB03cgdM0o7nsfb/OaaCc579vWl4OR1AFNEjh6evb04pTkjAJX0wORSDkHnI9ce1OGenHPYiqQh4POeD34NOX8z34qvdXMdrA0sv3R2rlL3WJ53fLYXPTsODx+P+e9TOrGG5pToyqbHahwf41z35BqTGASeBnrnNcDDdHk5AGM/d+v+H+e8wvpI8Mh6HC45/8A10liEtWi3hH0Z6J/OkzjpilYcHpz0yM03nPzHGDxz7VozzULjI68kEc1y0sbRvsOAVwD7V1Hp/hUc8Mc6kSop4+9jkfjXFjMM8QlyuzRvQreybv1MK2kC49fTrV6O4BHX29apXdrLBMQQSD0YDjFRLuGQCCK8qFeVJ8klZnY4RqLmRoTzAghuRnnH/1qzZnDScn5s9CeaewdztGWY9Fxz+VSxaZPJKqurIv8TMOg/wAaU5TrtKCuOKjTV2yzoCsDK38IUA+5P+TWuc456U1FVECRqFQcAAUo/D617NKn7Gmqd72PPqT9pJyD2PpR6+tFFaJkFeawtJ8edbRN824cdDSmyty5cx8kBT7gdKsHJ4BpQOfrV77j55dyoul2KuWFtGWI25I5I64qzFbwxuWSJAx6tjn86evWlxg81re4pTk92LUdxcQ2yhp5AgPQdSfoKbfXK2lq0pwSOFHqx6CuPurmSd3Yks7HBZiRn2HoOtcWNxywqUYq8n93zNsNhnW1exvza4iuFhhyD0Zzj9BWbqGpSXYKyLEUVhgKSDWZEkm4ExhvXBz/AJ/+tUzw4WTGcqQxz1rxauNxNanJVGuXTbbc9KOGpU3dbl6y2M+4HKg5Ktw2PX3robdQEGOmMjFcfbyNG6sBgg5HPX1rorG8zhTgDHHsM125bWh8LOfF0pbo0ZEBB3DJxWPfqqM2O3UA81pPOADyOe1ZV9NlSUG9uCACBn3yePz/AJ8V0Y1wcTnw8ZXLmiNh5EyclQfyOK1aw9EBN5lfuqpyfQHGK22rrwUr4eLZliVaoKO1UtXYrBGR/fAP4giroqnq4H2PJxw6nn61eMX+zz9DOl8aMfhFMcYATPI4wfXNXrQAIXbLbQSdoJJ/AdfpWS0m455HzHOR05rQsp87chSCOTn8uO/9MV4mFlF1Hc9CrB8psIirtc5PIHAJ747UuoECzkJ9v5imw3CHapPJIFLqYY2b7GCnKkkruyNwyMe449s5r6qgoeylyHm686ucprenteRb4FzMo2lQcZHqPcVxdzvjkweuSPb3/p/kV6Fbo8MKRy3E1zIv3ppggZuep2Kq+g4A/E81Vv8ATbe8YySKUlOMsuBnvyD1+teZWpc2x61DEez0lseeNI5+XnkYOT2H8uf5VEkbSMq4cZ46/wCePSu7XQLNB85lcDoNwQHjH+c//Xq1DZ2kMpSBUEigMRxuUEkBiOoBwR74PpXE6Eup1PGRXwop+HtN+xQ+bNgTuMAY+6M1rc+wHvSbuuep5wRTLif7PbyTE/dGR3ye1dMIcqOGUnOV31KGt6lHYRKpy0zDIX+6PU+3t715/fXkt1dNK+7eT06Ec9B/npVvVblrp5fMJbdy3cYPbHcdsc1mgbwQxyx649/849vWuSvU1sj1sPRVON+oidMj6cfzx/nrVjGwbfmBBxj8emRTETKv0JPByOD6f5/LNOZRsU5yCAOmcGuPobskTAHIXj2GP0q1EexHf19O/wBODVBHxk45/wA9Canjl+c4I/w9v8881rB2Ikrlth14JJ6dznPt2ppmzn+Hjg4/l2P4fpT4WEgyeSRxwOf0p6WzyTBUHLHAORz7f59Oa25W9iLpbkuntmYknjPTjj6+nT9K1r2VrqXC7jnjAXn8qfpuhScNcPtHoDk//qrbt7WK3yY1y3PJwTW9Kk0tTiq1o810QaXZ/ZYTuA81jlsHOPbNW8c4IyTzTx6kcnBPHf8AxpCPl9D7evXpXTGPKjkcnJ3Y0cHAB+n/ANanAfj+P8qCvHsc9KXt2OOmRTQhnCnjGCfToeg596eOnAHtz+dKwypBzgjmnAZHUnv9fegVwzwSB355/wA/pTuOh6j8KMY6ZGB0pFXHGOOuMd+5/nQIcM56gnpVHV9WsdHtWn1C4WGJepxkj04FaA4PP6V5X8UvA+oa9qX22xMk8YVV8gZDL75PauvCUqdWqo1ZcqNaEIzmlN2R2HiO9S4t7drWZZYHTzUkVvlbPQ5+n8zXN2yFmHHPA5HJ9v0/TtVTwxpF1onhpdPu2O1JHkhyd52MemeOhB9K19NU+aoUEksPlY4wO5HHOB2746ivNxUFHEckHdLZnowiqcGou5e+zsuMAlSMZLcfn/ntUNwgCk9ief0/WukuLYPbhlByOuOv1+vSsi7gbaS2QcY+gNS6fKrI54VeZnaziUN8g69CD0p7I7SROJnRVzmNQu18jgkkZGO2COvOez1bevyng+oxQScHPOf88V2ta3uePfoJj2xx0/z+FHIP8qVhnjn14OP8ik7HPrWbEGeMZGPSkVETGxEXA4wMYoJx/jSE/wCRSuuox2ec8Z9cc0AnOTmo2HT64xTDbQyTxXEsETzxBljlZAXQNjcAeozgZ9cCp53cLInP5cUdPwo9Oc0Y47daL3EKPxpAfSjPr+VA6D/HNMBw9xR7Uf40q4zWiEKvQ0pPGenrUVxPHaxF5m47DPJ9hXM6lq9y4ciQxJkhUT+p71nicXSwsff1fZG1HDzrPTYi8Wasvm2sCKWcO+MjIBxjP6/rWVAXlG7B/Tr35/KoI45TIxkmeUE7vnJOD7enetCCIIOgHbrwa+Vq1JV6jqzerPdhCNGCghVBzjPP+etWhcNKhKgGdRg56OPT/wCvVVmCjaAAO3PT/IpivtcEcYpqr7N6fNdGuxLjzE+Ff95FnGckNwR/+qpoJSo4PI7VHChubgIAN7N8uDjn6iupi0q2W1ihkXe6DmToS3c12YTC1K/NKi9F3OavXjSspGG07vjaTgjtzRBHJPLsjTzD6A8D6mtxNKtFOSrv7M5NXI0SNdsaKi9cKMV6FPLqk3etLTyOOWLil7iI7G3FrAEzlzy5Hc1MUBYEgEjocdKjuJ1t4tzZJPAHcms1555WzvYEcbVyB/8AXr0qlenQSh+COWMJVG5M2MVXvLfz7RoVJBwMEnPI9TVJZJgMrI/qMnNWYrzAAlwenzL/ADIpRr0a8XTlpfTUPZyg7o5u6hZXkVlYSL1U+mP1+tQxXWQrKc7gCOcCup1GxW7VZImCTL91+xHofasK402dHJe3fPPMXzqfw614GJwNfC1HyJyj0aPSo4iFSNpbi2VyXvYFB/5aLnj/AGhXS6hn7HJjrx/MVzWnWbC8t2EcmFdScqRjnPeul1Hm0f6r/MV7mTOboVHJW/4Y5MXy+0jymEXC89OnXtSgg8jGPTrUU8XmDK+nbpTo1IXvjAPP+f8APvW7KBsfxcg9Qe/+f61HIDg7TtcgfOVyR6H378ZqRicjOQR1/r/Sos5PsDkckisnEpFS9N8jxS2CxTIG2zWrnZvUn7ySdnUdjwR6Gq3ieQx6W207gWHXuO3FaJJO3+7g9RyfT/6//wBbmrq9sbvT5ogAWYEgEZ5znn2qZR7GtNpSVzzln3SkEZ3DjAH5/oaQYzyMj644FLeWxgmeKYH0JPp65/yaYGOcSNtbsc9e2f1rzKivqj215FiIqMHg+3Yjnn+f9Kczrs2r80Zz8yn7vPtUScjIIfPcUo3k5A3EjPPc/XpzgVjfoLlIivzKUb5uo7fy/P8AKlgW4G7zPKYByUKKUKocYU5JywweRgEAHAPFPjj3L93qODjGf8/nW5omkSXT7iGWMH5iQMgex9/1roo0eYmpUUFdho+lXM6odoWM4+Zj6HFddY6fBbKSib2A5c//AF/xqrq2o2Ph7SDcTMI0RCsMWPmkYDhQPWvHPEXjvWfFMwPh55dLaz3SIFco0rAjMbjpx1Fe5gctqYjWOke72OFRqYp3WiPYbvxLotrfR2M2pwG+kzst0+Z278AVkL8QvD3zhpLsFXEePIJLHOOMfXrXjs2r219q1heX2p2VnewtvedFIukb1/uke3XB/CurtdF0nVhfeb5UVxtDmW2myJEPR1Puc8Dv1r1pZXRoxTqX+Xr6bFvCU4r3mz0uPxXoUjMq6lFuUsCmOcjkj8q1bS7tryBJrWUSwPyroODXgL6bNoeqhr2zkS3nUm1kkAcxuwwASPu/jXafDLVvsC3NpqM8gvpXxcLMflLjoVPTleePQVhicthCnz0pN7f1p2/PQzq4RKHNB3PTwVJ25AJH3Scfzpy49fXoec1xLXV5rmu/ZAFhtkzK8EgLB4wQMqw9f06YrrnHQKW2A/Izc5NebUoOnZN6s5Jw5bXZZOCTgHAzQOnH8qjQynKyFST0bG38P/r04E9wR39MdKyaMyXH3TyMHIA47Y59acFAGMcD9aY7pFGXlYKo9aybzVnDn7MNqdQxHJ6fpUSkkVGDlsbYUnkDP0pB8pGc474/z9a5lru4dtzSPkdPmwf0q5Bq0648wBxnByOT+NKNVMt0JJGhrNobu0IJYyJyvPXA6Vx8CNbzAbTg+vfv/Wu4tLiO5j3xE56EHsao6jo0dwzSQYRyDlSMKaVWlzPmjuVQrcl4S2K1tqipDyckdfpWbqOoeaThRjpjA/z6VLNo10mSImOTwRjHWpbPw/LLIDMCo75A/pU++9LGq9lH3rnanB/KmkZBAOD0POMU2KVJow8ZO3JGCpXoSDwcHqDz/wDrp3HXI69fU10yZ5FrbiAADCgD6Dv3pRls8UozjGOT61k6lfNuaKIsEGQx7t/9asK1SNKPNI0pwdR2RbuL+2hz8+9uuIxn9elUTr0CyBBCduCQxYY4IGPr3HsDyO+Y8TSds8/KaqTWrKPmyM989ff8q8armNfeCSXpc9CnhKW0mdVb6naz4BYxk8/P0q7gYHOQa4ELJGQcnB549OvWtvSNTkixHOS6d+xFa4bNPaS5K6Sv1W3z/wAzOvguVc1NnQ5/2gc9Pej39+tLnupyDyD60mcdc5r1WrOzOAXtzzmlyPwPekHXnvSj9T0qkIUZ/wAaVOfxpoOOBUg498CtYbiZzutXBmuZNudkQ2rg9+5rHlXDjI5xz2/z/wDrrQiV5RgkMxG4tjAz3+n50yaAq4OMZGfxr5itGdb98+rf/APapNU1yIz1j2EZ/M9fr/Knkk8dqsOmFJGQMcd/xqo4Iyeg44rkkuU3T5hzNkDHbpmooE8+UInzkDpGN2P6Zp0bSeZmLHmKd/PTqM5H613FnbR26kRqoPfaMc10YXBPGSaTslv/AF3McRiPq621ZT0TTjaJ51wB9pbtx8g9Pr61qE0H60V9TSpwowVOmrJHiVJyqS5pB/OgUc0orREGZqD7roKvJVf1NWLWFdmTUV9HtuA+MKw5PuP/AK1WbY5TAPPeuKlG9ebnudEn7isSGNfSq81uMEr1q370mMj2rqqUYzVmjGMmijBOYG2n/V55GOn0rR47His67TYcjGAc4xVjT33QlTg7DgH2qcJVkm6M+mxdSKa50Wh1qLUP+PR/w/mKkXqOara1P9m02aXbu244zjuK9OL/AHcjGK95Ix2IDgFvnYHap7gYycd+cc+9BAznB+n+f/rVmrraggNbYBxyr9u3Wrlpd210cQuN/GUbhuP515ykj0HCUdWh+O/HUde3pTWB69gOpNS4AI7kdfz6Uwrgc8n9Dx6U2gTIdvHQZPJzzmlUdivtjrTyOrD+X1o29gOehGe3p/8AXqGh3MfVtCiv28yI+XcY5zyrn39K5268N3caMRGzKORt5B9/Ud/eu8UdMdD3/rSjjk9uB2rmqUYz1e5vTxM6eiPMv7MnJKiOUuDjp1NWYdFvJiuIZWU8jPH1/CvRDyM459xTfr+Z61nHDpPc2+uyeyOZ07w2FYPelVHXYDkk5zyen+TXRxRxxRlYkCRqM4Ap4HzAcZz3HbFZ3iRpo/DOptakLcG2kETDs2OK7KVJNqK6nO5yqySkzzjxvMPFIu57T5k0zzYvJ84ISw/iGeo4xmvINZS6ufO063kW3lWMTNDt8vcMD5eep5z6GvZ/D82gXmj2M2rm2N+ZFgdwQAZVPp0xx/8AX715T8QdPF1471BoRu89tsUZyjrgAZ/rzX2WWyUZujayjtf1/H8D16E7J00tEcqUQaLDd5tFuIJNhXGJHH+0O/1966T4ba4lvrE8Ey7YLiORbSMudsch5x7/AI8d65Ga0W5hMcMJju7cN5p3grJg9R71u+E9MEWr6OWleOS5nVIpAufLbOCfcdsfWvbrwhKlJS8/6/roOXme1JDqAjntZf8AS2twknmSDJxtzgno2eeeemKn8M6JZXfiSOe6vEmWOMuLQnO/dzwM9FPQ4z/OmabcX2nNJpr2l/OgjcvdrC21iSRge4xkjsCD3rPtv7JmkadLuZI57pZYby3I3W5DDcQOvOCGB7V8vyyakk7X6pf1b8/mc7vZrb0PRrqyitr+O70+MKI1YMF4yDzgfjU0Ef2We7cu7G4YMyufljI4+Udh3/OtV4mc7o9hPbBzntXM6D4iTVNc1LRZvsxvLPgCJslwOCcdfT8a8aKnOLa1SWvpf/M8xc0k2uh0SRh4gcnZnOc8jB61LAHMSmbbvx8xTO3/ABx9azrFDBfTQQoQhcyMpOQCevB6dv8AJq7qDmDT3I6n5eO2e9ctZcpNtbGJqE73N0SM7AcAdRgenvTra08wAsuR6k+9R2sW5xkHOB/DW7bRhR8vXHQ9q4l7zOmcuRWRVSyBU4XLdD7nHeqt3abfm/LGfxrdwCOAMAVUuVBRuCeeRWrgrGcajuUNGlENxiQ4VhtJPv0z/nvW+jBwSoYAMy8qVPBx3AOOOD0IwRkEGuWdSGIByOhxz/n+VdG1yI7ITuedvGT1NXSnZCrxu011C8v4bNfnyz/3F7fU1g3mtTSucEqgPKpxj3JqjO73EzlmLbucHjr3/XFSQ2LPkgEgZHT86iVWTdomsKMIK8tzvDknkcjv1z/n+lAyB60pAGew6elRHEb+ZK7EZCqADhSSAOB356np7DNbPc8tajbuQwWssgPzAfKT7muftoAhSONSEUDaM5xW9qS79PlxngjvzwayLQDzsZ5Pb2rzMauatCL2OzDu0GzRgtQDkldhAx8vOec5PTHTsO/XPCz2iEfKOT6Vaj+6OuTSkcdK7HRi42sc/tJXvcxLmwG3KnjORx0rJmQxuRyB1OO59Qa6q4wEYH/GufuVDSHb+ff/AD7142Pw8YfCd+GquW5uaRIZbBSx5DEDPYVc69+9VdJTy9PUkfeJb04q3+pNezST9nHm3sjz6tud27iHjOAcfypwHbBpoHPJ9qUkDJ5FaIgcPXr6U5eCPSowcHvnNPU4OKuMtSWc3Pus77yiDuHK8dVqZts0e4fd9uSPatTU7L7XErIf3sf3cnqO4Nc+zNDIVfKMD0PUGvBxEZ4WTpS1pvVf13R6NKarRTW6CeE44Kn+vNUpYsZLMgHoOtWJJSwztLrj0/wpiwyyybYraV3z6cA/U1xTcG7K52QbitWSabatcTLEBhXPP+71Jrsyc1n6Pp/2KEtKczuPm9F9hV+vpcvw7w9G0lZvU8nF1lVnpshPpQOaWiuo5Q7UvegVG00SPseRFb0Jq0mwSvsJcRedEVzhhyD71Sgco21gQV/Sr6zRHo6/nTLi2EpDA7XHf1+vrWFahJtVIbr8TSEre7LYekit0NP7dazHL27Yl454bsaX7S2DnIyOueKzjjIx0noynRb1RNduDkZ49Kj0tma6m3cYQcenJqsWMrjHLE/KqnkmtS0gEKHJBkbliP8APSlhr1q3tVsip2hDlfUsDqKqa3EJ9MmjYkBtvI7fMKsquGJ5+Y5OT/Km33Nq/wCH8xXsx1pyOeLtJNHFXOlMFY85PJ2jAxWNcK8BBRHdwwAWMgEc9ckgAZ/wwa7bHGe3Fc/rka7PM6Dvhckc9eO3+TXlThbY9ajVbdmXtJvDe2pLkGWMgMw/jHZquDIwOp9eOT7gdz7VheGmVZrgEjYYwST049/St0jjkE8dPWqg7oyqRUZNIZ8uRkcHnnuKCVjXc5CKOCTwKiv7pLK0knkxhQMAnGT7/wCe1efavrd1dSNukZVBwEU4Cj0/+v8AWs6lRR1NqGHlW22PQftMJOC4z79f/wBdTKRJgoVORxgjn1/SvIZNRuTgNM7KOg3YCjqPp9R7dqnt75i/O5STjcrlT16/y/SuT62r6nW8udrpnq2MEBuKQZwCRjgHHWuW0HX5CRDfO0qHje5y6D+orqePvAjnv61vCalscNSlKm7SFAOMEfl61zXxNnks/AOq3FvKYZIo9wYDIOT0x710vHZePSsbxxpM+ueCta0yycLdT27eXxncw52/jjGfeuzDzjGtBy2ur/eFKSjUi33Pky91DUbiOO5uLtbeGFiscULfdzzgqPX3rXttTnkFjZ6nqFvdRpE01tcqN7oDwVfvg4I9jkduOZuHNzbwr5UcNxGvluGwpdgcc571PcXCw6NYwvCv2mJnO4jBxnIH6n86/SHTUklbqe297m6PDEKX9sxu7eO0uIvOjeTPIzyCPUen0rS0uKWy8SWRESmCORcSrkABjjJOSMjt/nGZp+vDVrH7JqARJoogsTpHyxBJ59a37KOFNOtLmKZklDDzEOSCoIIIPt6VEpSUXGpvt/wSt0elXml629gyy6rdefZ7kiMZOZwT/Hn0GQPrXV+EJvDLaRavpy2UKklVThXRmzuXnocg8d+1Ylslt4ys1mtr1ojIDFiM5KunIYjsf881y/xHi0bw4zSXlzeQalIihZYiMTY6Er0PufrXzHs/rD+rybUr7Jfn3/T5nA0qvuSdn5HVa78UdI8L3t7YalC8ksO1rb7M2ROh65z91h6GvAPEvimbXPHGpaxpkr6W17KGU79pjAUAZYfTJ96n8Seb4iupL5baUHyg0ZVg7OAvLnHfjmuLmeRSq4x26YI5r6HLsuo4dc0V7zVn/XqbU6EKK5j6M+Beo6zfalrLXGtPqljFCiYmyxLk8EMenGeO+a9b1df+Jc2OxHH9K8s+BHhGfSNFj1221dJbXVB80CRcFFYjrnhs5+nevXpoVlheJ+FYY69PSvjc5cJ4qXs2rLTa2q0Z5mIlH2t4nOWhXf8Ay/P/AOsP/wBdbcLAoOBj3rBkie2n8pxtKnBzxn3q7Z3pbYGXG8HaOdwxzgjtwM+2K8OHuuzKqR5ldGwSCuf8/wCf8Kq3jhUI49wTSfagFHIzjJ5rPvLhmbaM5B/TFaynoZwg7kGd0wAyWzj6f59Kv67vhtoI8ERqOT059/8APrUek2TTN5rj92vOP73+fWtTV7c3Ni4Tll+Zcc0KL5S5zSmkcragNJgjJJIJ559R+VdLaIqxjGGH9K5YZifkcj6/hz/nvV+G/aNcHOef8/5+tRSlbRmtaDlsdqeeQSPp3prHzIvlLruGc4wR+BHX2Ip5+n40mOvSupnkIRgCpVh8rAgjHaub2SQOySfeQ+n610vPP+c1Hc26XCgPww+6w6iuXE4Z1kpRdmjajV9m7PZmfbXYGBnIqZrxOuQe3FUpdPmUjau9exXkmo/sF0xAMT/UkCuX21eK5eR3OjkpS1uOurvfnbjnrjv6VBaQPdTlVX6t2Hr+P+NX4tJwQZ5fwTr9M1oQrEieXBtCqSCAc8+/vUxwtStLmraLsKVaMI2pkmAAoAwoGB9KXHOc96Qc5xSj9K9HdnEAGAc5OcmmOQAecEe1PkIxg1TnkAYAHknpWdSXKioR5mWFOfY1KowOtQQAjGOn1qxjA6CqpXauKWjHKQfqPao7r7OE33KoewJGSfpSXVwlrA8rg7V7ep7AVzN1dyXMglYfMf4c8D2FTisVChHlkuZvoaUKEqjutEa/mWyBiLfjk9f6VKmoRxDiED6NWCjOwGOgP+f5VMsUrEggn8M1wxxs0+anDX0OuWHj9pm/b6hDO205jbtu6GrRwDWFa2T/AMSnbjmtBPNgGJDmL1PO2vSo4ipOP72NmcdSlBP3GXRz0pJHSNcyMAPeo/OCjmuZ1hBdo1q2oSwyPISxRckL/dPp2rthHmdhUqPtHZk7azdXN+1q1hcW8KlsyF1OV7MMHqfTtTdNWCONbfz5bmWMkF5zvkbJ7n1pmjvAisqSo89zulkZ/lZnIxjHoAP0qa4DW00EAbMEj7XlYhVQY7H19K3cVe239eZ2OMYvkirD52MNxbwxGBAT84PV+Ov50R3+pwtcstmJIImXaGmA3r3YH1Hp+teD/EXx7qUKWGmaHJCW02RobvWkiMke7OFUE8dPvHuenvQ0H43a6b6zsbqwt9Xtw5jkWONo5ZVPXbg4P0Ir2KeR4iVNVIpP10f6b+budDwcnHVJ/m/T1PqNZ4psIcZIztbuKQWluDkRJn6cVy+keItK1zw1FrOkS+bAQUCJ9+IjqjL1BHcfQ9CK6DS7ovaxLM4aUoHTJwXXt3614tTDtSaqR1XdHlzpygvdLqRRxk+XGq59BikuJkt4WllbCLTxWDq1z515sU/u4e+f4u5/DkfnXJicQsNT5kteiIpU3VlZk66jJLcwqf3YZ1+ReuM9z/StW9/49n/D+dc/BGwuLRiGQl0yh5IOR6fzHFbWsSeTp0sh/hKnrj+IUZfVqTp1PaO7X+RpWhFTiombIwC9QO+e1c5q9wHchcYGMDPOcn+nFS3V+7j5McHJycYH+P5D3ptnpsl43mSEpDwc/wARHsP61MveOynFU/ekTeHYmSGefCgvtCk8Zx1rW65GOen604IsaLHEu1FHCjnj+tRmIFCpJwRjIODg+n/1qIpoylLmdzmfHMzpb20S52HcTye2Mf0rgLgnOTnjOM8HH8q9E8a2klxaQywjd5JO5fVTjpXm8jZO7+I9SOD+f51wYlO6PawFvZ6Aq5PPHGOOPwx9f88VMkAbJHQ8YxwT7/5/nUcTAH0HXJ/Ht6/l1rQgI4HI7Buv+f8APTrXGo3OyUmi1YqdysOqn8Ov8uRXcaDdNPbeTIR5sQBUHqV/riuW0yEM6jGQeo6kf/W96tR3otLxHjVnZHDELxuGcHr61tR93Q87Ex9pdLc68kZPAPYc1JG+1w3XB/IfSqcd3bz/APHvMjf7O4ZxU4OMA8HrzXYpKR5jXc+Wfi14Kv8AR/EupyQWVy1nJctLbuiboyj/ADYGOhBJyK5zTIYbiyaHWvPRckROqAsr9we+O/4V9XeNvD7eJNG8m1l8m+t8yw7mKq5xjaxGSPqAfpXkh8C219J5V3ptwZ2f99JbyHK4/idSc468ivtsvzeNSilVeq7fn8/+AevQrRqRu3r1PN/DulvdahZ2WlRzXV3NJtLbCoUHgZ9AOp9q9c07wTPpN9O+o36z2qjaAqFQj4yevBHvSslj4cvbWKzP2fTpU2efFcZLHeD8567uo7V0l6tgjpHDNczzXj5ltFl+ZiR9/k8Lj0qsVj6lRrl0i121/wCB/VwnVbso7HBanYX1rql3N4YmubeeJ+JLbjK7d2COnHPNeU+JNRvb2926nPNcSxEgySsWYc849B7V9BWunPpmm6rPBqUlxFMNrxO33GAI5yeSRwenr2ryrx/4N/s8/wBpafbXX9mKFMisS7KCPX0znk//AFq7sBi6bqcsvRPrsXGSloZPhTUxp41GbT2WYrb8mZsbOxIXv2qrYafHdNNeu6XFyXY/Z2Bzk57Dr2rPs7eyV/OtUuLl848jYd3444wfavS/hn4Jmub6wkksJ/PW53zzCT5beMEHaw7kgdK7MRVhh4yqSdv6/r9C+ZRXNI9X+B1jd6b8P7ax1GKeCeGaSTyplI2K53Db7c5+pNegnk9qRcAcHgUp/T9M1+e4it7erKq1bmdz5+cuaTaKt/ZR3iAFgki/dfGfwIrDubSWA7JkyNwYEE4yOQQfrXT9eB0NOGT2H41yTpqQ4VXDQ5bEzKQquSeBtU4z9P6VpWOlE4a4O0dkB5/GtNriFPvTxKO+XA/rWdqetR2jbIwHkI7kYH+fSp5Yw1Zp7Sc/dijTRAsaoiBUA4X0p/TnAx7965X/AISC6LnGwr0+6Ov+NWbfX5t375InyO3y59waqNaHcl4epvYs6jo4k+e04PTZz+n+HSswaNdYx5R2/wB3/P8An862rbWrSY4fdD/tOQV/MfzrTOc+/wCee9X7KE9UCrVKfussbZDKcsnlEABdp3bs8nOeRjtj/wCtk61r9vpdxZwGOSae6J2bSBGoHVmc8AY/HioPEOoXiyW8elRLIAfMmZjhBGOuW9f8K811drzXLI3Kz2cGlyzK0VxeQs8akNt2Sk8bW45HQZJ9a9HDYVVHeT0/q3+fmGHwnPaU3odbD4o1nUNauLSxtrdYbTLTKTlpBj5REeA2epPaqaXGt3Oow3VreyWjXdowu3x58EWPuNGmcCQcgjoR16CjwlpH7lCZYRaQeZH5MJLIuRjKsedvXiop4tVsZdH0nT1trW1PmSXNxuyBGnVAMfI3oc45OeldDjTU3GCWnf53vffvaz6bndGFNNxikv6f3/8ADG4LzVYNKti00TSmBpHuAuM7epCdMkc4zir1h4lS4uVjkt5ktHSMx3jEBZXb+Er1X6nj+vK32oy297a6ReWfkaVdwg/2lAxKxO7ELGWPA6cnPeqM1h4a1/WbWCy1Sa6uNFhkhNlHcFVuiPvZI6kZ4P8AhWSoJq81pq7pX0+X3Wei3JeHhJe+vmux6xznjHJ9etNxzn/9dcF4C1jU5b97aTybnw88Zmt7sKUa3yQEhYHrxnn1Fd/jnH54FefiKLpS5X/X+XoebXoyoT5JCAYAwKeOFzihc5yetRXEm1SSeKwfuq7MLXdiK6mEaknpVO3zK285Oeh/wqjcTNd3TRp9xPvHPQ1sWUO3kjjtxiuK7qzt0OpxVOGu5aiTAzin9ST6UHAyBQOcZPA9q74JLRHI3fUy9dnUmODB4xI354FZcMRkb7vBqfV2zezhiCARnJ6DH/16fYFd/wB4de5rxpv2+Ilzeh6VNezpKxctrRQP51fjhC9KjhKgA5BzwOalDK33WBHbBr16VOMVojhqSk2SDj0qBiGOJDkenrUyMOxFVriHGX2/MemP5V0pkQ31FnZdjb2UdgSazb65hSycAqrBP3hPdsdKcsyXO4ysApJXY6gZIHT+tZwdLRJ7rXLm1gs/4RI42Rj6nj3rohC7s9zrp07biW9m58wS28flRxr5OfnYk/eG/qe1T3Wn22sacIdUt4LqIPv8mYEMmBxkA9a5tPiJ4Y/tKeyfXrMiJQ6SRNuXryNw49810NnKb69e7trcLFJErGfGBNjoM9eAa650q1O0ppx7PVfdc2kprV6Hlur/AA08QR6rqGneGb6zsPDWqRhZ4pV3lWHIUZBJ65zx1PtXkXifSdc0HVNJ8NataWlpNZOXjurSMlrxHbiTcOW6YAxnjHWvryQtH8wIOOVI5wfT2FVP7PspNWTU9Qt7eS9iGxJnUHygeuCenJNelhM6qU3eqlJW6bt2sm3100dzop42ad5fhu3ofO3we8W6Z4Ms/E9xqTXMjTFVt7NRhnf5uRnhe2T2468V2/w0+MFrcT6dB4ut/sRlHkWN4zbg53AYc+pyMtgDIP4eM/Fq5jt/iR4iW1WS6tmnO2bOPm2jcARxgHIrlzaSt4cmnicS2DuNjEgvG4Gce39fwr6Opl+Hxcfa1FrO3y06frfc2qU6dfmcVrZvta39dO+p+hR6GuSiB3xNtJJJywPQnJyfbjHHPNbfhu7/ALR8N6XeHf8A6TaRTHzOW+ZAeffmsp4jHMyMeEJU8fl+mK/KM5g4zhfo2eRhfdcomrFH5nkOOqMOB9RzVvVYVuLCSJyQCVOR7MD/AEqHT3BjXBHUZ4pviOd7bRriaJirrtwQQMfMB34r08KoqlOa6r9DCV3UUV3MuLTbaJkJQSHPJc5zgenQdvX8jxZVX2kSFWOTjam0BcnAxk84wCe5GcDoOHn8WXluhMriQ9d4jAx19e/Hf0qrH4svj8yXTsMHjapB9gcf5yK5uePc9L6nWlqegZB6EHt1z0OD+R4ppPPHB6+tcnYeK5xKv2xUuIyOu0K49QD0PPrjpXT2d1DeWqXFsxMbdc43I3UhvQj/APVTU1LYxqUZ0viQl1GJIypAz6V5p4k0R7G/cQnEUpaRF59eQPp29q9O6ADGMdugx6VX1CzttQtjb3SFkzuVhwUYdGB7Gsq1JTRthsQ6L8jx4I6sDjcw5HGf88npWlYxMSCc8nqR1rb1Twxd2zs8eJ4v7yDk/Udv89Kz44GRdxYEqT24HXqP8968yVJxdj2fbxqRvFl77UlnakK3JGD3/KsCa6aWU5OefqT/AJP8qdfuWYquSOufWptMsJLq42xITt5JJzjnqT/j9ahXm9BWjTXMxsErKyEt8+PlOCec8/54/wAOp0DVpHJtp5R8xxG7jPlH+o9iePpWbcaX5SDlSSu098jqRj8PyqtAPIuEBzndjKgtyMt26dM5PsOTitoNx9DlqctVHo8J4zz17jB+vtVLWtNkuEe404W8eogcPIMhh6e1TaZdrd2yyjhwQsg7Z9R9auZ4GD+dd1Ko17yPLu4SPEPHmk3mlxQC9t4w8zs5Nuu6NW45UY4HqP8AGrXhm6kka0i1GMJAil1nVcFBngkjkD/634+ysqSKRLGsi4IwwyP1rz23vvDMPjG/8J+W2m3mVljjkkJjuw6AnYT0YEkbfbI749unmKnS5Jx1XVf1p+J0fWU/j0ZTsor4W2sXd1aR6okLhYYY3AFwhHJzjlgDnPXP41mSC6KtHYacL2wMX7tJ5DHOgPWJv7wx07+tehWHhiGxkuhBOVtpVCoikgoP8mp9O8NWVkriR5rtmP352ywA6D8Kax9NXe+1t/8AM2+tQjdo4zQPA6QlXjS3uWEY2NJFsIbOeSPTIHrxXoem6fbababYYYoPlzKUGAx9T6/jzVpFVFVI1wBwAKx9bvN0n2eM4VG+Y+prgxOMqVvjZzTq1K7s2PuNZbOLdQF7Mep/wqq2pXirkTPn6D/CksbNpDk4Pvz/AJxVnV7FYLFpV5IODkk5z3rz5Sk9UNKnF8tjNuPEFyFCCQq+fmdccn/Jqk2pXExxJK7A8DLH/HH+T+GdOPmYZOPrSqMoUfjPAAOMGuR1p3tc7o0YJaIlknY5Jb1znpjHNRo5LZbJXHQ8/hRMcjocgZ4JyPfAqJRyvfHI556/yrNzk3qaqKsblha+eQBgnH4Een+fSrM+nMoOByfb+f8AntUnhdg06qSTwQMDrx/9augliDDBHTnPT2rthSUo3PPq1nCdjjZN8MmQxPc10GjzxX9stndAuqss0QJI5RlYDj+6yqR+XSs3V4tr4APuB3pfDOTex7QMBtxI75FOheE+Xox1Up0+bsVr3XtM0VUvNQmSPQreLzluSTxLJ8vlFFBZuPm56d+1P1S30/XLGawuNSY2t4itBEi4KqeQMAdDg4zXm3irxZYeFdLso7vT7e/1TVZWvTa2k+Y4Ygx2rvxywxjgdc/j0Xgzx3Z6z4cvtZhtJLL7BKIb2yaXzGRHxiUnj5Tz9MH05+xlgasIKtCL3snp30873vrs/Iv2c4STjvt8/wDg/idPczTw3E9zBLDbfZ7T7NDDM58qQryDtHIA6ZHr7Vja1BaW+gxWPiCa41SC5YFAkYWV5icjZjjao7n86g8VavpWmX1vqutatYrBbyKJbeCVZJJxjITb/dwQe2e5PFMNufGOhabqb3c+lTM7PGLOYuvlsTtR+2TxmueFPkUaktI9/Ozsr7+tu/3bUoqLi27L+vmbc2jS+fKkRSOzNrHbC0kQPmRuA55xwKzNS8KaRJaWdpJby2ZsbjzPLsSI5Z+MbiRnOcfrVPRrGdNWu7DUZL6G1eMmeC1n8ws0Sg+dz8y7sAbR36dap3/jsafc3Gk6po+pTarqsJa0tbMjzBGchd7nlSRzkZx1pRpVua1J3tZ6aeV9/W/5mj9pB+7K+23np/n/AJnRW15JatZRix+xajDD/pNs8m9baFmITcfukng16Bo1013p8MkjxM+OWiOVP/66+epfHyW+oJpeo2umGylljhuphdM8qr0YSZ5YDp+Br3jwxq1jqOm2cmneUtpKrCBUwMqpIyAO3Fc2ZYWdGKlKO/Xf9X93ZddzjzCk1FNo2mOBjHasfWLhkjIjG5zgDAzWuwyp/KqEtqGmDueQcDkkAn/PWvCrJtWR5tFpO7KGkWWxQGUbz146e1dCqKidMYFQ20IQY6cVOx/IUqNNQXmTWqOchoHB44NKMDPA/KkPX0pRxW0dDIwdajK3khCn5wGBA/CqlrceWw6YB71vanZi7gBQDz4+Uz3HcfQ1ycoZZCcEFWwQTyvt/OvDxilhq/N0ex6uGaqw5ex01tcjcORzwKsG5TnB9+lcet28fGR0xwfwqwLxzjkk57mtoZjZWYpYK7udI94B35HXipLR2lZycYReSexrn7V5Z5ljiO+Q9ADwM9zXU21ukFuIV54+Zu7E9TXbgqk8RJzfwr8zlrwjSVupyd4850+a5Kxx3ET5DA71TB9P8a+a/i/41PiHXxYQXEsun2CmBcZxLJn5nIHJ54HsK+oFt3iuXilAxkhlxneMghv6V8o+MrTS9H+Ier2Q06X9w0wZAcb3OSjLjGF5U49K+64eUHVlJq8krry/r9T1MFyzl0MK51L+wNUlt9GEEsgVA8mAwLDBIHYqSK97+G/xgsNWhi0/WLQ6XqaqBDEmfJlHT5c/d+hzx37V8y+Y0CvuGZCM5P8AKrWlXk76na3DvIfII2DdzgHoK+mxeApYyHLU379TSpatJRlv0XY+31inXzpruSMW7ZZQQAQnUZ965L4yXOpJ4Bu30WRlN15cT4XDMjEdD2Pb8arf8LO8O34topNQEV5JiJ4JoznJGCPQc+tUPG8E+reGdRsJHmRpIXuY7hQTF+6KnaWHA3dv618jhsLOjXhKtG1mt15/iclKlJVI866nzVHJNNbGxlciGNzJtf8AgbocH8KoRSGJ1t1DTQTPs8sDq5OB/OtS8tJrS42ypG8ci7y5bOV9jXonwA8Ez+JPFMGr3UIh0XS5VnTzUP76XOVC+wIyfw9a+0xGJhh6brS2X9fiz0MV+7jduzX5fla346H1hpcDWumWlu33ooUjP4KB/Squq2hLG4iDE4w6jqR2I/w71p0V+VYmlHExcJ/0z5iNRxlzIwrGVknhA4VmAyO+fSp/Ge7/AIRu7K4zlOp4++v+f8KufYIftCyxho2BDEIcA8+lVfGH/IuXfX+Dp1++tRg6FWjh6kajvvb7jZTjOtBx7r8zxu7tWuINrsRJw7HqfXAOBkdPoPfrFaWklsclht5355JIxjn65z+GMYOdhSN20MWBOfmPQk9Mj0+nSoyF8vcu5QRjO0jHXrx7flz0ry3N25XsfSqbtYqsmyQbjlX+Xqcgjj/61bHhfUZbbU4xu+WVhHMOPnB4HvkZ6/hWZPFuTCjB46enb6f05qWwTbexr1y69ec4Yc//AFvrTpP3kzOqlODTPS2XBxjge9N2/MRxn0x/n0FPlwXPQ859e9Nx8uOw7n0r0L3VzwwUkEEA59RUdza29yP9IhjZj/FjkfjT15GTxTj0wKxmkxptPQ811iza11CWEALh/lA7c5GfzrR0Hy4o3jUKHb5uevf/APVVnxjATehwM+ZGCMe3UfyrFs5ysgOTjIPA6DHX/wDVXA0oux6t3VppnVKpZWwxOecGsi8tljkYjgevtnp/n2q1BdqY1yVIHJ56Ecj/AD09aq3M3mPxxgY5bgc/Xj6/WqbVjKlFpmx4Xf5p0PO5Afryc/zrdz1GD/jXP+GYyZJpsAKqbRx6np/+r1reP6Drn+tb0r2OauvfYuQWB4zzg45HtXzh+0nol7P440e70q1uJ57i02KtujO5eNzzhec4Za+js88gAE4PtSj0OPauujVdKXNY5px5lY5L4Ry67ceBtPn8TXMNzdSoHikQ7mMRAK72yQzdeR7Zyc12YBPUZ6/5/wA+lcloIGia/d6HIpWzut19p4J+7lszQg/7LEOMfwv/ALNdaME5ODjNOT96/cFsLyNw74PX6Vya5aXJ65yfXr/OusXjHHHf3rm76E2t5IoXgMWXHcGsKvc6KD1aN2wUCEA/pUWuqW0yTHqCcfjn6VW027Xbszwau3UiSWkysRypxmmmmiGnGdzhbgYZjkk8nn+dRBsNgHIwc4749/8APSpL5QsjAAdyMj9R+FVUI3ENyRnjJ9un+e1ebU0Z68VdEjnK5b1x0980wZYc/Mc9qk6ZzggnK544/wAg/wCeaiVCOGO7jqcDd+VKSdy0dH4dlMdyj5wB36cH2rprq4CZJIBHQZrhrCQxDIz1x0/KtGa7LEHJPPr/AC967KVW0bM4K1DmncXUZVYk4yME+v8AP3Na3hiHEby93fcawoIJLiVI1VTI2OAM/wCfrXa2kBtUSJVUoqY3Fuc+mMenf9O9b0Y3fMzLESUIciPkz4ljT2+LWrrIkNvblFbzEkJWKUKPugcAlgQQO5yelefW08oubljK6GQlWVWI3egNdH8T78z/ABB11VtY41trry0wQc7eMn1yQT+Nc1qogivQ1rcQTxzRqzGNSoVioJHPocj8Pxr9dw0eWjBeS/r5npSqpRVvsv8A4Hzt89y7dXEF6iK0MUVxCgUiNcbsfxe5NavgXxhdaHqxbbdHTPJaOWCOYqxB5DJ2BBwfz9awbS1YWcltHEk99cuojbJLKP7oHqcio4YLvTbwpIjQ3Kho2VuqjoQf1qqkI1IuEloEueTjzK3e34J+Z9deHo4fEdlpWs6Jc/Z4ATIlyFVricY27ZewbO4Eewrx3x3q/ht/ijOPEWp3crRMYpdRsSqlSFwBtAI4PBxUnwS8Qa7pWrT+HbCKNjfQG5ghnHBkGMkcjgpu/KvM9T0O6k8VX1i8e2cXDx+U5+bO4jH1zXg4XA+xxNSMpaJaWtez6vr+n4GcYVYN8trrRd+9+/6Fq00awGsmQXX+gOHaK5nG1XP8IP6Z9K+gf2bNSudR0cxXEdqRYebarKiHzGXeGUM3TA3HA9hXz/4v0J/C72tlNdQ3kzRLI0cDE+Wx6IfQj096+rfglob6H4A09ZJAzXUa3LIEAEbMMlff6+v6ZZ7Xg8Kne/M1b/MnHzhCjypWb/NneEkjIIPHejHPX8aP88c0oA7c818Qz58AeMUHjA/Ojt/KjuegpALR9eKO9HSnYQoyPX61Tu9Oivl3ygxT5PzoeevH1q5kZGaUdsZonCFSPJNXQ4zcHeOjOem8Pz7swzQuMfxqVP6VHB4duCT5rwwp6plj9Rn+tdMDge1KMZzjmuT+ysI3fl/F2Oj67WStcis7WG0j2Qrgn7zH7zfU1OKb24qK+LLY3DR53iJiuPXBr0VaEbJWSOXWctXqxs8Syyq4CsV4JHUV4H8dfBrx3tt4ss7CW5ktpP8ATkhPzOi8iTIHbGD7Y9K9Ut9Rkt5U8tsEgADOfzrYivYbu18uYhJiCrHGQOOvuKMnzyEaiqQ0fZ9V6/1qelTjVwslJao+FpbpLuWSK0sRmWQurckjJ4WnahY3Ol3EcdzCyTsgfCYJUHoePb1r6r8XfBfw5rcW7TVbSbjaSZrRfkcnPVM+vp2rzi8+A3iCwglfSdSs7+aVfLPmMYmX1OTnPH86/RKGd4WqtZcvk7/nsejTxlGpvKz+639ep5Hp2vTPqWWm8p3j8k3BTcVTGM/l3/rXXaLoM+q65a+HdO1t/wCznQyTSwSM0G3kkkD1x3FVYPhN46kkjddICjmNnEyYABwcjNfQPwv+HVt4I0K5mDreareqPNccYUfwJnpyfzp47M6NCnenJOWySs9e79Cp4vkh72rKHhv4b+HLPyG+wmadRjzboFo39Dt6Y4GK9TsIWeOIzRogi4REXC8dCB2qtZWu7VEmLExi3EYUnrg+nQVs4wMDgV8VisVUxD5qkr/oeLisTKbs2FJS80DrXH1OEVeorJ8Y5/4Ru8x1+T/0Na1c4x9RWV4xOPDl2cE/c4HU/OtbX/cz9H+RpR/iw9V+Z5ci7VOA2Tzj27dvQ59aYXAbggYbbnuB6fSp5rSQybhwByQSOpI5z1qvJx057Aj8iP5f4mvnJXZ9QrMeh4Kg/TPr/nirujwtc6hbBRgu6scnoOv9KzbdGdvlxnAPPP5+v0FdxoOm/YYvOlH751AVc/dX+eTx+lbUYN6vZGGJqKEfNmrgD7qgAnOAMAk5JP4k5PvmkH54x06n/PFJjIGMkigsscbSyMFQfeYniu1+6jyrDsnOP5fXpSkADsB9OKwL3xGiMUtEDDp5jjg/h/n6VU/4SG83fejGT0Mf5isJVEtzdYeo1ex0V5axXtuYJgdp5Vh1RvWuEvLGW2upIpuJEIVgTgEdiP8AP510dv4hcsBc28bIeCY8gj8CcVsxm11CAOESaMHkSJhk/wAKwkozLhOdD4locGGfsevcdR3zV3TrGS+n8tPlUYLN2X0xXWGxshj/AEWHtztqZI1iXbDGkY/ugYGfwqY0UtS5YrT3URW1tHa2yQxE7V7kck9zUmcYA6dBx/jT+wHHv/n86aQPUkHjFdMVY5G77irgEYzn9aUDBGcjt9f8/wBKaBzycH9aeDg1aEzH8S6VJqdtbtZusWoWkwubSVgdoccFWI6KyllPsxI6Vtr0A547Y4pB35z+NOAOCe1VfoSA7f1qO8tY7yILLkMvKOOqn+o9ql654z+HWlzyf5+1O1wvbVHPXGn3NsfmTcn99BuU/wBRUJkY5XOD7jv/AJxXUhjnKnHX6GlLZ545796z9kuhr7d9UcgNKmvnICNsz9/GMf59ualHhe5J/wBdAUxycn+VdWST1PFKDnk4Ge2eM0LDwe6D61U6HMReGJCcyTxKOSNozVyLw5bIjeYzTtj5QcKAfb3racEqSMlsZHODmlPrnHtVqjBKxLxFR9Tnv+EaIIaOdCCOjjkZxkZHFWYdART+9nJ9lH+f8mtn/vnr0pQegGaapRE69R9SK1tobVSsCYJHJJ+Y1OPryeKQ+2aUdP8APFbpJGLberPmr9ovw5eaVPBf6fpdtcadd7fPu0gw8Ui5AXjoCMH3I+teJyWTTQx3caSeUW2FsfLu9M+vtX37rlqb+wnsxHGxmicIZQDGHxwGGcnOT0B4B9q+erv4KC2lhv54p4LWaOU3tus6t9kcdHU/xqevrj3r7HK84gqXsq7s1s+/9fd03PVw9aOIilVeu2v4W0+/v9yPAjY3Z1BgAwES73kQ52j1JHStS7W8vNNfVbkM0YIhEzNlpGAGfc4GMn396+hvA3hDwl4U8L3E2tpdrBqybJjfZzOo5UKqDcm7rg89OlefeLfhHrEGoDUfC9q1zoUgSSFHkUSoGGcbSc8Z616FPNqE6ji3ZX0b2fdJ97m9JRi5La776eVnpe3Vbs89tEv9P+xG2nlku5UBtHt5j5kGT0BByD1496sa44OyS7spNPuEgUblZmeaTvI245BJyeK6Wf4e+K9L8WW9hpypZfaVBjuLqdFKK3BY4Jxjnpz6dRXpfgr4Vyf2leXWsQxanewXcSwTzSs0bRjlpdv8WeMA0q+Z4elH2nMnp0f9I2c6dOL6WS9H6dX+HY434Q/D688VazHquradeSac5Je7vGK+Yf4iAeWJGQD2PPavqiwsrbTLG2sbCJYbS2jEcSKeFUDA9z9altoFt49qsxPfPTPsKkyCOnvXxOYZhUxs+aWi6I8HFYl132S/q4ingcfpSn/9dHQU72rzrHLcZyGxgAY4IP6YpQTj3pfwopgI+QBg0LkdfwNL0paLaiEI3HtxTx3JwB60i8+ua5rV9Q+1sVjz9mU4UD+P3Pt7VnXxEMNDmlq3sjSlRlVlZGzPqtnDJs8zzH7iIbsfU9KWPVbNuGkaM/7akfr0rj2LEYLADHGDjH0/l7UI7xv8pcdMD+X+f/115f8Aa9a9+RW+f5/8A7/7PhbfU7yKRJV3QyI65xlTkfpRPIIbeWVhlUQsR6gCuPsr97aTzYwQwHzDGAw9/wAq69Giu7XcpDRyLjg+or1sJi44qL5NJLp/W6OGvh3RavsefTzN+6MqAv1LLgdf06fyqS2vvJOCvC/L9P8AD/69M1azltLxrfLBlGU4+8nrms0sw7npjkY9/wDP1r4+nNwdnG0luux9DGEZwVtjroNQMeSgIAXIIbv71c/tpY1O5UfuHJx+FcrZlgnVgrHGcfypxl+dkbKlW4Pbp2r1oZhWhH3H+v4HJLBwk9To31qNGdooIlLfebPPvxWdLfuQBuLFMlc8Y/x71lsrcsozjnCnkf5/z1qDcQDjAzzjs3b/AD+NZTzbEz91ysaU8JTWx1Oh3XmX8KcYKsMDjtmulPWuT8JxGTUGkIG2CMr+Jxx+QrrDXu5bKUsMpS7s8jHJKrZCCkIORg4weffilortOQRxkLj+8P51m+L8f8I7dZUNynBGed61qDO4cDFVtbtheaZLAzFAxXLAkEYYHt9OnQ9DxXRGN6c/NFU5ctSLfdHlZuEaIlPnQ5w6ENnqDg565z+OarGMyyn5MDG5mDAjPp/9f0/I9mvhuPfua5KjOMKnbPHPr3/E9etWbbRLK3kD4kkcEEByMD8B/X1ryfq7b1Z7n1uEfhKHhrS1hjE88Xz8MgPXHr+ea3mHXoT14FPJzg49On+eKYN2MHGevHpmt4w5TgnNzlzMZj2/Gua8V3hMgtkb5UGW56sf/rV1Cj5unfniuD1Uu9/OTu5kb371nWdkdGFinO76FaGCSZtvzZ6Ek5I54+taC2KReSkjKjTsY4gf+WjAZ2g9M4BIHfBwDjifRrfJU9cHPBJHIx/n/wCvW3PYw3lo9tcwpNbuMNG4ypAORkexAIPUEAjBGa5Y077nRVrtOyMCWxZRu+bHbH+P5U20nlspleI7WHGOzD0Pr35rolgWK3jgDzPsURh5n8x3A6bmPLHpyeT3yeaxL+FUYkAYHINZzhybChU9ouWR0lrcLdW6TRZw3BX+63cVIOgx6ZrA8NTf6RLATnegbnjkf/WP6Vv/AIn345reDuctSHJKw1mC8HOO1GQw6g8dfWkZdw5AHc+9OAKryCMd+4+la2IBvQDpz0p2cHHJOOM/59qQ4Hb1p3XcM8/TvQIX+HvzkdaX6YyO9NXjdjGQOcfpThzgdeOnf61RIvX9etOJww5PGck9qaB6inL+tUkIcPxzR055560g68ZOeKX368VQheh79ySR2pSPzpO/p16il4AAx098UxC+uR+dBHHOfr0oOfbNIM5Hrg45pgL+HPT6U4H1P14pvb2pc5/H9aYhcccgjBPf/P8A9akIyeWOMEYDcEE9x68fqRS9OvT3oH8/SqQF0fKDUdzBDcwvDOgeNwVZT3FZLa27NhAig8jucf5FTJqZx88ijnndgD86xjjKTdosX1epHUH0S3MXlJJMiFNnDZIGMDBPOQOlVNN8KaVpli9pZJOkMjq8v75i0pUYGSTnGB0FXW1J0PzRIR3Gdp/Wr0ciTxeZEcqeOeo9jWkMQp3UJepUp1orV6GcdA0gyRu+nW0siY2vJGGYY6cnmtIbVXCKFX2GKUEZAyOvNAwTx2xSk5PdmMpyl8TuIenP40uOabE6yIkkZyjgMDjsRTwOfeoSuS9BAOSKU8YqG5uLaxhBmYRrjCqo5PsBWPJ4niVyEtCV7FpACazq4ihQfLVmk+xpCjUqawVzeJ96D0rLstetLh9koe3c9N/K/mK1MAjcD17iqpzp1Y81KSkvImcJQdpqwUnU8UvekGOgx+FUSVdXkMWnS4OGchBzjqf8K5SVhnjBJOBjpj/Peul8QJv03IOAsqnOOnP/ANeuXPMvJPWvEzNt11F9EepgUuRskt7ZZXDhQ0mNocjJ2nsD1AOBx7c5xV06e+MkYHr/AJ/z0qzpKqXGR2HvxW4yrt46DnNbYfAxqQ5mya2JlCVkcdcQeUSSMEc/T/CtLQrr7NcqpbEMgCP2w2flb8eR+XpSauy7+Bjr26/hWXG4L7DjJjxjPT/P+FckJ/VK/PF7fkbte3pWkdnfWNtexGO6iVhnIboVPqDWHN4WUuGguwV/uzR7/wBQQa3bGf7TZQTA5LqM/Xv+tTDj0r38Rg8PiHzVI3ffZ/erHlU69Wj7sXYxYvD0YizJOXuApCsBtUfhzXK3UM1tctDMNkynoeh9wTXoueahvLW3vYfKuollT/aHT6VxYzKoVop0fda08mv66nRQx06cvf1TPOmA3qViKyAbcjvSRKXmEUYLzSEBIxzz7j0712LeF9PJ+VrhB6LJxWjp+nWmnKRaQhC33mPJP41xU8nxE5r20kkvO52TzOmo+4m2R6Jpy6bZ7D808h3Sv6n/AOt0rQpM0V9FGMYRUIbI8Wc3OTlLdhS0Ux0LKy7mAbjjHH0qkSPjBUAFix9Tjn8qbef8ez/h/MUrOqMgY4LHCjuabfkC0kLdOM8Z7jtXVT+CQL4kZYHIPy/dwePft/n0oYZzkfWnKD34PqT/AFrCvdf8uQraIjKDgM4I5+nYcVxzlY7oQlN2ibRGMnCge/AzzSFWIGFJVgfnXGP8n19vpXG3t/cX+BO3y54VeB+VQx3M0MbLFLKinggMf5dK5pVkjpWFlbc7gqVIO3AGAOO1cb4gtWg1K4+UFWbzAT3B5OfXnNSaRrD2t0q3Ehe1c7XDMTs9GGe44zW9rOnC/gRoipmQfI2eHU+/+eamUlNWHC9CfvbHP6VMqONx5HOP8/5NdFDKrr1BPY1xsiSW87IysjJ8rRkDIOevv6elW4tQ2rtPU9Aa51Jx0ZvVpc+qOluJEVOgx3B5zXOaxcq7kDHcdaZc6kzr8v8An6/57VmSsWcs2Qq8Bjzken17VEnzbFUaPLqzY8OKzanGQpKgMc46CupOcYH1FY/huzNtbNPIpDygBR1wv/161zjGB/8Aq/z/AIV0U42OWvJSnoOxzwMEfjzTUCouEAUAAADpjsKPQ9R6UEE54J961aMRw6DpS5zx1zwOe9IvO49vYYpc85GOOcg9KVhDhyM8EY4xStjPTPcUxF2AooGASVGMYGc/1p5xVJCYv5E07BJ5Gcc//qpoXd1HU8D/AD+FYuta2sAMNkQ0vIaQ9FPt6mlKXKVCDm7I2Zri3tz/AKRPFG2OjNz+VVhrGm/8/aYPfa3NcI4kmdnkLNuySzDkn1qQQtzl29SQCe36isPbu+iOv6mrayPRLeWOdA1vIkq+qnNSf/rHNecxyS27iWJnBHOU4I4/+tXUaFrYuSLe7ZRJyEkPBJ9GH9fz5rSnXUnZ7mFXDSguZao3TxnsfQUuAcgjoc4x+VBGM8HIpMfXAPrXScwvb+uKX345HekHQUjukUTSSsAiDJNDdlcBzssaFpGVEHVmrOfXLBThXkcknoh5/E1zOq6o99PuPCjO1M8L7H39f/rVVifcSCEAx3PX/Dp9OT0rCVdp2O2GDurzNkRFgwxk4yTkg/XjkdOvt7U8IQp3AMMEFWAIPpnj6VsWoiCKWAPftUVy0ActGdpP4g8f5615jwqUea5ftm3y2IoE81jvP+0Se3pV+whLG4SOZonePb5iYLr6MMgrkZ7gg8ZBFZ6zfIcupHYjv9K1dEGEnY8kNtB9OOldGFUfax5dznxF1FtnOeNdfm0uJgqsYVfbLKSAEUDIb88fU/lXMeFvHuparZ2msT2wj0xcwzpEQGRt2FIB65HJHr09/SPEOi2+uadNZ3QUpIDwwyCe1cHb+A72104aUBGdPwNoViNjDrLnqW5IA/HOa+loVMN7JxqLW+/l1+Zph6mHlS5ZqzPSbSYXFtHLkHcOvrz1p1zOlrayTy/cQZIHf2qLTrVbOyhhVpCEULlzljjuT3NYfiq9JlFqhASP5nz0LEZAP0HNeLi66w9KVT7vU4aVL2tTlW36HP6pfz3MrSSsS5GPZR/dFY7SNuyS24HnHIGOv+frU8x3kbuhHQ88fh+dIsRK5wB7Y6cf5/KvjZNuTctWz6enFQjZDYZmGMc8dOx612PhjWI0txBeyFPn2o7cqc9MntXImFguTzweQKmtnZIpFY5UAZFdGEryw1aNSPzXdGOJoxrw5WeoMCDj8qT6dPSsHw3qnmrHaS7juGY2Pb/ZP6/lW8eDX1dKrCvBVYbP+rHzdWnKlLlkR3cP2i0mhwCXXAz0z2z+NcNIrq6lwVblSOvPfP4iu+B965zxDZrHOZ+BDMctkcKw/wAcfnXn5ph3OKrR3jo/T/gHXga3LJwfUg066CAfQHHp9K0ZtSGw4bmubJKO2/zEI9RnPvx2B4yaQzrgjEjHj+H+f+e358dPF1IQ5Uds8NGcrlm5m8+QliAv8RJwOKopIS29sgHkA9h/n/JprSE7Q/CjI2D+tW9HsHv7wQ8qigNMw7LnoPrgjFcijKtLkjq2bvlpQbeyOw0aPytJs177Ax+p5/rVv6UuAMBRgAYAHagGvr7JWS6HzknzNsKWk70CgQpziiilpoQUUUUxBS0gpGcLjPSndJXYDwBnPem3n/Hu/wCH86cjBgCpyDUWoypDZu8pwoKjOQOpA7kV1U/gbQL4kY+pymHTrh1IDldq/U1xAjZnGOnHU/oP89q3vE12oeCJBcOAu5lWB2GeoPA9M1k2k8LyhN43tyEbKsVHBIB6geo4rzKzurHtYeLjC5PBZ7lAK5J7Z/rT57Qc5HJ74Iq7bSALxjdnGP6/59fyZdzoUwRwcAg9D7mudxVh88nI5u4QqwPRemR2ra8LalMJIrOQBonzt+b/AFJ9vasu9ILHG0HPfA5PtVnw0G/teA8bQSeOR0NZU7qRtWSlSdzqNQsLe/AE6lZR9yVOGH+P0NYdz4cmBP2aeORcYw+VI/ziukz17daa5KoxVNzD+Hkbj/h+v410uCZwwqyhszlV8OXjEBzAAMH7+f5Vq2Oi21owklPnyDAyy/KPwFXrYnyEd5ppdzY3TReUScnACYGMn1zkY5PUyEgEklQB3Pb/AOt3pKmkXKvOWjZDdtcC2mNkkD3Ww+Us7MsbN2DFQSB7gE+1TsAWO3OM8Hvj3poGSGJIBHQnI656dz79e1KoyOMAden0/WtForGQHHuDnPPpn/P60rfxZPHvmjGMtxjHIFL+nPekIbjGST27+lOB9Mcfl1oxjIxgHPBpQMkhuPTPNMQvXHX64pc+uM9x6cUxiURmCO5AztQfN+pHX8KcOSDk8jOSMHntj8KYFPW7prWwYRnbLJ8oPQ+5rk44lB3FfmH5j/P+ffd8TMQYAAfu547/AOea50yAnAK46D359K5K0raHfho2jdE56/uwO/JzTCZQpILYz0H8qtWsYkzuyB1Yj+tXXszjODu7kjn/ADnHHvWHLc0c0nYxmwx5AVlP3l47/wCfypqDEuB8rDnKnG4f55/Kp7yMKxG0Y9SAe1VUfe6qfqpJ7/8A1/8AJ9Fdp2ZrHVHfaVctd6fDLIcy8q/1Bxn+VWup9fYVmeHOdKJyB+8YdO9aZz2wfavWjtqeNNWk0hep6k84/wDr1zvjG78uCGFScMS7DOM49cV0I+bGA2D27gGuE8RSmfUZ3OSEbC+wHH+fwrKtJpG+EgpVNehmbjI/Qk9MYxk/T+lXY4H2hhv+ucbvr+Xb/Cqtuo3AtjvnPoa3kliS32kDex4IYAf4f5NcUIp7np1JOOxpzMUUjn3zVMl5Gx64PT+tdc+mwvw5kOOPvU2PSrRCCY2k5yPMbIq6mW1m/iSR5ccbTitjG06zMiF1yEXksBkjHsOpznpXQQxRwRrFCMIO2eSfU1IAqoFjUKq9ABgAUy4mjt4i8p47ADkn0Aruo0IUI2X3nJVrSrMd2pe3U/WsifVnJIhVYx23DJ+vpUC6ndBh+9DZ7FOKwlj6EXa9xrDVGrm8uSQe/evPtWlaW7nkHVpWY+2OBn8BXX2uqFuJoQT/AHkP9DXMazbYuLp4STGpLkd1z2A+p/z1rgzWcatKDg7q/wCmh2YCLp1GpGEqkPxn0GOPwz/n8KvWcSuF9OuRx7fXrVJtpOcgfxcHGfpVm2nAUD+769K8Onbm1PYndrQu3MConBAOMDJxVNo/3DdcswXkY71eRnlHB4HVmP8AnPNQTsvYjYvQep9a3klzc/Rf0jGLewy2kaO6bysb0BdfYgZH17V6JHIJ4IpR0kQMPxGa85tlZnKAbnfKIoP3mIxj/PpXo0aeVBHFjhEC/kK9TJU1Cpfa6+/r+h52Z2vHuOHOaa6JNG0cqh42GCp7incY9RQ2VQletewjy+uhzuoeH5UXNg3mR9fKkbBX2B9PY1lHSdRaTBs5zg8/MuPXg5rqNPvpZZ2jlTHcEf1rRzz1IrzVluHre/G8fI7ljK1L3XZnG2nh7UJpf3qraRj+JmEjfgBx+ddTp1hBp1v5NsCATudmOWc+pNWc80Hn0967cPhKWG/hrXu9zCtiqlbSWwHp81ID1HPHc0v86PxroOcDyOaWge9HemIWigUtNIQlHSloqgGogRnYFsudxyxIHAHAPQcdBxnJ6k0rIHGDS0tUkuoXZn26TQX2zAMR79D7f1/+vzi1qcKT2MkUhYK2BleucjGPxqYAZBpt5/x7v+H861oQUKcoxLc+aaZwuq6LcxKZLUNcxcZCqPMH4Dr+H61kEiRAGZ9pbOVOGQ88r6MP8M8Zz3/K8rxj9Kzb3SLW7mMuZIpH+95fR/fHrXFVpcx6dLEW0mczbXjNFiQjzEYxyBTwCPT2IIYezCop5yehOevGRx/n+VbN54eZJlnt7otEV2yI6EsACcMpHXGWBHof9kA2YtAsNil3llyAQ2/CsODkY6j6VzOi+5t7emtTkAHkdVUb2J4UDJYn2/wrr9E0tbGJZZATdMoznPyD0Hv/AIVbtNOs7N91tbqHz99iWb8zVrBJ56U40uUyrYj2mi0Q0nnOc8/Wo1lR5HjVtzIAW4OBknHPTPyn6Y5xxmQjsTj39KDk4BJx6en+f89q0OcYeG6nJ9B1pBgkgbd2RkZ5HpmnFT68ntSBVVnYKoY43MOpx0ye+OntSAQYIUjv3oyOOcZzgd/wp3TOSeevNGOeD145pAN74/I04D+o6UYyOT+tKQR96gBMALwMYGMDjH0pcY4GOKUAkf54qG7ure0X/SZ4oicnDvg4+lDko7gld2RLjrxz9KQdW446DH0z/Wqlrqun3h8uG9idjwBvwc+xPf0PWrkaGONULF2Xgs33mxxlvU8c8dacZKSugaadmYniwHyInXqMrn0H+f8APWuUV9rdcfT+v+fSu48QRmXTScH5G3H2HvXEzIUc4zg8/wD681y14noYSScLGhZzFTwCcZ5HGPp7f59K0nuQAQSOc8A9R/nvXPI/zDJ456k/5/CpPO3A56k4GaxjKxrKld3JryTezc/eGDkfh1//AF9KpZ3OSCBkeuc/j/WpGO4knOTnO4fz/wA9vanJGck9Quc8/hQouTNV7qO18NqU0pc9C7ED09q0jz+NUtGhaHTIUcfNy+D2z0//AFVbKncDvfAByo6HOOT34xxz35zxj1YLQ8WprJscCAR0wPyri/EFo0GozDaWB+ZR6g9a7Squp2Eeo2wjZgkqZMb4zj2PtUVIc6sXQq+zldnAL8hPQLng9un8qrX13JbL0baeDzjHrx6ZrVvbOS1maKWMRyD+Fs4I7YPf+dV57UTRFSuT0I/x5/zntXC6TWjPXjOL1PStLu2m/cy4LKuVYdx6H3q+RzWBZkxXkLY/iC5478V0Br0MLUdSn7260PncRBRlp1I5HWKNpH+6oya564ke4mLOvzHjHoPQVq6u5WONc4BJY+vAqlYwZbcR0rkxnNVmqS2NqCUI87CCwL/MSc5781YewUg+nWr8QwuBTuByKuOFppbGcq82zC+ztC4ODweoqTy4ZJ1kmBGQUf0IPqK1ZY94IxWNcq0coXt/SuSrTVBaq8TenUdT1MLVfD01iWaPzJLTkhkG4p16gc4681RgtQSTGXkUHHy4GMDp/nmvQ7By1lESeQMH8KbPY2k7bp7eJ29ccmpq5NTk+alLfo9v8zaGYzj7tRXOK2lVGRwOijnn1985qKG1nvJvLgjM0nRgPur7E9uPxrtTpGnNnNnEM8kgYq3FGkKCOFFRB2UYFJZQ5P8Aez0Xb/gieYJL3FqZOhaL9gInuW33WMAD7qD0Fa/507vSGvUp0oUoKFNWR59SpKpLmluJ9aXp0paP61diCIBFf5VwT1qQe/WkxjrSjtngnsaav1G2A5zRjFL3oqrEh2pof5sGnjvRtAOadgCjFFZuramLT91AA1wRnnog9T/hSnONOLnN2RUISm+WJoTSxwRl55EjQdWcgCqp1axBAE27/dUn+QrlZJnkkMkrPLIM/O7Zx9B0AqPzzuAXke36V5U83d/3cdPM9CGXq3vM7O2vrW6IWGZWfsp4P5HmrJFcGs+4AEYCkbSOqn2+lb+ma4hUR3uVI/5aH7v4ntXTh8yhWkoVFZv7jKvgZQV4am7RQaK9O1tDgFHUVFfELauTkAYyQM4GRUo7Zpl3xA34fzreHwsa+JGWMMFZGVgcEEHII9jS9c89qXjj19hTT05FczOsD0yfXrVcwFSWt3MLsxc8bkY9yU9+vykEnnPrOAc556880n8Pt2NZMaIkcsWRkKyKASucgg9CDjkcY9Rj85ccZ6DB5PAxVa/ZYITdysVjtgXkP/TI8Pn2wA31QfSuY1bVnu/9QXW2YjACnL5wAx79MfhzWE5WNqdJ1HZHSyX1jG2HvIQR2DZxUlvcW9y222uYZH67VIz+Veftv5K5wRu4HHX/AD/nNR78MG2njGCOvtg1yuvbc6vqemjPSCMY6D1FQxCcTXP2gw+V5o8jbkER7Fzvz/Fv8zpxt2981leGtUluwba8kLy7Q0TkgM3qD6/WtwkEEdQfQ8VvGXMjjnFwfKxCMY5wBz1/wozwcn65pcZBByD2IPSjIIJ/rVEh/Dk8gZpMY7c96XAPQ/jigAHAPI780PRXAz9av/sNsPKIM7g7CcfKPXFcVexvdj5ixfOdxOea1NWdrq9mckMucAHsB2/l0+tSWFkGOehxjJPWueV72R30kqUbvc5exsJbSbLFio5weeOv4Dg+teh6Fetc24hmOZkUHfnlx/jVKXTB5Tbeu04FV0VrOdXXqhzn+mPTrTjdMVWSrLzOnZQ6MrgFCMEH0rktb0prVsjLQN9yQD7p9D26VvJrVm6Bn3hm5wvzA+4NXYZY7iISRMHicdxnPPQit7KaOaE5Unex56yEbiQpH16dM8/5/Gmxng5RQRkfKxORk4PbnGM9eeOnNd7c6VY3KMHt1UnqYyQRWenhq1WTeJps++B/KsXhjrji4NanLorZDZUHqAOv4fma6XRdG5W4vEBUD5Y2Byfc+1a1pp1nakGGEbxzubk+1Wid3U8n1rWFJRMKuKc9IiMwPzMeQercYzxS4x1/IUgxtHPHqaOn1/rXRaxygTzjqcenFL157Gk/p/n/AD9KAMnH9M0AEscc6bJ4klXPCsM/lVc6XYNjNso+jH/HmrII7f404VaiHNJbMrWkfm3cYHQNuPHTFbhqnpsHlx+aQdzjj2FXD7YFRh6Tp09d2YV580tOhS1RSYUYfwtgnOMA8f4VXsWwcelaciLIhRxlWGCKxZFe2mEbn5jwpz98f44rmxMfZ1FV6dS6T5o8hs9Pr0o6D6fjVCK8OBnnPOO9Pmv44o9zb8cfcQueSB0H1/AcngVarQavch0pJ2sWi4XOT9MVi3h8yYbSQBkYHQ9Of89s1ZubsHIB56cGoLaA3MxUZKEEMewH+NceIn7dqlA3pQ5PekaWnKVso85GcnB9zS3N7a2pImmRWHOzOW/LrUGr3xtIxHFjzXUkE9EUdSa51VaR8gltxyWPJb3Na4nFqg/Z01eX5BSw/tbzlojZbXUDEJayEdssAT+FWotWs5AMyGNj2dcfr0rn/sjbc7c03yXTdjAb8xn3rjWPxMfiSfyOh4Wi1ozr0KuAyMGU9CDkGlPT0rndMujYysHDGFuXUc7T/eH9cV0SkMAykFWGQfWvUoVo14c0d+q7HBVpOnK3QBS0UmfWtkjIBxR0FOxRjNUosVxByKKUDtSGnawCPkIdvX0qK3ZySGOfwqXPNLkf0qEot8zKvpYju5ltraWZ8bY1LcmuLlMhdzK2ZZG3Se5I6fhwAPaus1r/AJBN11OEyfpXJTcSEjcee3evIzWTlOFPpa56WXxVmyOTG0bvqcZP+f8APvRs3gDPQc8Y5pz4yeuSvfinpx6bh7YHP8hXl8t2ejeyI3QKAeAR6jpSRho3yvJHbr+H0/8Ar1YIzjJOBx05FQsqjB7c44qnBfISd9GdH4euQq/ZWYlOsOT0HdfoOo9uO1bfeuQhkaBy2cbGVsnPUf5/z1rr6+mwFaVWnae6PFxdNRlzLqY15dTNrMNuRsiRkYdfnyf6en+FXtbuxY6ZLcFC4QrlR1ILAf1qnOGbWgXwVXZtGORz/Lg1H46Xf4WvV552DjH99fXitcNJ8tZt7f5ByxlOnH0IdP1SwvwBa3I8w/8ALOT5Wz6c9fwNXWUqSCCCO1eWCQKCkkaurfMAQMe/B/n3/Wrtvrt+kIgju5ShwoQkMV7YBIzntWXt1Y754GV/cZ6IUZck5POcnt7f59aZ+n09PSvO9P1We3ZLizuWwwDBvvKw56g9uvv/AF6jSvEa3c6W93beVKxC+ZHnYWOcDn6ds449aFUUtEZVMNOnruh/imd4bO3jjbDSvkYGT8vP+H+eK5LTbcoyxwxl7cD5YY8BowD0QcAr6LnK9FyMKOr8ZQCTToCyhkRyjKRxgj+VcpZyPDMd24kZyD65/wAjvXNV3R1YZfutNzqrLTra4tzIrBlJxu5GGHYjqpHcHBHpWXrOni3Yg4ZCMgDv/nFakF6k+2WM/wCkldo5wJR2Rj784PVScjjINDU76K7gR4W3xSIHUkdQRkf/AF/oaiSTRFJzU9TK0uUwX8LjgpIG4+uP5GvQG++3bn8DXC6XayXN8kajOWDE56LnJNd1nL5/rTpKyRGLackNPbPb8hQQAmGxt65PHT/9QpxXA5wPc8U1CrfckQ/RhzWvMjlFxg8n9KDnDeuDSlWGMg/WkQMrEgliWzjsPYD/ADmm9VoI4jBaQnA3ZPUe/wDn9K6DTEVuhyOnPqCcn3PP+etZ+t2v2bUGIT93IfMQ/wAxz/nkVNp1ztI3ZznPJ9//AK9Y7SO6b54Jo3Ngbd7jGRVW7gEgJIwT159ecVZEokHyueRnj0/pUMzYiGTjAOB1z6/StnscsbpnNXaEMT69T3z/AIV0Hh8509lOSVc9scGsK+fdIQOBz7f5Na+lSLZ6RNdPnnc2PUjoKzi+U6a2sEatzcw26kzzRxr6scZqiuv6Y4yLtSMZyqkgfj6VwWsXT39w7z4LMe3YYx/PPTtVO1R1AbOMdctUutZ7mkMCnG8mesxPHNF5kDrJFn7ynOPalRgy8HJ6Hvz3B/l9a85sbue0k3xOYnB5Ydef5/8A1q6/R9aN3IsN2qrIflWVOAx9COxrelVU0c1bDSp6rVGxjB4NJjn+Wad9f1pu05zlu/f16/57c1sc4HBQgngjscH8MdKXpn29eaTPy5zTuAeeO/pTsAZ6/XNJPLHbwNLIflXpx1PXApeSOuCOfpWFrUpnvDFn5YxgfXuabuVCPM7HZ5yT7cUUUV0M88Qj0qOeFJoykoBHr6UUVLiuo02noUmsGwRGyMp6Hp/+uo2sJ84AQZ/2j/hRRXNLB0pK9jVV5ofBppBzNJ1HKx8D860IkWJFSNQqjjAHFFFVTpQp6QViZ1JT3OZ1Qma/mYZ+9tX1GB29OansrYEZI5PbOKKK8WklOrKT7nozk400kaqW4RcbckemKjmtRjcoHHpxiiivTnRhbY4VOV7mPLEqN8i7QSSAFxnOc5HvnNa+iTF4Xibny8FSfQ9v0/lRRXDgny4iy6pnXX1pNs0MdCT0rJ1DU33mOzIGODIBu59BRRXbjqsqUPc0uc+Fgpybl0MpjLKd0jySHBHzsT+g4qSKSaErsklQD/aOPyPB9KKK8tSmrSUnf1O922sblhfCcBJgElxwf4X+n+FXGFFFe3hqjrUVKW55leChLQruzBxwcHvSbycjqPeiioS1HbQeyrcRSRP9yRSp+hFcdLbSwO0c/M8Q2Mw4DL1DD2OPzoorjzSmvZxn1Tt951YKbU3FbEZBwc5yDSLncAfvHrg/pRRXk2WjPUuSK/AIB57Z5/z/APWp0a7n5xjGT3+n+f8A9VFFaQXNZMiWi0LUSb3ESg5mkAPJP3jk9+nsOB2rr+lFFe/ly9yT8zysbukULlCNSgcdGAXgdwf8Caq+Mxu8N3gxn7n/AKGtFFdVOKSq2/rQypv95T9V+Z5TINu5l4f6Dpnj/P8ASoApYYcZGT8u4D/JoorzJ7n1C2LarI+7IBPXcRuGcYHTr2/zipYlddrJkHgg+hHPaiilGKtfsZN30OytLttfsZYJAqSrtO8f3vcelc5qlhNazhbiEw7m4bG5T7g+w7daKK1UVK8WcFOXs6rhHYo2004jV3haN+cxl1bBye6/KQRg8evsafZ72aWEpukjmOABksjNvVxgd9xHplWHaiisIwTlY65PS53Gh2P2Kz+cbZ5TuYZ5HtT9TvVsoRgBpn+6v9TRRWh5cP3k/eOWuria8k3zEv1zkcflUTxsBkpgf54Hvz+VFFZpt31/q6O/RaIsWGp3Fm6qrl07xSHKke3p/niuqtriDUbXeqBlOVeJwDg+n/16KKulJvcwxNOKXMtxuoWq38LwNuWVBvSQrxuOeB+XI7ZHWuWQvDIVZWUg4ZR1B60UVrOKaIw7esTTgvXC5OcnuKgu74uxBI6n6CiipcbRT/rZGsYK5Tt7ae8l8uGEscjOWwApIyd2DggZ4xkke/Gl4uH2fSII4F/dCTYcemOM/j/OiiiaVkiXJurFHCBg8hA27geehxx/9ccVtadZmdRt54yAep5oormglc768nGOhebTSpxtORkjp9OuP51GmYX44xyGHUY5oorZq2qOaE3LRnY6Xci7sw4RVdCUYLgD14HbOasn/wDVxRRXZFaHnTVptIBuBOcHnqP8/Sl9h+IooqkQOTG9Rjv2NczndeSMeSZCfrzRRQ1ubUd2f//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: Peripheral blood smear shows neutrophils with toxic granulations, which are dark coarse granules. A D&ouml;hle body is also seen (arrow). Right panel: A neutrophil with toxic granulations, vacuoles (another toxic change), and a D&ouml;hle body (arrow). These abnormalities are characteristic of toxic systemic illnesses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7449=[""].join("\n");
var outline_f7_17_7449=null;
var title_f7_17_7450="Definition, epidemiology, and risk factors in inflammatory bowel disease";
var content_f7_17_7450=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Definition, epidemiology, and risk factors in inflammatory bowel disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Mark A Peppercorn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/17/7450/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/17/7450/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H531110184\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory bowel disease (IBD) is comprised of two major disorders: ulcerative colitis (UC) and Crohn's disease (CD). These disorders have both distinct and overlapping pathologic and clinical characteristics.",
"   </p>",
"   <p>",
"    The definition, epidemiology, and role of environmental factors in Crohn's disease and ulcerative colitis in adults will be reviewed here. Similar issues in children and adolescents, the role of genetic factors, clinical manifestations, diagnosis, and treatment of IBD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"     \"Genetic factors in inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19305?source=see_link\">",
"     \"Overview of the medical management of mild to moderate Crohn's disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6329?source=see_link\">",
"     \"Overview of the medical management of severe or refractory Crohn's disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=see_link\">",
"     \"Management of severe ulcerative colitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24250?source=see_link\">",
"     \"Approach to adults with steroid-refractory and steroid-dependent ulcerative colitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory bowel disease (IBD) is comprised of two major disorders: ulcerative colitis and Crohn's disease. Ulcerative colitis and Crohn's disease have distinct pathologic and clinical characteristics but their pathogenesis remains poorly understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Ulcerative colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulcerative colitis is a chronic inflammatory condition characterized by relapsing and remitting episodes of inflammation limited to the",
"    <strong>",
"     mucosal layer of the colon",
"    </strong>",
"    . It almost invariably involves the rectum and may extend in a proximal and continuous fashion to involve other portions of the colon. Different terms have been used to describe the degree of involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ulcerative proctitis refers to disease limited to the rectum",
"     </li>",
"     <li>",
"      Ulcerative proctosigmoiditis refers to disease limited to the rectum and sigmoid colon and not involving the descending colon",
"     </li>",
"     <li>",
"      Left-sided or distal ulcerative colitis is defined as disease that extends beyond the rectum and as far proximally as the splenic flexure",
"     </li>",
"     <li>",
"      Extensive colitis refers to disease extending proximal to the splenic flexure but sparing the cecum",
"     </li>",
"     <li>",
"      Pancolitis is used when the inflammatory process extends beyond the splenic flexure to the cecum",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Crohn's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Crohn's disease is characterized by",
"    <strong>",
"     transmural",
"    </strong>",
"    inflammation and by",
"    <strong>",
"     skip lesions",
"    </strong>",
"    . The transmural inflammatory nature of Crohn's disease often leads to fibrosis and to obstructive clinical presentations that are not typically seen in ulcerative colitis. The transmural inflammation can also result in sinus tracts that burrow through and penetrate the serosa, giving rise to microperforations and fistulae.",
"   </p>",
"   <p>",
"    Crohn's disease may involve the entire gastrointestinal tract from mouth to perianal area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both ulcerative colitis and Crohn&rsquo;s disease have been subclassified based on their clinical presentation and extent of involvement. This has provided a uniform framework for studies evaluating the genetic, serologic, and clinical factors that predict the evolution of these diseases (",
"    <a class=\"graphic graphic_table graphicRef86283 \" href=\"UTD.htm?32/52/33611\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef86284 \" href=\"UTD.htm?24/28/25035\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531100387\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have evaluated the epidemiology of inflammatory bowel disease (IBD) in various geographic regions.",
"   </p>",
"   <p>",
"    In North America, incidence rates range from 2.2 to 19.2 cases per 100,000 person-years for ulcerative colitis and 3.1 to 20.2 cases per 100,000 person-years for Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In one of the largest studies, based upon nine million health insurance claims, the prevalence of ulcerative colitis in adults in the United States was 238 per 100,000 population and the prevalence of Crohn's disease was 201 per 100,000 population [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence and prevalence of Crohn's disease and ulcerative colitis appear to be lower in Asia and the Middle East [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Geographic variation in the incidence of IBD has also been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/6\">",
"     6",
"    </a>",
"    ]. In some European countries, the incidence of IBD has been observed to be lower in southern compared with northern latitudes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/7-13\">",
"     7-13",
"    </a>",
"    ]. This trend has also been seen in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/5,14\">",
"     5,14",
"    </a>",
"    ]. Seasonal variation in flares of IBD (with peaks in the spring) has been suggested in some reports; however, the magnitude of the association, if any, is weak, and discordant data have also been published [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/15-27\">",
"     15-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of IBD may have changed over time. Ulcerative colitis was more common than Crohn's disease in northern Europe and America throughout the first several decades of the 20",
"    <sup>",
"     th",
"    </sup>",
"    century. While the incidence of ulcerative colitis remained essentially stable from the 1950s through the 1980s (",
"    <a class=\"graphic graphic_figure graphicRef85903 \" href=\"UTD.htm?28/17/28959\">",
"     figure 1",
"    </a>",
"    ), a rise in incidence of Crohn's disease was consistently observed (",
"    <a class=\"graphic graphic_figure graphicRef85901 \" href=\"UTD.htm?1/35/1584\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. The incidence of Crohn's disease appears to have leveled off, and is now approximately equivalent to ulcerative colitis in North America and Europe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531113796\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the pathogenesis of inflammatory bowel disease (IBD) remains unclear, a number of risk factors have been identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531113302\">",
"    <span class=\"h2\">",
"     Age and gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age of onset of most cases of ulcerative colitis and Crohn's disease is between 15 and 40 years. Many studies suggest a bimodal age distribution for both disorders with a second peak between 50 and 80 years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/27\">",
"     27",
"    </a>",
"    ]. It is not clear whether this second peak relates to greater susceptibility to disease with increased age, the late expression of an earlier environmental exposure, or misdiagnosis of ischemic colitis as IBD.",
"   </p>",
"   <p>",
"    There appear to be small differences in IBD incidence by gender. In general, there is a slight female predominance in Crohn&rsquo;s disease, although in some low incidence areas a male predominance exists. The female predominance, especially among women in late adolescence and early adulthood, suggests that hormonal factors may play a role in disease expression. In contrast, there may be a slight male predominance in ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531113309\">",
"    <span class=\"h2\">",
"     Racial and ethnicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both ulcerative colitis and Crohn's disease are more common in Jews than non-Jews [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. The incidence of IBD is lower in black and Hispanic populations compared to whites [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/14,37,38\">",
"     14,37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, ethnic and racial differences may be related to environmental and lifestyle factors as well as due to underlying genetic differences [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/6,39\">",
"     6,39",
"    </a>",
"    ]. As an example, the rates of IBD in Israel are higher in European and American-born Jews than in Jews from Asia and Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H531100387\">",
"     'Epidemiology'",
"    </a>",
"    above.) In addition, the rate of IBD rises in non-whites with urbanization and in some instances may equal or exceed those of whites [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/37,41\">",
"     37,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genetic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 to 25 percent of individuals with IBD have a first degree relative with either Crohn's disease or ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Studies have also demonstrated a concordance for the same disease type within families, especially with Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/45\">",
"     45",
"    </a>",
"    ]. The role of genetic factors that increase susceptibility to IBD and genetic syndromes associated with IBD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=see_link\">",
"     \"Genetic factors in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531109547\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking has different effects on ulcerative colitis and Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/46-54\">",
"     46-54",
"    </a>",
"    ]. While the basis for this dichotomy has yet to be resolved, nicotine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    smoking byproducts may directly affect mucosal immune responses, smooth muscle tone, gut permeability, and microvasculature.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking is associated with an increased risk of Crohn&rsquo;s disease. Current as well as past smokers are more likely to develop Crohn&rsquo;s disease than those who had never smoked (HR = 1.4 to 1.9) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/54,55\">",
"       54,55",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Smoking may also increase the risk of recurrence of Crohn's disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/54,56\">",
"       54,56",
"      </a>",
"      ]. At least one study suggested that patients who stop smoking for more than one year can decrease the risk of flares [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, studies suggest that current smoking is not a risk factor for and may be protective of the development of ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/46,51\">",
"       46,51",
"      </a>",
"      ]. In a large prospective cohort study of 229,111 women, the risk of ulcerative colitis was similar in current smokers as compared with those who had never smoked, while former smokers had an increased risk of ulcerative colitis as compared with those who had never smoked (HR 1.6, 95% CI 1.3-1.9) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/54\">",
"       54",
"      </a>",
"      ]. The risk of ulcerative colitis increased two years after cessation of smoking and persisted for over 20 years. The increase in risk associated with smoking cessation may be explained by loss of the protective effect of smoking, which then precipitates the onset of or unmasks the symptoms of ulcerative colitis.",
"      <br/>",
"      <br/>",
"      Cigarette smoking may also influence the course of ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]. Smoking cessation in patients with ulcerative colitis is associated with an increase in the disease activity and hospitalization.",
"      <br/>",
"      <br/>",
"      While clinical trials to evaluate the effectiveness of transdermal nicotine patches for the treatment of mild to moderate ulcerative colitis have suggested that these agents can improve ulcerative colitis associated symptoms, they have not shown any effects on objective measures of disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/60,61\">",
"       60,61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food antigens are thought to trigger an immunologic response resulting in the development of IBD. However, specific pathogenic antigens have not been identified. While studies attempting to associate specific diets with the development of IBD have had inconsistent results, the data suggest that a \"Western\" style diet (processed, fried, and sugary foods) is associated with an increased risk of developing Crohn's disease, and possibly ulcerative colitis.",
"   </p>",
"   <p>",
"    A number of studies have implicated dietary risk factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypersensitivity to cow's milk protein in infancy has been postulated as a cause of IBD, especially ulcerative colitis. A survey of IBD patients and controls noted cow's milk hypersensitivity was more common in patients with ulcerative colitis and Crohn&rsquo;s disease compared with controls (21, 9, and 3 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Refined sugar intake has been linked to the development of IBD, especially Crohn&rsquo;s disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/63-65\">",
"       63-65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decreased vegetable and fiber intake has been associated with the development of ulcerative colitis and Crohn&rsquo;s disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/64,66\">",
"       64,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased dietary intake of total fat, animal fat, polyunsaturated fatty acids, and milk protein has been correlated with an increased incidence of ulcerative colitis and Crohn&rsquo;s disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/65-67\">",
"       65-67",
"      </a>",
"      ] and relapse in patients with ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/68\">",
"       68",
"      </a>",
"      ]. In addition, a higher intake of omega-3 fatty acids and a lower intake of omega-6 fatty acids have been associated with a lower risk of developing Crohn&rsquo;s disease [",
"      <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dietary interventions to improve nutrition and eliminate food triggers in the treatment of patients with IBD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44152?source=see_link&amp;anchor=H2283304#H2283304\">",
"     \"Nutrition and dietary interventions in adults with inflammatory bowel disease\", section on 'Elimination diet'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531109779\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accumulation of intra-abdominal fat may contribute to mucosal inflammation thereby affecting the clinical course in patients with established IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/69\">",
"     69",
"    </a>",
"    ]. In a study of patients with Crohn's disease, anoperineal complications occurred earlier in obese patients compared with nonobese patients. Obese patients were more likely to develop active disease (OR 1.5, 95% CI 1.1-2.1) and to require hospitalization (OR 2.4, 95% CI 1.6-3.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/70\">",
"     70",
"    </a>",
"    ]. In a study of children with IBD, children who were overweight or obese were more likely to require IBD-related surgery (OR 1.7, 95% CI 1.1-2.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531098436\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysbiosis or an imbalance in the gut microbiome may contribute to the development of IBD. The role of dysbiosis in the pathogenesis of IBD is suggested by the correlation between specific microorganisms and IBD and the association between acute gastroenteritis and IBD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=see_link\">",
"     \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of studies have evaluated the possible role of specific infectious agents in the pathogenesis of IBD. As an example, an association between Crohn&rsquo;s disease susceptibility and specific infectious agents (eg, measles virus, Mycobacterium paratuberculosis, paramyxovirus) has been suggested but remains unproven [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/72-77\">",
"     72-77",
"    </a>",
"    ]. One hypothesis is that normal intestinal microflora may contribute to the development of IBD in susceptible individuals. This is supported by the observation that animals that are genetically altered to be susceptible to IBD do not develop the disease when raised in a germ-free environment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/78,79\">",
"     78,79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several observational studies have suggested an association between acute gastroenteritis and the development of IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/80-83\">",
"     80-83",
"    </a>",
"    ]. As an example, a case control study included over 3000 patients with incident IBD and over 11,600 controls [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/80\">",
"     80",
"    </a>",
"    ]. After excluding patients who had acute gastroenteritis within six months of IBD diagnosis and adjusting for potential confounders, the risk of IBD was significantly increased in patients with a prior episode of acute gastroenteritis (OR 1.4; 95% CI 1.2-1.7). There was also an approximate fivefold increase in IBD risk in individuals with a previous diagnosis of irritable bowel syndrome (IBS). It is unclear if this association between IBS and IBD was due to IBS-like symptoms in patients with undiagnosed IBD, or if IBS actually predisposes individuals to the development of IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/84\">",
"     84",
"    </a>",
"    ]. However, when individuals with a prior IBS diagnosis were excluded from the analysis, the association between acute enteric infection and IBD persisted.",
"   </p>",
"   <p>",
"    An increased risk of developing IBD was also found in a population-based cohort study of 13,148 patients with documented Salmonella or Campylobacter gastroenteritis when compared with a matched control group (1.2 versus 0.5 percent, HR 2.9, 95% CI 2.2-3.9) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/81\">",
"     81",
"    </a>",
"    ]. While the increased risk was highest during the first year after infection, it remained elevated during the entire 15-year follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531109876\">",
"    <span class=\"h2\">",
"     Nursing and other perinatal events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding stimulates the development and maturation of the gastrointestinal mucosa of infants and may protect them from gastrointestinal infections in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/85\">",
"     85",
"    </a>",
"    ]. A study of children with Crohn's disease and their unaffected siblings found that those with Crohn's disease were three to four times less likely to have been breast fed [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/86\">",
"     86",
"    </a>",
"    ]. The same report noted that the affected children were also three times more likely to have had a diarrheal illness during infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/86\">",
"     86",
"    </a>",
"    ]. Other studies have",
"    <strong>",
"     not",
"    </strong>",
"    confirmed the association of breastfeeding with Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/87\">",
"     87",
"    </a>",
"    ] or ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/88\">",
"     88",
"    </a>",
"    ] but did confirm the increased incidence of diarrheal illness during infancy in those who later developed ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/88\">",
"     88",
"    </a>",
"    ]. The concept that perinatal events may be etiologically related to the development of IBD in childhood has been further supported in a Swedish study showing a fourfold increased risk of IBD in those who had \"health events\" in the perinatal period [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/89\">",
"     89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents\", section on 'Perinatal and early exposures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531108235\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been hypothesized that antibiotic use by altering the gut flora may be a risk factor for IBD. While antibiotic use has been associated with IBD, it is unclear if this causal association [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/87,90-93\">",
"     87,90-93",
"    </a>",
"    ]. In one case control study, patients with IBD were significantly more likely to have been prescribed antibiotics two to five years before their diagnosis than controls. In the same study, patients who received three or more antibiotic prescriptions two years before the study were 1.5 times more likely to have IBD (95% CI 1.3-1.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531110049\">",
"    <span class=\"h2\">",
"     Isotretinoin",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    , used in the treatment of acne vulgaris, and IBD has been suggested by case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/94,95\">",
"     94,95",
"    </a>",
"    ]. While an association may be biologically plausible based on the pleiotropic effects of isotretinoin on the innate and adaptive intestinal immunoregulatory capacity, case control studies evaluating this association have yielded variable results [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/96-100\">",
"     96-100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potentially confounding the association of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    use and the development of IBD is the fact that many patients treated with isotretinoin have also been treated with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    class antibiotics, which some data suggest may be associated with the development of IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/101\">",
"     101",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H531108235\">",
"     'Antibiotics'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531100138\">",
"    <span class=\"h2\">",
"     Nonsteroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclooxygenase-mediated disruption of the intestinal epithelial barrier associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or nonsteroidal antiinflammatory drug (NSAID) use can affect the interaction between the gut microbiome and immune cells in the intestine lining. In addition, NSAIDs and aspirin alter platelet aggregation, the release of inflammatory mediators, and microvascular response to stress, which are key events in the pathogenesis of IBD. While a number of reports suggest that NSAIDs increase the risk for the development of IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/102,103\">",
"     102,103",
"    </a>",
"    ] and may exacerbate underlying IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/104-107\">",
"     104-107",
"    </a>",
"    ], the absolute risk appears to be small and some patients with IBD appear to be able to tolerate NSAIDs, particularly when given in low doses [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/108,109\">",
"     108,109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the Nurses&rsquo; Health Study, the association between NSAIDs and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    use and the development of IBD was studied in 76,795 women [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/103\">",
"     103",
"    </a>",
"    ]. NSAIDs but not aspirin use for at least 15 days per month increased the risk of IBD (HR for ulcerative colitis 1.87, 95% CI 1.16-2.99; HR for Crohn&rsquo;s disease 1.59, 95% CI 0.99-2.56). However, this represented a small absolute increase in risk (absolute difference 7",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    person-years for ulcerative colitis and 6",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    person-years for Crohn&rsquo;s disease).",
"   </p>",
"   <p>",
"    Experience with the COX-2 selective inhibitors in patients with IBD is limited. Although small case series suggested an increased risk of exacerbation of IBD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/110,111\">",
"     110,111",
"    </a>",
"    ], randomized controlled trials have demonstrated no significant increase in disease activity or relapse in patients treated with short-term COX-2 selective inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/112,113\">",
"     112,113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Oral contraceptives and hormone replacement therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral contraceptive and hormone replacement therapy may predispose to the development of IBD through thrombotic effects on the microvasculature. However, there are conflicting data concerning an association and, if present, the risk appears to be small [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/114-117\">",
"     114-117",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In a 2008 meta-analysis that included 75,815 premenopausal women, the risk of ulcerative colitis and Crohn&rsquo;s disease was increased in women using oral contraceptives, after adjusting for smoking (RR for ulcerative colitis 1.3, 95% CI 1.1-1.5; RR for Crohn&rsquo;s disease 1.5, 95% CI 1.3-1.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/115\">",
"     115",
"    </a>",
"    ]. However, oral contraceptives do not appear to influence Crohn&rsquo;s disease activity in patients with established Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective study of 108,844 postmenopausal women, hormone replacement therapy was associated with an increased risk of ulcerative colitis but not Crohn&rsquo;s disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/116\">",
"     116",
"    </a>",
"    ]. The risk of ulcerative colitis was increased among both current and past users as compared with women who had never used postmenopausal hormone therapy (HR current users 1.7, 95% CI, 1.1-2.7; HR past users 1.7, 95% CI, 1.0-2.7). The risk of ulcerative colitis increased with longer duration of hormone use and decreased with time since discontinuation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Appendectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have suggested that appendectomy may protect against the development of ulcerative colitis, but the mechanism of the protective effect is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/83,119-122\">",
"     83,119-122",
"    </a>",
"    ]. One hypothesis is that alterations in mucosal immune responses leading to appendicitis or resulting from appendectomy may negatively affect the pathogenetic mechanisms of ulcerative colitis.",
"   </p>",
"   <p>",
"    In a cohort study that included 212,963 patients who underwent appendectomy between 1964 and 1993, the risk of developing ulcerative colitis was decreased by about 55 percent in those who underwent appendectomy before they were 20 years old for an inflammatory condition (appendicitis or lymphadenitis), but not for nonspecific abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/123\">",
"     123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, some studies have suggested that risk of Crohn&rsquo;s disease is increased after appendectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/124\">",
"     124",
"    </a>",
"    ]. However, a 2008 meta-analysis suggested that the apparent increased risk may be due to a misdiagnosis in patients with incipient Crohn&rsquo;s disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186033080\">",
"    <span class=\"h2\">",
"     Psychosocial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies examining the association between psychological factors and the risk of developing IBD have yielded inconsistent results [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/126-130\">",
"     126-130",
"    </a>",
"    ]. However, stress may have a role in the exacerbation of symptoms in patients with established IBD, possibly via activation of the enteric nervous system and the elaboration of proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?7/17/7450/abstract/131-133\">",
"     131-133",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/56/10115?source=see_link\">",
"       \"Patient information: Crohn's disease in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/17/42258?source=see_link\">",
"       \"Patient information: Ulcerative colitis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/40/24196?source=see_link\">",
"       \"Patient information: Crohn's disease (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=see_link\">",
"       \"Patient information: Ulcerative colitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83127808\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory bowel disease (IBD) includes ulcerative colitis and Crohn's disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ulcerative colitis is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon. It almost invariably involves the rectum and may extend in a proximal and continuous fashion to involve other parts of the colon.",
"     </li>",
"     <li>",
"      Crohn's disease is characterized by transmural inflammation and by skip lesions. The transmural inflammation leads to fibrosis and obstruction in addition to sinus tracts that burrow through and penetrate the serosa, giving rise to microperforations and fistulae.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Over time, the incidence of ulcerative colitis has been relatively constant. The increase in incidence of Crohn&rsquo;s disease between the 1950s and 1980s has levelled off and the incidence of ulcerative colitis and Crohn&rsquo;s disease in the North America and Europe is now similar. IBD is more prevalent in North America and Europe and less prevalent in Asia, Japan, and South America. (See",
"      <a class=\"local\" href=\"#H531100387\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ulcerative colitis and Crohn's disease are more common in individuals with Jewish ancestry and in whites as compared to black and Hispanic populations. (See",
"      <a class=\"local\" href=\"#H531113309\">",
"       'Racial and ethnicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The peak incidence of IBD is between the ages 15 and 40 years with a second peak between age 50 and 80 years. There appear to be small differences in IBD incidence by gender with a slight female predominance in Crohn&rsquo;s disease and a male predominance in ulcerative colitis. (See",
"      <a class=\"local\" href=\"#H531113302\">",
"       'Age and gender'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately 10 to 25 percent of affected patients have a first-degree relative with either ulcerative colitis or Crohn&rsquo;s disease. Family members have also been noted to demonstrate concordance in disease type, location, and severity of the clinical course. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic susceptibility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cigarette smoking increases the risk for Crohn's disease and may be protective of the development of ulcerative colitis. (See",
"      <a class=\"local\" href=\"#H531109547\">",
"       'Smoking'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appendectomy may protect against the development of ulcerative colitis. An apparent increased risk of Crohn&rsquo;s disease after appendectomy, seen in some studies, may be due to misdiagnosis in patients with incipient Crohn&rsquo;s disease. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Appendectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some features of a \"Western\" style diet (processed, fried, and sugary foods) are associated with an increased risk of developing Crohn&rsquo;s disease, and possibly ulcerative colitis. In patients with Crohn&rsquo;s disease, obesity is associated with increased disease activity and anoperineal complications. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diet'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H531109779\">",
"       'Obesity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several observational studies have suggested an association between acute gastroenteritis and the development of IBD in adults. Studies have also demonstrated a fourfold increased risk of childhood IBD in those who had \"health events\" such as a diarrheal illness during the perinatal period. Antibiotic use has been associated with IBD but it is unclear if this is a causal association. (See",
"      <a class=\"local\" href=\"#H531098436\">",
"       'Infections'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H531109876\">",
"       'Nursing and other perinatal events'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H531108235\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonsteroidal antiinflammatory drugs (NSAIDs) may increase the risk for the development of IBD and may exacerbate underlying IBD. Available data pertaining to COX-2 selective inhibitors suggest that most patients can tolerate at least short-term treatment without exacerbation of disease. (See",
"      <a class=\"local\" href=\"#H531100138\">",
"       'Nonsteroidal antiinflammatory drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are conflicting data concerning an association between oral contraceptives, hormone replacement therapy and IBD. If present, the risk appears to be small. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Oral contraceptives and hormone replacement therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/1\">",
"      Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/2\">",
"      Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/3\">",
"      Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/4\">",
"      Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/5\">",
"      Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/6\">",
"      Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012; 61:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/7\">",
"      Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996; 31:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/8\">",
"      Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/9\">",
"      Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol 1996; 31:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/10\">",
"      Ranzi T, Bodini P, Zambelli A, et al. Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study. Eur J Gastroenterol Hepatol 1996; 8:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/11\">",
"      Tragnone A, Corrao G, Miglio F, et al. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol 1996; 25:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/12\">",
"      Tragnone A, Hanau C, Bazzocchi G, Lanfranchi GA. Epidemiological characteristics of inflammatory bowel disease in Bologna, Italy--incidence and risk factors. Digestion 1993; 54:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/13\">",
"      Manousos ON, Giannadaki E, Mouzas IA, et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 1996; 8:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/14\">",
"      Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/15\">",
"      Lewis JD, Aberra FN, Lichtenstein GR, et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 2004; 126:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/16\">",
"      Auslander JN, Lieberman DA, Sonnenberg A. Lack of seasonal variation in the endoscopic diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2005; 100:2233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/17\">",
"      Myszor M, Calam J. Seasonality of ulcerative colitis. Lancet 1984; 2:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/18\">",
"      Don BA, Goldacre MJ. Absence of seasonality in emergency hospital admissions for inflammatory bowel disease. Lancet 1984; 2:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/19\">",
"      Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990; 31:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/20\">",
"      Sellu DP. Seasonal variation in onset of exacerbations of ulcerative proctocolitis. J R Coll Surg Edinb 1986; 31:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/21\">",
"      Tysk C, J&auml;rnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993; 28:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/22\">",
"      Sonnenberg A, Jacobsen SJ, Wasserman IH. Periodicity of hospital admissions for inflammatory bowel disease. Am J Gastroenterol 1994; 89:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/23\">",
"      Zeng L, Anderson FH. Seasonal change in the exacerbations of Crohn's disease. Scand J Gastroenterol 1996; 31:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/24\">",
"      Karamanolis DG, Delis KC, Papatheodoridis GV, et al. Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology 1997; 44:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/25\">",
"      Moum B, Aadland E, Ekbom A, Vatn MH. Seasonal variations in the onset of ulcerative colitis. Gut 1996; 38:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/26\">",
"      Vergara M, Fraga X, Casellas F, et al. Seasonal influence in exacerbations of inflammatory bowel disease. Rev Esp Enferm Dig 1997; 89:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/27\">",
"      Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/28\">",
"      Brahme F, Lindstr&ouml;m C, Wenckert A. Crohn's disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malm&ouml;, Sweden. Gastroenterology 1975; 69:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/29\">",
"      Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 1979; 490:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/30\">",
"      Binder V, Both H, Hansen PK, et al. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/31\">",
"      Halme L, von Smitten K, Husa A. The incidence of Crohn's disease in the Helsinki metropolitan area during 1975-1985. Ann Chir Gynaecol 1989; 78:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/32\">",
"      Gollop JH, Phillips SF, Melton LJ 3rd, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988; 29:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/33\">",
"      Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/34\">",
"      Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/35\">",
"      ACHESON ED. The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion. Gut 1960; 1:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/36\">",
"      Mayberry JF, Judd D, Smart H, et al. Crohn's disease in Jewish people--an epidemiological study in south-east Wales. Digestion 1986; 35:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/37\">",
"      Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984; 29:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/38\">",
"      Roth MP, Petersen GM, McElree C, et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989; 97:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/39\">",
"      Gilat T, Grossman A, Fireman Z, et al. Inflammatory bowel disease in Jews. Front Gastrointest Res 1986; 11:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/40\">",
"      Niv Y, Abukasis G. Prevalence of ulcerative colitis in the Israeli kibbutz population. J Clin Gastroenterol 1991; 13:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/41\">",
"      Hiatt RA, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 1988; 149:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/42\">",
"      Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/43\">",
"      Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/44\">",
"      Bayless TM, Tokayer AZ, Polito JM 2nd, et al. Crohn's disease: concordance for site and clinical type in affected family members--potential hereditary influences. Gastroenterology 1996; 111:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/45\">",
"      Lashner BA, Evans AA, Kirsner JB, Hanauer SB. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 1986; 91:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/46\">",
"      Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987; 316:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/47\">",
"      Logan RF, Edmond M, Somerville KW, Langman MJ. Smoking and ulcerative colitis. Br Med J (Clin Res Ed) 1984; 288:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/48\">",
"      Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/49\">",
"      Tobin MV, Logan RF, Langman MJ, et al. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/50\">",
"      Vessey M, Jewell D, Smith A, et al. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br Med J (Clin Res Ed) 1986; 292:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/51\">",
"      Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/52\">",
"      Harries AD, Jones L, Heatley RV, Rhodes J. Smoking habits and inflammatory bowel disease: effect on nutrition. Br Med J (Clin Res Ed) 1982; 284:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/53\">",
"      Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/54\">",
"      Higuchi LM, Khalili H, Chan AT, et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 2012; 107:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/55\">",
"      Silverstein MD, Lashner BA, Hanauer SB, et al. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989; 84:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/56\">",
"      Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/57\">",
"      Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/58\">",
"      Boyko EJ, Perera DR, Koepsell TD, et al. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/59\">",
"      Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001; 96:2113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/60\">",
"      Sandborn WJ, Tremaine WJ, Offord KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/61\">",
"      Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/62\">",
"      Glassman MS, Newman LJ, Berezin S, Gryboski JD. Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease. Am J Gastroenterol 1990; 85:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/63\">",
"      Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/64\">",
"      Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/65\">",
"      Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/66\">",
"      Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102:2016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/67\">",
"      Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000; 95:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/68\">",
"      Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/69\">",
"      Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/70\">",
"      Blain A, Cattan S, Beaugerie L, et al. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002; 21:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/71\">",
"      Long MD, Crandall WV, Leibowitz IH, et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:2162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/72\">",
"      Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/73\">",
"      Jones P, Fine P, Piracha S. Crohn's disease and measles. Lancet 1997; 349:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/74\">",
"      Wakefield AJ, Ekbom A, Dhillon AP, et al. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/75\">",
"      Lisby G, Andersen J, Engbaek K, Binder V. Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand J Gastroenterol 1994; 29:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/76\">",
"      Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/77\">",
"      Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999; 116:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/78\">",
"      Contractor NV, Bassiri H, Reya T, et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol 1998; 160:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/79\">",
"      Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180:2359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/80\">",
"      Porter CK, Tribble DR, Aliaga PA, et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008; 135:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/81\">",
"      Gradel KO, Nielsen HL, Sch&oslash;nheyder HC, et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009; 137:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/82\">",
"      Garc&iacute;a Rodr&iacute;guez LA, Ruig&oacute;mez A, Pan&eacute;s J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/83\">",
"      L&oacute;pez-Serrano P, P&eacute;rez-Calle JL, P&eacute;rez-Fern&aacute;ndez MT, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/84\">",
"      Porter CK, Cash BD, Pimentel M, et al. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol 2012; 12:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/85\">",
"      Davis MK. Breastfeeding and chronic disease in childhood and adolescence. Pediatr Clin North Am 2001; 48:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/86\">",
"      Koletzko S, Sherman P, Corey M, et al. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ 1989; 298:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/87\">",
"      Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/88\">",
"      Koletzko S, Griffiths A, Corey M, et al. Infant feeding practices and ulcerative colitis in childhood. BMJ 1991; 302:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/89\">",
"      Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/90\">",
"      Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 2004; 53:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/91\">",
"      Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994; 39:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/92\">",
"      Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011; 106:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/93\">",
"      Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study. Am J Epidemiol 2012; 175:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/94\">",
"      Bankar RN, Dafe CO, K&ouml;hnke A, Babu PS. Ulcerative colitis probably associated with isotretinoin. Indian J Gastroenterol 2006; 25:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/95\">",
"      Reniers DE, Howard JM. Isotretinoin-induced inflammatory bowel disease in an adolescent. Ann Pharmacother 2001; 35:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/96\">",
"      Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol 2009; 104:2774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/97\">",
"      Crockett SD, Porter CQ, Martin CF, et al. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol 2010; 105:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/98\">",
"      Reddy D, Siegel CA, Sands BE, Kane S. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006; 101:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/99\">",
"      Shale M, Kaplan GG, Panaccione R, Ghosh S. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut 2009; 58:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/100\">",
"      Crockett SD, Gulati A, Sandler RS, Kappelman MD. A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol 2009; 104:2387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/101\">",
"      Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol 2010; 105:2610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/102\">",
"      Tanner AR, Raghunath AS. Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 1988; 41:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/103\">",
"      Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med 2012; 156:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/104\">",
"      Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987; 107:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/105\">",
"      Felder JB, Korelitz BI, Rajapakse R, et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 2000; 95:1949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/106\">",
"      Evans JM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997; 40:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/107\">",
"      Takeuchi K, Smale S, Premchand P, et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/108\">",
"      Bonner GF, Walczak M, Kitchen L, Bayona M. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease. Am J Gastroenterol 2000; 95:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/109\">",
"      Bonner GF, Fakhri A, Vennamaneni SR. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/110\">",
"      Reinisch W, Miehsler WP, Dejaco C, et al. Treatment of peripheral arthropathy in IBD with Rofecoxib, a selective COX-2 inhibitor (abstract). Gastroenterology 2001; 120:A277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/111\">",
"      Mahadevan U, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol 2002; 97:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/112\">",
"      El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 2006; 101:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/113\">",
"      Sandborn WJ, Stenson WF, Brynskov J, et al. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol 2006; 4:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/114\">",
"      Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995; 37:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/115\">",
"      Cornish JA, Tan E, Simillis C, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008; 103:2394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/116\">",
"      Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 2012; 143:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/117\">",
"      Garc&iacute;a Rodr&iacute;guez LA, Gonz&aacute;lez-P&eacute;rez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005; 22:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/118\">",
"      Cosnes J, Carbonnel F, Carrat F, et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999; 45:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/119\">",
"      Sandler RS. Appendicectomy and ulcerative colitis. Lancet 1998; 352:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/120\">",
"      Rutgeerts P, D'Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/121\">",
"      Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/122\">",
"      Okazaki K, Onodera H, Watanabe N, et al. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 2000; 119:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/123\">",
"      Andersson RE, Ekbom A. Appendectomy and protection against ulcerative colitis (letter). N Engl J Med 2001; 345:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/124\">",
"      Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003; 124:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/125\">",
"      Kaplan GG, Jackson T, Sands BE, et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008; 103:2925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/126\">",
"      Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984; 86:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/127\">",
"      Lerebours E, Gower-Rousseau C, Merle V, et al. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol 2007; 102:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/128\">",
"      Ananthakrishnan AN, Khalili H, Pan A, et al. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol 2013; 11:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/129\">",
"      Li J, N&oslash;rgard B, Precht DH, Olsen J. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol 2004; 99:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/130\">",
"      Tocchi A, Lepre L, Liotta G, et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol 1997; 29:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/131\">",
"      Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994; 89:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/132\">",
"      Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/17/7450/abstract/133\">",
"      Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 2009; 104:1298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4066 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-4E1BBEB838-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7450=[""].join("\n");
var outline_f7_17_7450=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H83127808\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H531110184\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H531100387\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H531113796\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531113302\">",
"      Age and gender",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531113309\">",
"      Racial and ethnicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genetic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531109547\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531109779\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531098436\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531109876\">",
"      Nursing and other perinatal events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531108235\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531110049\">",
"      Isotretinoin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H531100138\">",
"      Nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Oral contraceptives and hormone replacement therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Appendectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186033080\">",
"      Psychosocial factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H83127808\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4066\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4066|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/17/28959\" title=\"figure 1\">",
"      Temporal trends in incidence rates of ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/35/1584\" title=\"figure 2\">",
"      Temporal trends in incidence rates of Crohns disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4066|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/52/33611\" title=\"table 1\">",
"      Montreal classification for Crohns disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/28/25035\" title=\"table 2\">",
"      Montreal classification of severity of ulcerative colitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24250?source=related_link\">",
"      Approach to adults with steroid-refractory and steroid-dependent ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=related_link\">",
"      Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44455?source=related_link\">",
"      Genetic factors in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=related_link\">",
"      Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=related_link\">",
"      Management of severe ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44152?source=related_link\">",
"      Nutrition and dietary interventions in adults with inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19305?source=related_link\">",
"      Overview of the medical management of mild to moderate Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6329?source=related_link\">",
"      Overview of the medical management of severe or refractory Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/40/24196?source=related_link\">",
"      Patient information: Crohn's disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/56/10115?source=related_link\">",
"      Patient information: Crohn's disease in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=related_link\">",
"      Patient information: Ulcerative colitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/17/42258?source=related_link\">",
"      Patient information: Ulcerative colitis in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_17_7451="Drugs causing lymphadenopathy";
var content_f7_17_7451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs that cause lymphadenopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Allopurinol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atenolol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Captopril",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cephalosporins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydralazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyrimethamine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfonamides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulindac",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data&nbsp;from Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol 1993; 20:570.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7451=[""].join("\n");
var outline_f7_17_7451=null;
var title_f7_17_7452="WHO vitamin mix";
var content_f7_17_7452=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Composition of vitamin mix",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Vitamin",
"       </td>",
"       <td class=\"subtitle1\">",
"        Amount per litre of liquid diet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Water-soluble",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thiamine (vitamin B1)",
"       </td>",
"       <td>",
"        0.7 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Riboflavin (vitamin B2)",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nicotinic acid",
"       </td>",
"       <td>",
"        10 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pyridoxine (vitamin B6)",
"       </td>",
"       <td>",
"        0.7 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyanocobalamin (vitamin B12)",
"       </td>",
"       <td>",
"        1 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Folic acid",
"       </td>",
"       <td>",
"        0.35 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ascorbic acid (vitamin C)",
"       </td>",
"       <td>",
"        100 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pantothenic acid (vitamin B5)",
"       </td>",
"       <td>",
"        3 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Biotin",
"       </td>",
"       <td>",
"        0.1 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Fat-soluble",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Retinol (vitamin A)",
"       </td>",
"       <td>",
"        1.5 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Calciferol (vitamin D)",
"       </td>",
"       <td>",
"        30 mcg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        alpha-Tocopherol (vitamin E)",
"       </td>",
"       <td>",
"        22 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vitamin K",
"       </td>",
"       <td>",
"        40 mcg",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Management of Severe Malnutrition: A Manual for Physicians and other Senior Health Workers. World Health Organization, Geneva, 1999. Copyright &copy; 1999 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7452=[""].join("\n");
var outline_f7_17_7452=null;
var title_f7_17_7453="Ultrasound assessment of suspected skeletal dysplasia";
var content_f7_17_7453=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound assessment of suspected skeletal dysplasia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Obtain the following",
"       </td>",
"       <td class=\"subtitle1\">",
"        General comment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specific comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Accurate gestational age",
"       </td>",
"       <td>",
"        LMP or early dating ultrasound",
"       </td>",
"       <td>",
"        If unable to obtain accurate dating consider BPD:FL ratios",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Measure all long bones",
"       </td>",
"       <td>",
"        Determine the pattern and degree of limb shortening",
"       </td>",
"       <td>",
"        Rhizomelia, Mesomelia, Acromelia, Micromelia (mild, severe, severe/bowed)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Measure foot length",
"       </td>",
"       <td>",
"        Calculate femur:foot length ratio",
"       </td>",
"       <td>",
"        &lt;0.9 abnormal",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Assess the shape and contour of long bones",
"       </td>",
"       <td>",
"        Bowing, angulations, fractures",
"       </td>",
"       <td>",
"        If fractures query occasional or numerous",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Determine if decreased mineralization",
"       </td>",
"       <td>",
"        Determine if diffuse or focal",
"       </td>",
"       <td>",
"        If focal specifically determine if the calvarium or spine or specific bones appear \"absent\"",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Determine if this may be a lethal condition",
"       </td>",
"       <td>",
"        Obtain axial, coronal, Sagittal images of the thorax",
"       </td>",
"       <td>",
"        Look for narrow AP diameter on sagittal Look for bell-shape thorax on coronal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain chest circumference",
"       </td>",
"       <td>",
"        Chest circumference &lt;5th percentile suspicious",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Determine if ribs appear short",
"       </td>",
"       <td>",
"        Ribs should encircle &gt;70 percent thoracic circumference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain chest: abdomen circumference ratio",
"       </td>",
"       <td>",
"        Chest: abdomen ratio &lt; 0.6 concern for lethality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain femur length:abdominal circumference ratio",
"       </td>",
"       <td>",
"        &lt;0.16 concern for lethality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Consider obtaining lung volume",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Skull",
"       </td>",
"       <td>",
"        Shape, size, mineralization",
"       </td>",
"       <td>",
"        Assess for cloverleaf deformity, macrocranium, compressibility",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Facial profile",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Look for frontal bossing, micrognathia, flat nasal bridge, cleft lip/palate",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Vertebrae/spine",
"       </td>",
"       <td>",
"        Degree and pattern of demineralization, shape, alignment",
"       </td>",
"       <td>",
"        Is there platyspondyly?",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Abnormal posturing of joints",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Query kyphoscoliosis, fixed contractures",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Hands and feet",
"       </td>",
"       <td>",
"        Postural deformitites, abnormal number of digits",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Scapulae size and shape",
"       </td>",
"       <td>",
"        Hypoplastic or dysplastic",
"       </td>",
"       <td>",
"        Think campomelic dysplasia",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Growth parameters",
"       </td>",
"       <td>",
"        Placental and well being parameters",
"       </td>",
"       <td>",
"        Is there Iintrauterine growth restriction?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LMP: last menstrual period; BPD: biparietal diameter; FL: femur length; AP: anterior-posterior.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7453=[""].join("\n");
var outline_f7_17_7453=null;
var title_f7_17_7454="Example of epinephrine infusion - adult";
var content_f7_17_7454=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F75682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F75682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example of epinephrine infusion - adult",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Example of preparation of epinephrine infusion for refractory symptoms of anaphylaxis (adult patient) for emergency/critical care units",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"3\">",
"        <p>",
"         Epinephrine 4 micrograms/mL (0.004 mg/mL)",
"        </p>",
"        <p>",
"         Add 1 mg (1000 micrograms) of epinephrine to 250 mL of 5 percent dextrose water (D5W).",
"         <br/>",
"         Resulting concentration is 4 micrograms per milliliter (mL).",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Preparation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        1.",
"        <strong>",
"         CHECK",
"        </strong>",
"        vial strength.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        2. To prepare epinephrine infusion for a final concentration of 4 micrograms per mL, dilute",
"        <strong>",
"         10 mL",
"        </strong>",
"        of",
"        <strong>",
"         0.1 mg/mL",
"        </strong>",
"        epinephrine (also labeled 1:10,000)",
"        <strong>",
"         OR",
"        </strong>",
"        1 mL of 1 mg/mL epinephrine (also labeled 1:1000) in 250 mL of D5W.*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Administration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Infuse an initial dose of 2 to 10 micrograms per minute using a programmable infusion pump and titrate as needed while continuously monitoring the patient's cardiac rhythm and blood pressure.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Adult dose",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        <p>",
"         Administration rate",
"        </p>",
"        <p>",
"         1 milligram epinephrine diluted in 250 mL D5W",
"        </p>",
"        <p>",
"         4 micrograms per milliliter",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Micrograms per minute",
"       </td>",
"       <td class=\"subtitle3\">",
"        mL per minute",
"       </td>",
"       <td class=\"subtitle3\">",
"        mL per hour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        0.25",
"       </td>",
"       <td class=\"centered\">",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         2",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         0.5",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         30",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        0.75",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         4",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         1",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         60",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        1.25",
"       </td>",
"       <td class=\"centered\">",
"        75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         6",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         1.5",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         90",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        1.75",
"       </td>",
"       <td class=\"centered\">",
"        105",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         8",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         2",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         120",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td class=\"centered\">",
"        2.25",
"       </td>",
"       <td class=\"centered\">",
"        135",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         10",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         2.5",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         150",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        11",
"       </td>",
"       <td class=\"centered\">",
"        2.75",
"       </td>",
"       <td class=\"centered\">",
"        165",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         12",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         3",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         180",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        3.25",
"       </td>",
"       <td class=\"centered\">",
"        195",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         14",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         3.5",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         210",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        15",
"       </td>",
"       <td class=\"centered\">",
"        3.75",
"       </td>",
"       <td class=\"centered\">",
"        225",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         16",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         4",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #0000ff;\">",
"         240",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        <ul>",
"         <li>",
"          To reduce the risk of making a medication error, we suggest that centers have available an institutionally approved protocol for epinephrine infusion that includes steps on how to prepare and administer the infusion and standard concentration(s)",
"         </li>",
"         <li>",
"          The above table is provided as an example; there are other acceptable concentrations",
"         </li>",
"         <li>",
"          <strong>",
"           Intravenous epinephrine, like all vasopressors,&nbsp;can cause&nbsp;life-threatening hypertension, cardiac ischemia, and ventricular arrhythmias. It should be administered ONLY by clinicians trained and experienced in dose titration of intravenous epinephrine using continuous&nbsp;non-invasive electronic monitoring of heart rate and blood pressure.",
"          </strong>",
"         </li>",
"         <li>",
"          Epinephrine is an ischemia causing agent and peripheral venous irritant. Monitor infusion site for extravasation. See Lexicomp drug reference for information on managing extravasation including infiltration of phentolamine. Central line administration is preferred when available.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Unused diluted solutions should be discarded within 24 hours or less of preparation depending on local standards.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      To calculate the adult dose based on body weight, initial dose range is 0.03 micrograms/kg of body weight per minute to up to 0.14 mircrograms/kg of body weight per minute.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References: Gahart BL, Nazareno AR; Intravenous Medications 28th ed. Elsevier-Mosby &copy; 2012 St. Louis, MO; Lieberman P, et al. J Allergy Clin Immunol 2010; 126(3):477.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7454=[""].join("\n");
var outline_f7_17_7454=null;
var title_f7_17_7455="Meningitis treatment based on susceptibility";
var content_f7_17_7455=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81209%7EID%2F60707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81209%7EID%2F60707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for specific antimicrobial therapy of bacterial meningitis based on isolated pathogen and susceptibility testing*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Microorganism, susceptibility",
"       </td>",
"       <td class=\"subtitle1\">",
"        Standard therapy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Alternative therapies",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        <em>",
"         Streptococcus pneumoniae",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"4\">",
"        Penicillin MIC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;0.06 mcg/mL",
"       </td>",
"       <td class=\"sublist_other\">",
"        Penicillin G or ampicillin",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , chloramphenicol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"3\">",
"        &ge;0.12 mcg/mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"        MIC &lt;1.0 mcg/mL",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Cefepime, meropenem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"        MIC &ge;1.0 mcg/mL",
"       </td>",
"       <td class=\"sublist_other\">",
"        Vancomycin plus a third-generation cephalosporin",
"        <sup>",
"         &Delta;&sect;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Fluoroquinolone",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        <em>",
"         Neisseria meningitidis",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"4\">",
"        Penicillin MIC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &lt;0.1 mcg/mL",
"       </td>",
"       <td class=\"sublist_other\">",
"        Penicillin G or ampicillin",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , chloramphenicol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        0.1-1.0 mcg/mL",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Chloramphenicol, fluoroquinolone, meropenem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Listeria monocytogenes",
"        </em>",
"       </td>",
"       <td>",
"        Ampicillin",
"        <sup>",
"         ",
"        </sup>",
"        or penicillin G",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        Trimethoprim-sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Streptococcus agalactiae",
"        </em>",
"       </td>",
"       <td>",
"        Ampicillin",
"        <sup>",
"         ",
"        </sup>",
"        or penicillin G",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Escherichia coli",
"        </em>",
"        and other Enterobacteriaceae",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Aztreonam, fluoroquinolone, meropenem, trimethoprim-sulfamethoxazole, ampicillin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Pseudomonas aeruginosa",
"        </em>",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        Cefepime",
"        <sup>",
"         ",
"        </sup>",
"        or ceftazidime",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        Aztreonam",
"        <sup>",
"         ",
"        </sup>",
"        , ciprofloxacin",
"        <sup>",
"         ",
"        </sup>",
"        , meropenem",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        <em>",
"         Haemophilus influenzae",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Beta-lactamase negative",
"       </td>",
"       <td class=\"sublist_other\">",
"        Ampicillin",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , cefepime, chloramphenicol, fluoroquinolone, aztreonam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Beta-lactamase positive",
"       </td>",
"       <td class=\"sublist_other\">",
"        Third-generation cephalosporin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Cefepime, chloramphenicol, fluoroquinolone, aztreonam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        <em>",
"         Staphylococcus aureus",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Methicillin susceptible",
"       </td>",
"       <td class=\"sublist_other\">",
"        Nafcillin or oxacillin",
"       </td>",
"       <td class=\"sublist_other\">",
"        Vancomycin, meropenem, linezolid, daptomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Methicillin resistant",
"       </td>",
"       <td class=\"sublist_other\">",
"        Vancomycin**",
"       </td>",
"       <td class=\"sublist_other\">",
"        Trimethoprim-sulfamethoxazole, linezolid, daptomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Staphylococcus epidermidis",
"        </em>",
"       </td>",
"       <td>",
"        Vancomycin**",
"       </td>",
"       <td>",
"        Linezolid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\">",
"        <em>",
"         Enterococcus",
"        </em>",
"        species",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ampicillin susceptible",
"       </td>",
"       <td class=\"sublist_other\">",
"        Ampicillin plus gentamicin",
"       </td>",
"       <td class=\"sublist_other\">",
"        ...",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ampicillin resistant",
"       </td>",
"       <td class=\"sublist_other\">",
"        Vancomycin plus gentamicin",
"       </td>",
"       <td class=\"sublist_other\">",
"        ...",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ampicillin and vancomycin resistant",
"       </td>",
"       <td class=\"sublist_other\">",
"        Linezolid",
"       </td>",
"       <td class=\"sublist_other\">",
"        ...",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    MIC: Minimum inhibitory concentration",
"    <div class=\"footnotes\">",
"     * For recommended dosages, see the table on the recommended intravenous dosages of antimicrobial therapy for adults with bacterial meningitis.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      There may not be clinical data to support all recommendations for alternative antibiotics in patients with bacterial meningitis, but specific agents are recommended based on cerebrospinal fluid (CSF) penetration in experimental animal models and in vitro activity against the offending organism.",
"      <br>",
"       &Delta; Ceftriaxone or cefotaxime.",
"       <br>",
"        &loz;&nbsp;Consider addition of rifampin if the MIC of ceftriaxone is &gt;4 mcg/mL.",
"        <br>",
"         &sect;&nbsp;Moxifloxacin is recommended given its excellent CSF penetration and in vitro activity against",
"         <em>",
"          Streptococcus pneumoniae",
"         </em>",
"         , although there are no clinical data available. If used, many authorities would combine moxifloxacin with vancomycin or a third-generation cephalosporin (cefotaxime or ceftriaxone).",
"         <br>",
"          &yen;&nbsp;Addition of an aminoglycoside should be considered.",
"          <br>",
"           &Dagger;&nbsp;Choice of a specific antimicrobial regimen must be guided by in vitro susceptibility test results.",
"           <br>",
"            &dagger;&nbsp;Consider addition of rifampin.",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267. Copyright &copy; 2004 University of Chicago Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.journals.uchicago.edu/\">",
"      file://www.journals.uchicago.edu/",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended intravenous dosages of antimicrobial therapy for adults with bacterial meningitis who have normal renal and hepatic function",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antimicrobial agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose (adult)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amikacin",
"       </td>",
"       <td>",
"        5 mg/kg every 8 hours*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ampicillin",
"       </td>",
"       <td>",
"        2 g every 4 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aztreonam",
"       </td>",
"       <td>",
"        2&nbsp;g every 6 to 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cefepime",
"       </td>",
"       <td>",
"        2 g every 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cefotaxime",
"       </td>",
"       <td>",
"        2&nbsp;g every 4 to 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ceftazidime",
"       </td>",
"       <td>",
"        2 g every 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ceftriaxone",
"       </td>",
"       <td>",
"        2 g every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chloramphenicol",
"       </td>",
"       <td>",
"        1 to 1.5 g every 6 hours",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciprofloxacin",
"       </td>",
"       <td>",
"        400 mg every 8 to 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gentamicin",
"       </td>",
"       <td>",
"        1.7&nbsp;mg/kg every 8 hours*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meropenem",
"       </td>",
"       <td>",
"        2&nbsp;g every 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moxifloxacin",
"       </td>",
"       <td>",
"        400 mg every 24&nbsp;hours",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nafcillin",
"       </td>",
"       <td>",
"        1.5 to 2&nbsp;g every 4 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxacillin",
"       </td>",
"       <td>",
"        1.5 to 2 g every 4 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin G potassium",
"       </td>",
"       <td>",
"        4 million units every 4 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifampin",
"       </td>",
"       <td>",
"        600 mg every 24 hours",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tobramycin",
"       </td>",
"       <td>",
"        1.7&nbsp;mg/kg every 8 hours*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim-sulfamethoxazole (cotrimoxazole)",
"       </td>",
"       <td>",
"        5 mg/kg every 6 to 12 hours",
"        <sup>",
"         &sect;&yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin",
"       </td>",
"       <td>",
"        15 to 20 mg/kg every 8&nbsp;to 12 hours",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    MRSA: methicillin-resistant",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    <div class=\"footnotes\">",
"     * Dose based on ideal body weight or dosing weight, except in underweight patients. A calculator for ideal body weight and dosing weight is available in UpToDate.&nbsp;Dosage and interval must be individualized to produce a peak serum concentration of 7-9 mg/L and trough &lt;1-2 mg/L for gentamicin or tobramycin and a peak of 25-40 mg/L and trough &lt;4-8 mg/L for amikacin. For additional information, see the topic review on aminoglycosides.",
"     <br>",
"      &bull;&nbsp;The higher dose is recommended for patients with pneumococcal meningitis.",
"      <br>",
"       &Delta;&nbsp;No data on optimal dosage needed in patients with bacterial meningitis.",
"       <br>",
"        &loz;&nbsp;For the treatment of MRSA meningitis, the Infectious Diseases Society of America (IDSA)&nbsp;suggests a rifampin dose of 600 mg orally once daily or 300 to 450 mg twice daily.",
"        <sup>",
"         [1]",
"        </sup>",
"        <br>",
"         &sect;&nbsp;Dosage is based on the trimethoprim component.",
"         <br>",
"          &yen;&nbsp;For the treatment of MRSA meningitis, the IDSA suggests a trimethoprim-sulfamethoxazole dose of 5 mg/kg (based on the trimethoprim component) IV twice or three times daily.",
"          <sup>",
"           [1]",
"           <br/>",
"          </sup>",
"          &Dagger;&nbsp;The vancomycin dose should not exceed 2 g per dose or a total daily dose of 60 mg/kg.&nbsp;Adjust dose to achieve vancomycin serum trough concentrations of 15 to 20 mcg/mL.",
"          <sup>",
"           [1]",
"          </sup>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267. Copyright &copy; 2004 University of Chicago Press.",
"     <br>",
"      <em>",
"       Additional data from:",
"       <br/>",
"      </em>",
"      [1] Liu C, Bayer A, Cosgrove SE, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary. Clin Infect Dis 2011; 52:285.",
"     </br>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.journals.uchicago.edu/\">",
"      file://www.journals.uchicago.edu/",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_17_7455=[""].join("\n");
var outline_f7_17_7455=null;
